Current Awareness
Identifieur interne : 000F24 ( Istex/Corpus ); précédent : 000F23; suivant : 000F25Current Awareness
Auteurs :Source :
- Pharmacoepidemiology and Drug Safety [ 1053-8569 ] ; 2002-06.
English descriptors
- Teeft :
- Acad, Adverse events, Allergy, Anaesth, Anesthesiol, Anesthesiology, Antenatal, Antipsychotic, Arch intern, Assoc, Best pract, Biol, Brit, Brit columbia, Cardiol, Cardiovascular, Cardiovascular events, Case report, Case reports, Chan, Clin, Clin obstet gynecol, Clin pharm, Clin pharmacol, Clin psychopharmacol, Clozapine, Coll, Copyright, Corticosteroid, Curr, Current awareness, Dept, Dept anesthesiol, Dept clin pharmacol, Dept dermatol, Dept neurol, Dept ophthalmol, Dept pediat, Dept psychiat, Dermatol, Drug safety, Epidemiol, Epilepsy, Evaluat, Gastroenterol, Gastroenterol clin, Gastroenterol clin biol, Geriatr, Gynecol, Hamburg, Hlth, Hosp, Hypersensitivity, Immunol, Inhaled, Inhibitor, Inst, Jama, John wiley sons, Klin, Lancet, Neurol, Neurology, Nonsteroidal, Nonsteroidal drugs, Nottingham, Obstet, Obstet gynecol, Oncol, Ophthalmol, Oral contraceptives, Pathol, Pediat, Pediatr, Pharm, Pharmaceut, Pharmacoepidemiology, Pharmacokinetics, Pharmacol, Pharmacother, Psychiat, Psychiatr, Psychiatry, Psychopharmacol, Randomized, Reprod, Rheumatol, Serotonin, Serotonin syndrome, Serv, Side effects, Steroid, Suppl, Surg, Syndrome, Toxicity, Toxicol, Univ, Vaccine, Vancouver.
Abstract
In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 19 sections: 1 Books, Reviews & Symposia; 2 General; 3 Anti‐infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non‐steroidal Anti‐inflammatory Agents; 7 CNS Agents; 8 Anti‐neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator‐Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti‐inflammatory Agents ‐ Steroidal; 19 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.
Url:
DOI: 10.1002/pds.660
Links to Exploration step
ISTEX:FE49A01C08E6D3C543D17E6F9A4EA88920C928E8Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Current Awareness</title></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:FE49A01C08E6D3C543D17E6F9A4EA88920C928E8</idno><date when="2002" year="2002">2002</date><idno type="doi">10.1002/pds.660</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-87JH6LG4-8/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000F24</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000F24</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Current Awareness</title></analytic><monogr></monogr><series><title level="j" type="main">Pharmacoepidemiology and Drug Safety</title><title level="j" type="alt">PHARMACOEPIDEMIOLOGY AND DRUG SAFETY</title><idno type="ISSN">1053-8569</idno><idno type="eISSN">1099-1557</idno><imprint><biblScope unit="vol">11</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="345">345</biblScope><biblScope unit="page" to="360">360</biblScope><biblScope unit="page-count">16</biblScope><publisher>John Wiley & Sons, Ltd.</publisher><pubPlace>Chichester, UK</pubPlace><date type="published" when="2002-06">2002-06</date></imprint><idno type="ISSN">1053-8569</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1053-8569</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acad</term><term>Adverse events</term><term>Allergy</term><term>Anaesth</term><term>Anesthesiol</term><term>Anesthesiology</term><term>Antenatal</term><term>Antipsychotic</term><term>Arch intern</term><term>Assoc</term><term>Best pract</term><term>Biol</term><term>Brit</term><term>Brit columbia</term><term>Cardiol</term><term>Cardiovascular</term><term>Cardiovascular events</term><term>Case report</term><term>Case reports</term><term>Chan</term><term>Clin</term><term>Clin obstet gynecol</term><term>Clin pharm</term><term>Clin pharmacol</term><term>Clin psychopharmacol</term><term>Clozapine</term><term>Coll</term><term>Copyright</term><term>Corticosteroid</term><term>Curr</term><term>Current awareness</term><term>Dept</term><term>Dept anesthesiol</term><term>Dept clin pharmacol</term><term>Dept dermatol</term><term>Dept neurol</term><term>Dept ophthalmol</term><term>Dept pediat</term><term>Dept psychiat</term><term>Dermatol</term><term>Drug safety</term><term>Epidemiol</term><term>Epilepsy</term><term>Evaluat</term><term>Gastroenterol</term><term>Gastroenterol clin</term><term>Gastroenterol clin biol</term><term>Geriatr</term><term>Gynecol</term><term>Hamburg</term><term>Hlth</term><term>Hosp</term><term>Hypersensitivity</term><term>Immunol</term><term>Inhaled</term><term>Inhibitor</term><term>Inst</term><term>Jama</term><term>John wiley sons</term><term>Klin</term><term>Lancet</term><term>Neurol</term><term>Neurology</term><term>Nonsteroidal</term><term>Nonsteroidal drugs</term><term>Nottingham</term><term>Obstet</term><term>Obstet gynecol</term><term>Oncol</term><term>Ophthalmol</term><term>Oral contraceptives</term><term>Pathol</term><term>Pediat</term><term>Pediatr</term><term>Pharm</term><term>Pharmaceut</term><term>Pharmacoepidemiology</term><term>Pharmacokinetics</term><term>Pharmacol</term><term>Pharmacother</term><term>Psychiat</term><term>Psychiatr</term><term>Psychiatry</term><term>Psychopharmacol</term><term>Randomized</term><term>Reprod</term><term>Rheumatol</term><term>Serotonin</term><term>Serotonin syndrome</term><term>Serv</term><term>Side effects</term><term>Steroid</term><term>Suppl</term><term>Surg</term><term>Syndrome</term><term>Toxicity</term><term>Toxicol</term><term>Univ</term><term>Vaccine</term><term>Vancouver</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 19 sections: 1 Books, Reviews & Symposia; 2 General; 3 Anti‐infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non‐steroidal Anti‐inflammatory Agents; 7 CNS Agents; 8 Anti‐neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator‐Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti‐inflammatory Agents ‐ Steroidal; 19 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.</div></front></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>univ</json:string><json:string>clin</json:string><json:string>hosp</json:string><json:string>dermatol</json:string><json:string>pharmacol</json:string><json:string>hlth</json:string><json:string>case report</json:string><json:string>inst</json:string><json:string>pharmacoepidemiology</json:string><json:string>serv</json:string><json:string>psychiat</json:string><json:string>drug safety</json:string><json:string>pharm</json:string><json:string>gastroenterol</json:string><json:string>obstet</json:string><json:string>surg</json:string><json:string>pharmacother</json:string><json:string>gynecol</json:string><json:string>clin pharmacol</json:string><json:string>dept</json:string><json:string>biol</json:string><json:string>jama</json:string><json:string>dept psychiat</json:string><json:string>oncol</json:string><json:string>neurol</json:string><json:string>john wiley sons</json:string><json:string>copyright</json:string><json:string>coll</json:string><json:string>toxicity</json:string><json:string>psychopharmacol</json:string><json:string>dept dermatol</json:string><json:string>assoc</json:string><json:string>clin psychopharmacol</json:string><json:string>immunol</json:string><json:string>allergy</json:string><json:string>toxicol</json:string><json:string>randomized</json:string><json:string>suppl</json:string><json:string>antipsychotic</json:string><json:string>clin pharm</json:string><json:string>cardiovascular events</json:string><json:string>cardiol</json:string><json:string>ophthalmol</json:string><json:string>acad</json:string><json:string>hamburg</json:string><json:string>current awareness</json:string><json:string>pediat</json:string><json:string>vaccine</json:string><json:string>pediatr</json:string><json:string>rheumatol</json:string><json:string>epidemiol</json:string><json:string>epilepsy</json:string><json:string>arch intern</json:string><json:string>clozapine</json:string><json:string>nonsteroidal</json:string><json:string>evaluat</json:string><json:string>vancouver</json:string><json:string>pathol</json:string><json:string>side effects</json:string><json:string>cardiovascular</json:string><json:string>pharmacokinetics</json:string><json:string>anesthesiology</json:string><json:string>lancet</json:string><json:string>case reports</json:string><json:string>reprod</json:string><json:string>klin</json:string><json:string>brit columbia</json:string><json:string>geriatr</json:string><json:string>brit</json:string><json:string>dept neurol</json:string><json:string>corticosteroid</json:string><json:string>anaesth</json:string><json:string>inhaled</json:string><json:string>pharmaceut</json:string><json:string>chan</json:string><json:string>anesthesiol</json:string><json:string>neurology</json:string><json:string>curr</json:string><json:string>serotonin</json:string><json:string>antenatal</json:string><json:string>psychiatr</json:string><json:string>nottingham</json:string><json:string>hypersensitivity</json:string><json:string>inhibitor</json:string><json:string>syndrome</json:string><json:string>oral contraceptives</json:string><json:string>dept ophthalmol</json:string><json:string>serotonin syndrome</json:string><json:string>nonsteroidal drugs</json:string><json:string>obstet gynecol</json:string><json:string>gastroenterol clin biol</json:string><json:string>steroid</json:string><json:string>dept clin pharmacol</json:string><json:string>adverse events</json:string><json:string>gastroenterol clin</json:string><json:string>best pract</json:string><json:string>dept anesthesiol</json:string><json:string>clin obstet gynecol</json:string><json:string>dept pediat</json:string><json:string>psychiatry</json:string><json:string>antenatal steroids</json:string><json:string>tufts univ</json:string><json:string>helicobacter pylori</json:string><json:string>hormone replacement therapy</json:string><json:string>coll pharm</json:string><json:string>intensive care</json:string><json:string>interna serv</json:string><json:string>publ hlth</json:string><json:string>prog neuropsychopharmacol biol psychiatry</json:string><json:string>harvard univ</json:string><json:string>dept cardiol</json:string><json:string>hong kong</json:string><json:string>dermatol venereol</json:string><json:string>acad dermatol</json:string><json:string>univ hamburg</json:string><json:string>univ hosp</json:string><json:string>univ british columbia</json:string><json:string>weekly courses</json:string><json:string>univ texas</json:string><json:string>safety profile</json:string><json:string>drug monit</json:string><json:string>arthritis rheum</json:string><json:string>rheumatoid arthritis</json:string><json:string>clin psychiatry</json:string><json:string>asthma</json:string><json:string>rockville</json:string><json:string>intern</json:string><json:string>contraceptive</json:string><json:string>comparative efficacy</json:string><json:string>intraarterial thrombolysis</json:string><json:string>perioperative stroke</json:string><json:string>cardiac operation</json:string><json:string>thorac surg</json:string><json:string>sildenafil citrate</json:string><json:string>myocardial infarction</json:string><json:string>serv hepatogastroenterol</json:string><json:string>combination vaccines</json:string><json:string>dept pharmacol</json:string><json:string>rockville pike</json:string><json:string>hosp eppendorf</json:string><json:string>univ alabama</json:string><json:string>dept surg</json:string><json:string>antimicrob chemother</json:string><json:string>wales hosp</json:string><json:string>stanford univ</json:string><json:string>adverse drug reactions</json:string><json:string>dept urol</json:string><json:string>johns hopkins univ</json:string><json:string>fatal case</json:string><json:string>clin rheumatol</json:string><json:string>systematic review</json:string><json:string>drug evaluat</json:string><json:string>acute hepatitis</json:string><json:string>acad child adolesc psychiatry</json:string><json:string>risk factors</json:string><json:string>atypical antipsychotics</json:string><json:string>antiretroviral therapy</json:string><json:string>univ penn</json:string><json:string>univ amsterdam</json:string><json:string>univ vienna</json:string><json:string>antipsychotic drugs</json:string><json:string>intracranial hemorrhages</json:string><json:string>systemic effects</json:string><json:string>dept emergency</json:string><json:string>inhaled steroids</json:string><json:string>dept obstet gynecol</json:string><json:string>reprod toxicol</json:string><json:string>sect</json:string><json:string>ontario</json:string><json:string>netherlands</json:string></teeft></keywords><articleId><json:string>PDS660</json:string></articleId><arkIstex>ark:/67375/WNG-87JH6LG4-8</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>bibliography</json:string></originalGenre><abstract>In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 19 sections: 1 Books, Reviews & Symposia; 2 General; 3 Anti‐infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non‐steroidal Anti‐inflammatory Agents; 7 CNS Agents; 8 Anti‐neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator‐Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti‐inflammatory Agents ‐ Steroidal; 19 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.</abstract><qualityIndicators><score>8.788</score><pdfWordCount>16777</pdfWordCount><pdfCharCount>104349</pdfCharCount><pdfVersion>1.3</pdfVersion><pdfPageCount>16</pdfPageCount><pdfPageSize>595 x 842 pts (A4)</pdfPageSize><pdfWordsPerPage>1049</pdfWordsPerPage><pdfText>true</pdfText><refBibsNative>true</refBibsNative><abstractWordCount>149</abstractWordCount><abstractCharCount>1052</abstractCharCount><keywordCount>0</keywordCount></qualityIndicators><title>Current Awareness</title><genre><json:string>other</json:string></genre><host><title>Pharmacoepidemiology and Drug Safety</title><language><json:string>unknown</json:string></language><doi><json:string>10.1002/(ISSN)1099-1557</json:string></doi><issn><json:string>1053-8569</json:string></issn><eissn><json:string>1099-1557</json:string></eissn><publisherId><json:string>PDS</json:string></publisherId><volume>11</volume><issue>4</issue><pages><first>345</first><last>360</last><total>16</total></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Current Awareness</value></json:item><json:item><value>Current Awareness</value></json:item></subject></host><namedEntities><unitex><date><json:string>1-1-1</json:string><json:string>from 1991 through 1998</json:string><json:string>2287</json:string><json:string>2002</json:string><json:string>3-1-1</json:string></date><geogName><json:string>Creek Pkwy</json:string></geogName><orgName><json:string>Merck US Human Hlth, Med</json:string><json:string>Pharmacia Corp</json:string><json:string>State Israel Minist Hlth Geriatrr Ctr, Netanya, Israel</json:string><json:string>Boehringer Ingelheim Pharmaceut Inc</json:string><json:string>US/FDA, Div Therapeut Prod, Clin Proteomics Program, Ctr Biol Evaluat</json:string><json:string>US Milit Acad, Dermatol Serv, West Point, NY</json:string><json:string>Beth Israel Deaconess Med Ctr, Div Gen Med</json:string><json:string>US/ FDA, Dept Health</json:string><json:string>Novartis Ophthalm Inc</json:string><json:string>Lebanon, NH</json:string><json:string>Organization of Teratology Information Services Public Affairs Committee</json:string><json:string>Denver, Co</json:string><json:string>Sepracor Inc</json:string><json:string>Sons, Ltd.</json:string><json:string>Co Inc</json:string><json:string>Clin Ctr Serbia, Inst Cardiovasc Dis</json:string><json:string>Mount Gould Hospital, Stroke Unit, Plymouth P</json:string><json:string>Pfizer Inc</json:string><json:string>US/FDA, Off Biostat</json:string><json:string>West Congress Pkwy</json:string><json:string>Mexico City, DF, Mexico</json:string><json:string>Technion-Israel Inst Technol, Rappaport Fac Med, Haemek Med Ctr, Infect Dis Unit, Rehovot, Israel</json:string><json:string>Natl Taiwan Univ, Coll Med, Dept Psychiat</json:string><json:string>Netherlands Pharmacovigilance Fdn Lareb, Goudsbloemvallei</json:string><json:string>Beth Israel Deaconess Med Ctr</json:string><json:string>Hospital Information System</json:string><json:string>Technion-Israel Inst Technol, Dept Internal Med</json:string><json:string>Univ New Mexico, Dept Internal Med, Hlth Sci Ctr, Div Infect Dis, Albuquerque, NM</json:string><json:string>US/FDA, Ctr Drug Evaluat</json:string><json:string>US/FDA, Rockville, Md Alvarado RG, Liu JY, Zwolak RM</json:string><json:string>World Health Organization</json:string></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName><json:string>La Boy-Goral</json:string><json:string>Div Infect</json:string><json:string>Gen Lanzarote</json:string><json:string>Duncan Bldg</json:string><json:string>Yunus M. Ctr</json:string><json:string>S. City</json:string><json:string>M. Med</json:string><json:string>Carl Gustav</json:string><json:string>C. Tech</json:string><json:string>D. AstraZeneca</json:string><json:string>Philadelphia Pa</json:string><json:string>Div Oncol</json:string><json:string>F. Royal</json:string><json:string>Teratogenic</json:string><json:string>Van de Laar</json:string><json:string>Van Weert</json:string><json:string>Van Reesema</json:string><json:string>Rose St</json:string><json:string>Milton Rd</json:string><json:string>M. Univ</json:string><json:string>E. Max-Planck-Inst</json:string><json:string>H. Prince</json:string><json:string>Univ Texas</json:string><json:string>D. Address</json:string><json:string>Systematic</json:string><json:string>Duke Univ</json:string><json:string>Gustave L Levy</json:string><json:string>T. Address</json:string><json:string>Al Hoqail</json:string><json:string>Spontaneous</json:string><json:string>M. Rheumatism</json:string><json:string>Rey J. Hosp</json:string><json:string>Div Paediat</json:string><json:string>C. Vet</json:string><json:string>Div Nephrol</json:string><json:string>T. Hirosaki</json:string><json:string>Ann Rheum</json:string><json:string>Ave Gen</json:string><json:string>S. Douglas</json:string><json:string>Mansoura Univ</json:string><json:string>Fred Hutchinson</json:string><json:string>Miranda Ave</json:string><json:string>Sung Kyun</json:string><json:string>Adelaide Rd</json:string><json:string>F. Inst</json:string><json:string>Div Med</json:string><json:string>Vasco de Quiroga</json:string><json:string>K. Karolinska</json:string><json:string>Monroe Community</json:string><json:string>Van Bocxlaer</json:string><json:string>Ann Oncol</json:string><json:string>K. Mannikontie</json:string><json:string>D. State</json:string><json:string>John Wiley</json:string><json:string>El Gomhoria</json:string><json:string>G. Yahya</json:string><json:string>Al Khoud</json:string><json:string>Luther King</json:string><json:string>U. Dresden</json:string><json:string>Van de Putte</json:string><json:string>Sullivan Res</json:string><json:string>B. Univ</json:string><json:string>Henrietta Rd</json:string><json:string>CHU Vaudois</json:string><json:string>S. Univ</json:string><json:string>La Fe</json:string><json:string>Ann Thorac</json:string><json:string>Gustav Carus</json:string><json:string>Div Pulm</json:string><json:string>Nat Cancer</json:string><json:string>D. Univ</json:string><json:string>Ave Nth</json:string><json:string>Ari Yapi</json:string><json:string>M. Natl</json:string><json:string>Div Cardiol</json:string><json:string>Y. Kyushu</json:string><json:string>Son Dureta</json:string><json:string>J. Address</json:string><json:string>Ave Sth</json:string><json:string>R. Address</json:string><json:string>Gaston Ave</json:string><json:string>O. Hop</json:string><json:string>M. McGill</json:string><json:string>Washington Univ</json:string><json:string>W. Univ</json:string><json:string>Mario Negri</json:string><json:string>F. European</json:string><json:string>Erasmus Univ</json:string><json:string>S. Hansakatu</json:string><json:string>D. Children</json:string><json:string>Jost V. Takeda</json:string><json:string>Div Hematol</json:string><json:string>S. Lab</json:string><json:string>Carson St</json:string><json:string>H. Univ</json:string><json:string>Landry S. Univ</json:string><json:string>Sigmund Freud</json:string><json:string>Brain Inst</json:string><json:string>Floyd St</json:string><json:string>M. Bezirkskrankenhaus</json:string><json:string>G. Mario</json:string><json:string>Opin</json:string><json:string>M. RxIntelligence</json:string><json:string>A. City</json:string><json:string>Div Dermatol</json:string><json:string>Robert Debre</json:string><json:string>M. Address</json:string><json:string>N. Doseme</json:string><json:string>Catherine Rd</json:string><json:string>E. Ben Gurion</json:string><json:string>S. Hirosaki</json:string><json:string>J. Univ</json:string><json:string>Edouard Herriot</json:string><json:string>Calhoun St</json:string><json:string>Address</json:string><json:string>Washington St</json:string><json:string>Van Denderen</json:string><json:string>Irving Pl</json:string><json:string>L. Douglas</json:string><json:string>Wallace Blvd</json:string><json:string>Div Pediat</json:string><json:string>Asthma</json:string><json:string>Van Puijenbroek</json:string><json:string>A. Dartmouth</json:string><json:string>J. Amadeo</json:string><json:string>Ann Intern</json:string><json:string>Div St</json:string><json:string>E. Minist</json:string><json:string>Sinai Med</json:string><json:string>Li M. Prince</json:string><json:string>B. Karl</json:string><json:string>Searle Pkwy</json:string><json:string>Ann Arbor</json:string><json:string>Virginia Commonwealth</json:string><json:string>Danish Epilepsy</json:string><json:string>C. Novartis</json:string><json:string>P. Address</json:string><json:string>Div Gastroenterol</json:string><json:string>Madison Ave</json:string><json:string>T. Akita</json:string><json:string>N. Univ</json:string><json:string>Cristina Univ</json:string><json:string>La Paz</json:string><json:string>Henri Mondor</json:string><json:string>Div Allergy</json:string><json:string>Van Gehuchten</json:string><json:string>B. Ctr</json:string><json:string>Clarke S. Royal</json:string><json:string>Van Meter</json:string><json:string>H. Kamitsugasogo</json:string><json:string>Maria de Molina</json:string><json:string>Morena A. Hosp</json:string><json:string>Faith Sitesi</json:string><json:string>F. Hosp</json:string><json:string>Pacific St</json:string><json:string>Gen Univ</json:string><json:string>Mai Univ</json:string><json:string>V. Inst</json:string><json:string>M. Temple</json:string><json:string>P. Univ</json:string><json:string>Griffin Hosp</json:string><json:string>Serres G. Univ</json:string><json:string>Van Oers</json:string><json:string>B. Maison</json:string><json:string>Dr</json:string><json:string>Robert Koch</json:string><json:string>Roman St</json:string><json:string>H. Hosp</json:string><json:string>Gen Psychiatry</json:string><json:string>A. Univ</json:string><json:string>K. Sultan</json:string><json:string>Baptist Med</json:string><json:string>S. Address</json:string><json:string>Davies W. Address</json:string><json:string>Div Gynecol</json:string><json:string>M. Cent</json:string><json:string>Rey C. Cardiol</json:string><json:string>G. Allgemeinen</json:string><json:string>Shan Sth</json:string><json:string>Joseph M. Address</json:string><json:string>St</json:string><json:string>J. Hosp</json:string><json:string>Div Clin</json:string><json:string>Harrison Suite</json:string><json:string>C. Univ</json:string><json:string>La Roche</json:string><json:string>Virginia Hlth</json:string><json:string>Case</json:string><json:string>E. Consorci</json:string><json:string>Ann Dermatol</json:string><json:string>T. Univ</json:string><json:string>Albert Schweitzer</json:string><json:string>P. Chulalongkorn</json:string><json:string>Ave Paris</json:string><json:string>Div Neonatol</json:string><json:string>CHU Ctr</json:string><json:string>Lausanne Hosp</json:string><json:string>Glen Oaks</json:string><json:string>Anderson Canc</json:string><json:string>L. Hosp</json:string><json:string>F. Address</json:string><json:string>E. Univ</json:string><json:string>O. Karolinksa</json:string><json:string>K. Brown</json:string><json:string>F. Hop</json:string><json:string>S. Boston</json:string><json:string>V. Univ</json:string><json:string>Div Pneumol</json:string><json:string>Salvador Zubiran</json:string><json:string>Harrison Ave</json:string><json:string>Wales Private</json:string><json:string>Levy R. Hop</json:string><json:string>K. Creighton</json:string><json:string>G. Univ</json:string><json:string>London Hosp</json:string><json:string>Div Special</json:string><json:string>Sinai Hosp</json:string><json:string>La Grenade</json:string><json:string>S. McLean</json:string><json:string>Div Maternal</json:string><json:string>Costa J. Harbor</json:string><json:string>Carolina Univ</json:string><json:string>Div Dept</json:string><json:string>Ann Emerg</json:string><json:string>Van Harten</json:string><json:string>SUNY Buffalo</json:string><json:string>Ave Denfert</json:string><json:string>S. Allergy</json:string><json:string>G. Dresden</json:string><json:string>Louisiana Monroe</json:string><json:string>Laurent B. Ctr</json:string><json:string>Roma La Sapienza</json:string><json:string>Olivier B. Leyenburg</json:string><json:string>F. Sonderkrankenanstalt</json:string><json:string>Alberta</json:string><json:string>Thomas Jefferson</json:string><json:string>Van Peteghem</json:string></persName><placeName><json:string>Naples</json:string><json:string>Iowa City</json:string><json:string>Bedford</json:string><json:string>Minneapolis</json:string><json:string>Groningen</json:string><json:string>Porto Alegre</json:string><json:string>Durham</json:string><json:string>Verdun</json:string><json:string>Leiden</json:string><json:string>Lund</json:string><json:string>Jamestown</json:string><json:string>Linz</json:string><json:string>Utrecht</json:string><json:string>Cagliari</json:string><json:string>Fukuoka</json:string><json:string>Calgary</json:string><json:string>Buffalo</json:string><json:string>Berlin</json:string><json:string>Tel Aviv</json:string><json:string>Uppsala</json:string><json:string>Kyoto</json:string><json:string>Brisbane</json:string><json:string>Ankara</json:string><json:string>Birmingham</json:string><json:string>San Diego</json:string><json:string>Paris</json:string><json:string>Rochester</json:string><json:string>Bristol</json:string><json:string>Venezuela</json:string><json:string>Southampton</json:string><json:string>Miami</json:string><json:string>Sofia</json:string><json:string>Switzerland</json:string><json:string>Marburg</json:string><json:string>Columbia</json:string><json:string>Alicante</json:string><json:string>Yugoslavia</json:string><json:string>Greece</json:string><json:string>Adana</json:string><json:string>Thailand</json:string><json:string>Munich</json:string><json:string>St Justine</json:string><json:string>Ghent</json:string><json:string>Udine</json:string><json:string>Antwerp</json:string><json:string>St James</json:string><json:string>Finland</json:string><json:string>NY</json:string><json:string>Jena</json:string><json:string>Australia</json:string><json:string>Hartford</json:string><json:string>Bangladesh</json:string><json:string>SY</json:string><json:string>Jamaica</json:string><json:string>Chile</json:string><json:string>Eisenach</json:string><json:string>Charleston</json:string><json:string>Korea</json:string><json:string>Jacksonville</json:string><json:string>Grenoble</json:string><json:string>Seoul</json:string><json:string>Brazil</json:string><json:string>Valencia</json:string><json:string>St Lucia</json:string><json:string>UK</json:string><json:string>Santos</json:string><json:string>Bangkok</json:string><json:string>Austria</json:string><json:string>Grunwald</json:string><json:string>Pisa</json:string><json:string>Badajoz</json:string><json:string>Girona</json:string><json:string>Toxicity</json:string><json:string>Turin</json:string><json:string>NV</json:string><json:string>Turkey</json:string><json:string>Oklahoma City</json:string><json:string>Dunedin</json:string><json:string>Richmond</json:string><json:string>Mannheim</json:string><json:string>Nashville</json:string><json:string>Eppendorf</json:string><json:string>Wilmington</json:string><json:string>Taiwan</json:string><json:string>Salford</json:string><json:string>Edinburgh</json:string><json:string>Canada</json:string><json:string>Genoa</json:string><json:string>St Francis</json:string><json:string>Kuri City</json:string><json:string>Chandigarh</json:string><json:string>Belgrade</json:string><json:string>Seville</json:string><json:string>Houston</json:string><json:string>Nephrotoxicity</json:string><json:string>Hamburg</json:string><json:string>St Lukes</json:string><json:string>NC</json:string><json:string>Palo Alto</json:string><json:string>Parma</json:string><json:string>Lombard</json:string><json:string>SC</json:string><json:string>Nottingham</json:string><json:string>Hampshire</json:string><json:string>Madrid</json:string><json:string>The Hague</json:string><json:string>Okayama</json:string><json:string>St Philibert</json:string><json:string>Graz</json:string><json:string>India</json:string><json:string>Cincinnati</json:string><json:string>Reims</json:string><json:string>Seattle</json:string><json:string>West Indies</json:string><json:string>Haifa</json:string><json:string>Valladolid</json:string><json:string>China</json:string><json:string>Rijeka</json:string><json:string>Nijmegen</json:string><json:string>Vancouver</json:string><json:string>Santiago</json:string><json:string>Bulgaria</json:string><json:string>Greifswald</json:string><json:string>Toronto</json:string><json:string>Atlanta</json:string><json:string>Hebron</json:string><json:string>Milan</json:string><json:string>Marlborough</json:string><json:string>Los Angeles</json:string><json:string>Athens</json:string><json:string>Japan</json:string><json:string>New Sth</json:string><json:string>Jerusalem</json:string><json:string>Strasbourg</json:string><json:string>Brussels</json:string><json:string>Leeds</json:string><json:string>Vienna</json:string><json:string>Liverpool</json:string><json:string>Manchester</json:string><json:string>Takashima</json:string><json:string>St Helier</json:string><json:string>Barcelona</json:string><json:string>DE</json:string><json:string>Basel</json:string><json:string>Aachen</json:string><json:string>Gloucester</json:string><json:string>Gloucestershire</json:string><json:string>Dublin</json:string><json:string>Rordorf</json:string><json:string>Amsterdam</json:string><json:string>Kanuma City</json:string><json:string>New Zealand</json:string><json:string>Chiba</json:string><json:string>Rome</json:string><json:string>Rotterdam</json:string><json:string>Gaziantep</json:string><json:string>Chicago</json:string><json:string>Patras</json:string><json:string>Stoke on Trent</json:string><json:string>Hamilton</json:string><json:string>Israel</json:string><json:string>Angers</json:string><json:string>York</json:string><json:string>St Radboud</json:string><json:string>Caracas</json:string><json:string>Ottawa</json:string><json:string>St Vincent</json:string><json:string>Kansas City</json:string><json:string>Ototoxicity</json:string><json:string>Ireland</json:string><json:string>Egypt</json:string><json:string>Oldham</json:string><json:string>Stockholm</json:string><json:string>Padua</json:string><json:string>Croatia</json:string><json:string>NJ</json:string><json:string>Morristown</json:string><json:string>Quebec</json:string><json:string>Eritrea</json:string><json:string>Copenhagen</json:string><json:string>Greenville</json:string><json:string>Izmir</json:string><json:string>Salem</json:string><json:string>Sao Paulo</json:string><json:string>Hepatotoxicity</json:string><json:string>Pitt City</json:string><json:string>Limoges</json:string><json:string>Hungary</json:string><json:string>Italy</json:string><json:string>Louisville</json:string><json:string>Luton</json:string><json:string>Vilnius</json:string><json:string>Cleveland</json:string><json:string>Sweden</json:string><json:string>Postgrad</json:string><json:string>Zagreb</json:string><json:string>Lille</json:string><json:string>England</json:string><json:string>Worcester</json:string><json:string>San Camillo</json:string><json:string>Catania</json:string><json:string>Sapporo</json:string><json:string>St Bartholomew</json:string><json:string>Liege</json:string><json:string>Lithuania</json:string><json:string>Budapest</json:string><json:string>Bedfordshire</json:string><json:string>Lyon</json:string><json:string>Belgium</json:string><json:string>Stirling</json:string><json:string>Osaka</json:string><json:string>Tucson</json:string><json:string>Friedrichstadt</json:string></placeName><ref_url></ref_url><ref_bibl><json:string>Italy, 2000</json:string><json:string>Classen Immunotherapies Inc, 6517</json:string><json:string>US Army, Med Res Inst Infect Dis, Div Med, 1425</json:string><json:string>US FDA, Natl Ctr Toxicol Res, Behav Toxicol Lab, Div Neurotoxicol, 3900</json:string></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/WNG-87JH6LG4-8</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - pharmacology & pharmacy</json:string></wos><scienceMetrix><json:string>1 - health sciences</json:string><json:string>2 - clinical medicine</json:string><json:string>3 - pharmacology & pharmacy</json:string></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Pharmacology (medical)</json:string><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Epidemiology</json:string></scopus><inist><json:string>1 - sciences appliquees, technologies et medecines</json:string><json:string>2 - sciences biologiques et medicales</json:string><json:string>3 - sciences medicales</json:string></inist></categories><publicationDate>2002</publicationDate><copyrightDate>2002</copyrightDate><doi><json:string>10.1002/pds.660</json:string></doi><id>FE49A01C08E6D3C543D17E6F9A4EA88920C928E8</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-87JH6LG4-8/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-87JH6LG4-8/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-87JH6LG4-8/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Current Awareness</title><title level="a" type="short" xml:lang="en">Current Awareness</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>John Wiley & Sons, Ltd.</publisher><pubPlace>Chichester, UK</pubPlace><availability><licence>Copyright © 2002 John Wiley & Sons, Ltd.</licence></availability><date type="published" when="2002-06"></date></publicationStmt><notesStmt><note type="content-type" subtype="other" source="bibliography" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-7474895G-0">other</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="other"><analytic><title level="a" type="main">Current Awareness</title><title level="a" type="short" xml:lang="en">Current Awareness</title><idno type="istex">FE49A01C08E6D3C543D17E6F9A4EA88920C928E8</idno><idno type="ark">ark:/67375/WNG-87JH6LG4-8</idno><idno type="DOI">10.1002/pds.660</idno><idno type="unit">PDS660</idno><idno type="toTypesetVersion">file:PDS.PDS660.pdf</idno></analytic><monogr><title level="j" type="main">Pharmacoepidemiology and Drug Safety</title><title level="j" type="alt">PHARMACOEPIDEMIOLOGY AND DRUG SAFETY</title><idno type="pISSN">1053-8569</idno><idno type="eISSN">1099-1557</idno><idno type="book-DOI">10.1002/(ISSN)1099-1557</idno><idno type="book-part-DOI">10.1002/pds.v11:4</idno><idno type="product">PDS</idno><imprint><biblScope unit="vol">11</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="345">345</biblScope><biblScope unit="page" to="360">360</biblScope><biblScope unit="page-count">16</biblScope><publisher>John Wiley & Sons, Ltd.</publisher><pubPlace>Chichester, UK</pubPlace><date type="published" when="2002-06"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-20"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><abstract xml:lang="en" style="main"><head>Abstract</head><p>In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 19 sections: 1 Books, Reviews & Symposia; 2 General; 3 Anti‐infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non‐steroidal Anti‐inflammatory Agents; 7 CNS Agents; 8 Anti‐neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator‐Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti‐inflammatory Agents ‐ Steroidal; 19 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted. </p></abstract><textClass><keywords rend="articleCategory"><term>Current Awareness</term></keywords><keywords rend="tocHeading1"><term>Current Awareness</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-87JH6LG4-8/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>John Wiley & Sons, Ltd.</publisherName><publisherLoc>Chichester, UK</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1099-1557</doi><issn type="print">1053-8569</issn><issn type="electronic">1099-1557</issn><idGroup><id type="product" value="PDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="PHARMACOEPIDEMIOLOGY AND DRUG SAFETY">Pharmacoepidemiology and Drug Safety</title><title type="short">Pharmacoepidem. Drug Safe.</title></titleGroup></publicationMeta><publicationMeta level="part" position="40"><doi origin="wiley" registered="yes">10.1002/pds.v11:4</doi><numberingGroup><numbering type="journalVolume" number="11">11</numbering><numbering type="journalIssue">4</numbering></numberingGroup><coverDate startDate="2002-06">June 2002</coverDate></publicationMeta><publicationMeta level="unit" type="bibliography" position="999" status="forIssue"><doi origin="wiley" registered="yes">10.1002/pds.660</doi><idGroup><id type="unit" value="PDS660"></id></idGroup><countGroup><count type="pageTotal" number="16"></count></countGroup><titleGroup><title type="articleCategory">Current Awareness</title><title type="tocHeading1">Current Awareness</title></titleGroup><copyright ownership="publisher">Copyright © 2002 John Wiley & Sons, Ltd.</copyright><eventGroup><event type="firstOnline" date="2002-06-06"></event><event type="publishedOnlineFinalForm" date="2002-06-06"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.18.1 mode:FullText source:FullText result:FullText" date="2010-09-09"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-06"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-11-03"></event></eventGroup><numberingGroup><numbering type="pageFirst">345</numbering><numbering type="pageLast">360</numbering></numberingGroup><linkGroup><link type="toTypesetVersion" href="file:PDS.PDS660.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="0"></count><count type="referenceTotal" number="492"></count></countGroup><titleGroup><title type="main" xml:lang="en">Current Awareness</title><title type="short" xml:lang="en">Current Awareness</title></titleGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 19 sections: 1 Books, Reviews & Symposia; 2 General; 3 Anti‐infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non‐steroidal Anti‐inflammatory Agents; 7 CNS Agents; 8 Anti‐neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator‐Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti‐inflammatory Agents ‐ Steroidal; 19 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted. </p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Current Awareness</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Current Awareness</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Current Awareness</title></titleInfo><typeOfResource>text</typeOfResource><genre type="other" displayLabel="bibliography" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-7474895G-0">other</genre><originInfo><publisher>John Wiley & Sons, Ltd.</publisher><place><placeTerm type="text">Chichester, UK</placeTerm></place><dateIssued encoding="w3cdtf">2002-06</dateIssued><copyrightDate encoding="w3cdtf">2002</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><extent unit="figures">0</extent><extent unit="tables">0</extent><extent unit="references">492</extent></physicalDescription><abstract lang="en">In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 19 sections: 1 Books, Reviews & Symposia; 2 General; 3 Anti‐infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non‐steroidal Anti‐inflammatory Agents; 7 CNS Agents; 8 Anti‐neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator‐Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti‐inflammatory Agents ‐ Steroidal; 19 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.</abstract><relatedItem type="host"><titleInfo><title>Pharmacoepidemiology and Drug Safety</title></titleInfo><titleInfo type="abbreviated"><title>Pharmacoepidem. Drug Safe.</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><subject><genre>article-category</genre><topic>Current Awareness</topic><topic>Current Awareness</topic></subject><identifier type="ISSN">1053-8569</identifier><identifier type="eISSN">1099-1557</identifier><identifier type="DOI">10.1002/(ISSN)1099-1557</identifier><identifier type="PublisherID">PDS</identifier><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><detail type="issue"><caption>no.</caption><number>4</number></detail><extent unit="pages"><start>345</start><end>360</end><total>16</total></extent></part></relatedItem><relatedItem type="references" displayLabel="cit1"><titleInfo><title>1. Books, reviews & symposia</title></titleInfo><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit2"><titleInfo><title>Special issue: Drugs ‐ Prescription by the physician and use by the patient</title></titleInfo><genre>journal-article</genre><note type="citation/reference">Special issue: Drugs ‐ Prescription by the physician and use by the patient. Int J Clin Pharm Ther (2001); 39:</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>39</number></detail></part><relatedItem type="host"><titleInfo><title>Int J Clin Pharm Ther</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>39</number></detail></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit3"><titleInfo><title>XVIIth International Conference of Pharmacoepidemiology ‐ Toronto, Canada, 23‐26 August, 2001 (Abstracts)</title></titleInfo><genre>journal-article</genre><note type="citation/reference">XVIIth International Conference of Pharmacoepidemiology ‐ Toronto, Canada, 23‐26 August, 2001 (Abstracts). Pharmacoepidemiol Drug Saf (2001); 10:</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>10</number></detail></part><relatedItem type="host"><titleInfo><title>Pharmacoepidemiol Drug Saf</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>10</number></detail></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit4"><titleInfo><title>Safety of inhaled corticosteroids in children with asthma</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bazzy‐Asaad A. Safety of inhaled corticosteroids in children with asthma. Curr Opin Pediatr (2001); 13: 523.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>523</start></extent></part><relatedItem type="host"><titleInfo><title>Curr Opin Pediatr</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>523</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit5"><titleInfo><title>Efficacy, safety, and patient preference of inhaled nasal corticosteroids: A review of pertinent published data</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Blaiss MS. Efficacy, safety, and patient preference of inhaled nasal corticosteroids: A review of pertinent published data. Allergy Asthma Proc (2001); 22: S5.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>S5</start></extent></part><relatedItem type="host"><titleInfo><title>Allergy Asthma Proc</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>S5</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit6"><titleInfo><title>Drug interactions of the statins and consequences for drug selection</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Boger RH. Drug interactions of the statins and consequences for drug selection. Int J Clin Pharm Ther (2001); 39: 369.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>369</start></extent></part><relatedItem type="host"><titleInfo><title>Int J Clin Pharm Ther</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>369</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit7"><titleInfo><title>The mechanisms of thrombotic risk induced by hormone replacement therapy (Review)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cano A, Van Baal WM. The mechanisms of thrombotic risk induced by hormone replacement therapy (Review). Maturitas (2001); 40: 17.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>17</start></extent></part><relatedItem type="host"><titleInfo><title>Maturitas</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>17</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit8"><titleInfo><title>Safety aspects of pharmacological GH therapy in adults (Review)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Carroll PV, Van den Berghe G. Safety aspects of pharmacological GH therapy in adults (Review). Growth Horm IGF Res (2001); 11: 166.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>166</start></extent></part><relatedItem type="host"><titleInfo><title>Growth Horm IGF Res</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>166</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit9"><titleInfo><title>Helicobacter pylori and nonsteroidal anti‐inflammatory drugs</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Chan FKL. Helicobacter pylori and nonsteroidal anti‐inflammatory drugs. Gastroenterol Clin North Am (2001); 30: 937.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>937</start></extent></part><relatedItem type="host"><titleInfo><title>Gastroenterol Clin North Am</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>937</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit10"><titleInfo><title>Pancreatitis associated with valproic acid: A review of the literature</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Chapman SA, Wacksman GP, Patterson BD. Pancreatitis associated with valproic acid: A review of the literature. Pharmacotherapy (2001); 21: 1549.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>1549</start></extent></part><relatedItem type="host"><titleInfo><title>Pharmacotherapy</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>1549</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit11"><titleInfo><title>Taste and smell dysfunction in patients receiving chemotherapy: A review of current knowledge</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Comeau TB, Epstein JB, Migas C. Taste and smell dysfunction in patients receiving chemotherapy: A review of current knowledge. Support Care Cancer (2001); 9: 575.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>9</number></detail><extent unit="pages"><start>575</start></extent></part><relatedItem type="host"><titleInfo><title>Support Care Cancer</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>9</number></detail><extent unit="pages"><start>575</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit12"><titleInfo><title>Prescribing for psychiatric disorders in pregnancy and lactation</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Craig M, Abel K. Prescribing for psychiatric disorders in pregnancy and lactation. Best Pract Res Clin Obstet Gynecol (2001); 15: 1013.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>1013</start></extent></part><relatedItem type="host"><titleInfo><title>Best Pract Res Clin Obstet Gynecol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>1013</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit13"><titleInfo><title>Pharmacokinetic and other drug interactions in patients with AIDS (Review)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Dasgupta A, Okhuysen PC. Pharmacokinetic and other drug interactions in patients with AIDS (Review). Ther Drug Monit (2001); 23: 591.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>591</start></extent></part><relatedItem type="host"><titleInfo><title>Ther Drug Monit</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>591</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit14"><titleInfo><title>A systematic review of the safety profile of levetiracetam: A new antiepileptic drug</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">French J, Edrich P, Cramer JA. A systematic review of the safety profile of levetiracetam: A new antiepileptic drug. Epilepsy Res (2001); 47: 77.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>77</start></extent></part><relatedItem type="host"><titleInfo><title>Epilepsy Res</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>77</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit15"><titleInfo><title>Anticoagulants</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gibson PS, Rosene‐Montella K. Anticoagulants. Best Pract Res Clin Obstet Gynecol (2001); 15: 847.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>847</start></extent></part><relatedItem type="host"><titleInfo><title>Best Pract Res Clin Obstet Gynecol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>847</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit16"><titleInfo><title>Post‐traumatic stress disorder: A review of psychobiology and pharmacotherapy</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hageman I, Andersen HS, Jorgensen MB. Post‐traumatic stress disorder: A review of psychobiology and pharmacotherapy. Acta Psychiatr Scand (2001); 104: 411.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>104</number></detail><extent unit="pages"><start>411</start></extent></part><relatedItem type="host"><titleInfo><title>Acta Psychiatr Scand</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>104</number></detail><extent unit="pages"><start>411</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit17"><titleInfo><title>Gastrointestinal safety of COX‐2 specific inhibitors</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hawkey CJ. Gastrointestinal safety of COX‐2 specific inhibitors. Gastroenterol Clin North Am (2001); 30: 921.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>921</start></extent></part><relatedItem type="host"><titleInfo><title>Gastroenterol Clin North Am</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>921</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit18"><titleInfo><title>Multidisciplinary management of breast cancer concurrent with pregnancy (Review)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Keleher AJ, Theriault RL, Gwyn KM, Hunt KK, Stelling CB, Singletary SE, Ames FC, Buchholz TA, Sahin AA, Kuerer HM. Multidisciplinary management of breast cancer concurrent with pregnancy (Review). J Am Coll Surg (2002); 194: 54.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>194</number></detail><extent unit="pages"><start>54</start></extent></part><relatedItem type="host"><titleInfo><title>J Am Coll Surg</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>194</number></detail><extent unit="pages"><start>54</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit19"><titleInfo><title>Renal and cardiovascular effects of selective cyclooxygenase‐2 inhibitors (Review)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Komers R, Anderson S, Epstein M. Renal and cardiovascular effects of selective cyclooxygenase‐2 inhibitors (Review). Am J Kidney Dis (2001); 38: 1145.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>1145</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Kidney Dis</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>1145</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit20"><titleInfo><title>Antipsychotic drugs and neuroplasticity: Insights into the treatment and neurobiology of schizophrenia (Review)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Konradi C, Heckers S. Antipsychotic drugs and neuroplasticity: Insights into the treatment and neurobiology of schizophrenia (Review). Biol Psychiatry (2001); 50: 729.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>50</number></detail><extent unit="pages"><start>729</start></extent></part><relatedItem type="host"><titleInfo><title>Biol Psychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>50</number></detail><extent unit="pages"><start>729</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit21"><titleInfo><title>Drugs in pregnancy: Anticonvulsants and drugs for neurological disease</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lowe SA. Drugs in pregnancy: Anticonvulsants and drugs for neurological disease. Best Pract Res Clin Obstet Gynecol (2001); 15: 863.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>863</start></extent></part><relatedItem type="host"><titleInfo><title>Best Pract Res Clin Obstet Gynecol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>863</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit22"><titleInfo><title>Ketorolac in the era of cyclo‐oxygenase‐2 selective nonsteroidal anti‐inflammatory drugs: A systematic review of efficacy, side effects, and regulatory issues</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Macario A, Lipman AG. Ketorolac in the era of cyclo‐oxygenase‐2 selective nonsteroidal anti‐inflammatory drugs: A systematic review of efficacy, side effects, and regulatory issues. Pain Med (2001); 2: 336.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>336</start></extent></part><relatedItem type="host"><titleInfo><title>Pain Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>336</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit23"><titleInfo><title>Drugs in pregnancy: Antihypertensives</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Magee LA. Drugs in pregnancy: Antihypertensives. Best Pract Res Clin Obstet Gynecol (2001); 15: 827.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>827</start></extent></part><relatedItem type="host"><titleInfo><title>Best Pract Res Clin Obstet Gynecol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>827</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit24"><titleInfo><title>Neurodevelopment of children exposed in utero to treatment of maternal malignancy (Review)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nulman I, Laslo D, Fried S, Uleryk E, Lishner M, Koren G. Neurodevelopment of children exposed in utero to treatment of maternal malignancy (Review). Br J Cancer (2001); 85: 1611.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>1611</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Cancer</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>1611</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit25"><titleInfo><title>Dermatological steroid therapy during pregnancy and lactation (Review) (German, English Abstract)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Pfeiffer C. Dermatological steroid therapy during pregnancy and lactation (Review) (German, English Abstract). Hautarzt (2001); 52: 998.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>998</start></extent></part><relatedItem type="host"><titleInfo><title>Hautarzt</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>998</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit26"><titleInfo><title>The risk of oral contraceptive pills</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Pymar HC, Creinin MD. The risk of oral contraceptive pills. Semin Reprod Med (2001); 19: 305.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>305</start></extent></part><relatedItem type="host"><titleInfo><title>Semin Reprod Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>305</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit27"><titleInfo><title>Safety of the new macrolide immunomodulators (Review)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Robinson N, Singri P, Gordon KB. Safety of the new macrolide immunomodulators (Review). Semin Cutan Med Surg (2001); 20: 242.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>242</start></extent></part><relatedItem type="host"><titleInfo><title>Semin Cutan Med Surg</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>242</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit28"><titleInfo><title>Association between aspirin and upper gastrointestinal complications: Systematic review of epidemiologic studies</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rodriguez LAG, Hernandez‐Diaz S, De Abajo FJ. Association between aspirin and upper gastrointestinal complications: Systematic review of epidemiologic studies. Br J Clin Pharmacol (2001); 52: 563.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>563</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Clin Pharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>563</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit29"><titleInfo><title>Alfuzosin: Overview of pharmacokinetics, safety, and efficacy of a clinically uroselective α‐blocker</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Roehrborn CG. Alfuzosin: Overview of pharmacokinetics, safety, and efficacy of a clinically uroselective α‐blocker. Urology (2001); 58: 55.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>58</number></detail><extent unit="pages"><start>55</start></extent></part><relatedItem type="host"><titleInfo><title>Urology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>58</number></detail><extent unit="pages"><start>55</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit30"><titleInfo><title>An evidence‐based approach to the gastrointestinal safety profile of COX‐2‐selective anti‐inflammatories</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Schoenfeld. An evidence‐based approach to the gastrointestinal safety profile of COX‐2‐selective anti‐inflammatories. Gastroenterol Clin North Am (2001); 30: 1027.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>1027</start></extent></part><relatedItem type="host"><titleInfo><title>Gastroenterol Clin North Am</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>1027</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit31"><titleInfo><title>Drugs to avoid</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Shehata HA, Nelson‐Piercy C. Drugs to avoid. Best Pract Res Clin Obstet Gynecol (2001); 15: 971.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>971</start></extent></part><relatedItem type="host"><titleInfo><title>Best Pract Res Clin Obstet Gynecol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>971</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit32"><titleInfo><title>COX‐2 inhibitors: Are they nonsteroidal anti‐inflammatory drugs with a better safety profile?</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Simon LS. COX‐2 inhibitors: Are they nonsteroidal anti‐inflammatory drugs with a better safety profile?. Gastroenterol Clin North Am (2001); 30: 1011.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>1011</start></extent></part><relatedItem type="host"><titleInfo><title>Gastroenterol Clin North Am</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>1011</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit33"><titleInfo><title>Angiotensin‐converting enzyme inhibitors as inducers of adverse cutaneous reactions (Review)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Steckelings UM, Artuc M, Wollschlager T, Wiehstutz S, Henz BM. Angiotensin‐converting enzyme inhibitors as inducers of adverse cutaneous reactions (Review). Acta Derm Venereol (2001); 81: 321.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>81</number></detail><extent unit="pages"><start>321</start></extent></part><relatedItem type="host"><titleInfo><title>Acta Derm Venereol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>81</number></detail><extent unit="pages"><start>321</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit34"><titleInfo><title>Alfuzosin: Overview of pharmacokinetics, safety, and efficacy of a clinically uroselective α‐blocker (Discussion)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Steers WD, Roehrborn CG, Price D, Kaplan SA, O'Leary MP. Alfuzosin: Overview of pharmacokinetics, safety, and efficacy of a clinically uroselective α‐blocker (Discussion). Urology (2001); 58: 63.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>58</number></detail><extent unit="pages"><start>63</start></extent></part><relatedItem type="host"><titleInfo><title>Urology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>58</number></detail><extent unit="pages"><start>63</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit35"><titleInfo><title>Maternal antiepileptic drug use and effects on fetal development</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Stoler JM. Maternal antiepileptic drug use and effects on fetal development. Curr Opin Pediatr (2001); 13: 566.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>566</start></extent></part><relatedItem type="host"><titleInfo><title>Curr Opin Pediatr</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>566</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit36"><titleInfo><title>Gastrointestinal toxicity associated with nonsteroidal anti‐inflammatory drugs; Epidemiologic and economic issues</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Straus WL, Ofman JJ. Gastrointestinal toxicity associated with nonsteroidal anti‐inflammatory drugs; Epidemiologic and economic issues. Gastroenterol Clin North Am (2001); 30: 895.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>895</start></extent></part><relatedItem type="host"><titleInfo><title>Gastroenterol Clin North Am</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>895</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit37"><titleInfo><title>Metabolic syndromes associated with HIV; Mitigating the side effects of drug therapy</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Stringer WW, Sattler FR. Metabolic syndromes associated with HIV; Mitigating the side effects of drug therapy. Physician Sportsmed (2001); 29: 19.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>29</number></detail><extent unit="pages"><start>19</start></extent></part><relatedItem type="host"><titleInfo><title>Physician Sportsmed</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>29</number></detail><extent unit="pages"><start>19</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit38"><titleInfo><title>Headache induced by chronic overuse of antimigraine drugs and antalgesics (French)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Taimi C, Navez M, Perrin AM, Laurent B. Headache induced by chronic overuse of antimigraine drugs and antalgesics (French). Rev Neurol (2001); 157: 1221.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>157</number></detail><extent unit="pages"><start>1221</start></extent></part><relatedItem type="host"><titleInfo><title>Rev Neurol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>157</number></detail><extent unit="pages"><start>1221</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit39"><titleInfo><title>Immediate allergic reactions after vaccinations: A post‐marketing surveillance review</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Zent O, Arras‐Reiter C, Broeker M, Hennig R. Immediate allergic reactions after vaccinations: A post‐marketing surveillance review. Eur J Pediatr (2002); 161: 21.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>21</start></extent></part><relatedItem type="host"><titleInfo><title>Eur J Pediatr</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>21</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit40"><titleInfo><title>2. General</title></titleInfo><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit41"><titleInfo><title>Postmarketing drug surveillance: What it would take to make it work (Editorial)</title></titleInfo><genre>journal-article</genre><note type="citation/reference">Postmarketing drug surveillance: What it would take to make it work (Editorial). Can Med Assoc J (2001); 165: 1293.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>165</number></detail><extent unit="pages"><start>1293</start></extent></part><relatedItem type="host"><titleInfo><title>Can Med Assoc J</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>165</number></detail><extent unit="pages"><start>1293</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit42"><titleInfo><title>QTc prolongation and drugs (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Abernethy DR. QTc prolongation and drugs (Reply). Clin Pharm Ther (2001); 70: 568.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>70</number></detail><extent unit="pages"><start>568</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Pharm Ther</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>70</number></detail><extent unit="pages"><start>568</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit43"><titleInfo><title>Molecular profiling of cancer and drug‐induced toxicity using new proteomic technologies</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ardekani AM, Herman EH, Sistare FD, Liotta LA, Petricoin EF. Molecular profiling of cancer and drug‐induced toxicity using new proteomic technologies. Curr Ther Res (2001); 62: 803.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>803</start></extent></part><relatedItem type="host"><titleInfo><title>Curr Ther Res</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>803</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit44"><titleInfo><title>The AHA guidelines on hormone replacement therapy and cardiovascular disease (Editorial)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Burger H, Teede H. The AHA guidelines on hormone replacement therapy and cardiovascular disease (Editorial). Maturitas (2001); 40: 1.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>1</start></extent></part><relatedItem type="host"><titleInfo><title>Maturitas</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>1</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit45"><titleInfo><title>Hepatitis B vaccination and serious side‐effects: Sequence is not consequence (Editorial) (French)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cales P. Hepatitis B vaccination and serious side‐effects: Sequence is not consequence (Editorial) (French). Gastroenterol Clin Biol (2001); 25: 859.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>859</start></extent></part><relatedItem type="host"><titleInfo><title>Gastroenterol Clin Biol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>859</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit46"><titleInfo><title>Drug prescribing in out‐patient children in Southern Italy</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cazzato T, Pandolfini C, Campi R, Bonati M. Drug prescribing in out‐patient children in Southern Italy. Eur J Clin Pharmacol (2001); 57: 611.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>611</start></extent></part><relatedItem type="host"><titleInfo><title>Eur J Clin Pharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>611</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit47"><titleInfo><title>Oral contraceptives and myocardial infarction: The search for the smoking gun (Editorial)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Chasan‐Taber L, Stampfer M. Oral contraceptives and myocardial infarction: The search for the smoking gun (Editorial). N Engl J Med (2001); 345: 1841.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>345</number></detail><extent unit="pages"><start>1841</start></extent></part><relatedItem type="host"><titleInfo><title>N Engl J Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>345</number></detail><extent unit="pages"><start>1841</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit48"><titleInfo><title>Hormonal, oral contraceptives, coagulation and thrombosis (Editorial) (Spanish)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cortes AE, GilabertEstelles J. Hormonal, oral contraceptives, coagulation and thrombosis (Editorial) (Spanish). Rev Clin Esp (2001); 201: 681.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>201</number></detail><extent unit="pages"><start>681</start></extent></part><relatedItem type="host"><titleInfo><title>Rev Clin Esp</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>201</number></detail><extent unit="pages"><start>681</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit49"><titleInfo><title>Drug‐induced urticaria (French, English Abstract)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cousin F, Phillips K, Larbre JP, Catelain A, Favier B, Nicolas JF. Drug‐induced urticaria (French, English Abstract). Ann Dermatol Venereol (2001); 128: 1166.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>128</number></detail><extent unit="pages"><start>1166</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Dermatol Venereol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>128</number></detail><extent unit="pages"><start>1166</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit50"><titleInfo><title>Hormone replacement therapy and the breast: We should worry about the increase in the risk of breast cancer (Editorial)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Dixon JM. Hormone replacement therapy and the breast: We should worry about the increase in the risk of breast cancer (Editorial). Br Med J (2001); 323: 1381.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>323</number></detail><extent unit="pages"><start>1381</start></extent></part><relatedItem type="host"><titleInfo><title>Br Med J</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>323</number></detail><extent unit="pages"><start>1381</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit51"><titleInfo><title>Transient eruptive seborrheic keratoses associated with erythrodermic psoriasis and erythrodermic drug eruption: Report of two cases</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Flugman SL, McClain SA, Clark RAF. Transient eruptive seborrheic keratoses associated with erythrodermic psoriasis and erythrodermic drug eruption: Report of two cases. J Am Acad Dermatol (2001); 45: S212.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>S212</start></extent></part><relatedItem type="host"><titleInfo><title>J Am Acad Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>S212</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit52"><titleInfo><title>Prescription‐event monitoring and reporting of adverse drug reactions</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Heeley E, Riley J, Layton D, Wilton LV, Shakir SAW. Prescription‐event monitoring and reporting of adverse drug reactions. Lancet (2001); 358: 1872.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>358</number></detail><extent unit="pages"><start>1872</start></extent></part><relatedItem type="host"><titleInfo><title>Lancet</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>358</number></detail><extent unit="pages"><start>1872</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit53"><titleInfo><title>QTc prolongation and drugs (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Henderson W. QTc prolongation and drugs (Letter). Clin Pharm Ther (2001); 70: 567.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>70</number></detail><extent unit="pages"><start>567</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Pharm Ther</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>70</number></detail><extent unit="pages"><start>567</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit54"><titleInfo><title>Polypharmacy, adverse drug‐related events, and potential adverse drug interactions in elderly patients presenting to an emergency department</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hohl CM, Dankoff J, Colacone A, Afilalo M. Polypharmacy, adverse drug‐related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med (2001); 38: 666.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>666</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Emerg Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>666</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit55"><titleInfo><title>Safety assessment and drug selection</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Iserte JT. Safety assessment and drug selection. Methods Find Exp Clin Pharmacol (2001); 23: 311.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>311</start></extent></part><relatedItem type="host"><titleInfo><title>Methods Find Exp Clin Pharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>311</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit56"><titleInfo><title>The progressive decrease of visual acuity in patients who are administered drugs parenterally</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jover F, Cuadrado JM, Andreu L, Schargel K, Merino J. The progressive decrease of visual acuity in patients who are administered drugs parenterally. Enferm Infect Microbiol Clin (2001); 19: 447.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>447</start></extent></part><relatedItem type="host"><titleInfo><title>Enferm Infect Microbiol Clin</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>447</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit57"><titleInfo><title>Developing and integrating an adverse drug reaction reporting system with the Hospital Information System (Japanese, English Abstract)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kataoka S, Ohe K, Mochizuki M, Ueda S. Developing and integrating an adverse drug reaction reporting system with the Hospital Information System (Japanese, English Abstract). Yakugaku Zasshi (2002); 122: 113.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>122</number></detail><extent unit="pages"><start>113</start></extent></part><relatedItem type="host"><titleInfo><title>Yakugaku Zasshi</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>122</number></detail><extent unit="pages"><start>113</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit58"><titleInfo><title>Heart and soul: There's no life like it (News)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kent H. Heart and soul: There's no life like it (News). Can Med Assoc J (2002); 166: 84.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>166</number></detail><extent unit="pages"><start>84</start></extent></part><relatedItem type="host"><titleInfo><title>Can Med Assoc J</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>166</number></detail><extent unit="pages"><start>84</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit59"><titleInfo><title>Photopatch testing in seven cases of photosensitive drug eruptions (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lee AY, Joo HJ, Chey WY, Kim YG. Photopatch testing in seven cases of photosensitive drug eruptions (Case Report). Ann Pharmacother (2001); 35: 1584.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1584</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Pharmacother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1584</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit60"><titleInfo><title>Toxicity and safety of epidural local anaesthetics (Editorial)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lyons G, Reynolds F. Toxicity and safety of epidural local anaesthetics (Editorial). Int J Obstet Anesth (2001); 10: 259.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>259</start></extent></part><relatedItem type="host"><titleInfo><title>Int J Obstet Anesth</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>259</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit61"><titleInfo><title>Adverse drug effects: New information about an old problem</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Miller CA. Adverse drug effects: New information about an old problem. Geriatr Nurs (2001); 22: 336.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>336</start></extent></part><relatedItem type="host"><titleInfo><title>Geriatr Nurs</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>336</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit62"><titleInfo><title>The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Miserocchi E, Baltatzis S, Roque MR, Ahmed AR, Foster CS. The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid. Ophthalmology (2002); 109: 111.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>111</start></extent></part><relatedItem type="host"><titleInfo><title>Ophthalmology</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>111</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit63"><titleInfo><title>Retrospective analysis of drug‐induced urticaria and angioedema: A survey of 2287 patients</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nettis E, Marcandrea M, Di Maggio G, Ferrannini A, Tursi A. Retrospective analysis of drug‐induced urticaria and angioedema: A survey of 2287 patients. Immunopharmacol Immunotoxicol (2001); 23: 585.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>585</start></extent></part><relatedItem type="host"><titleInfo><title>Immunopharmacol Immunotoxicol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>585</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit64"><titleInfo><title>Using identical behavioral tasks in children, monkeys, and rats to study the effects of drugs</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Paule MG. Using identical behavioral tasks in children, monkeys, and rats to study the effects of drugs. Curr Ther Res (2001); 62: 820.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>820</start></extent></part><relatedItem type="host"><titleInfo><title>Curr Ther Res</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>820</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit65"><titleInfo><title>Helicobacter pylori and NSAIDs: the end of the debate? (Editorial)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Pounder RE. Helicobacter pylori and NSAIDs: the end of the debate? (Editorial). Lancet (2002); 359: 3.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>359</number></detail><extent unit="pages"><start>3</start></extent></part><relatedItem type="host"><titleInfo><title>Lancet</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>359</number></detail><extent unit="pages"><start>3</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit66"><titleInfo><title>The role of Internet‐based registries in tandem with genetic screening for the study of drug‐induced arrhythmias</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Remich SA, Kilborn MJ, Woosley RL. The role of Internet‐based registries in tandem with genetic screening for the study of drug‐induced arrhythmias. Curr Ther Res (2001); 62: 787.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>787</start></extent></part><relatedItem type="host"><titleInfo><title>Curr Ther Res</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>787</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit67"><titleInfo><title>Drug consumption in a very elderly community‐dwelling population (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Simiand‐Erdociain E, Lapeyre‐Mestre M, Bagheri‐Charabiani H, Montastruc JL. Drug consumption in a very elderly community‐dwelling population (Letter). Eur J Clin Pharmacol (2001); 57: 691.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>691</start></extent></part><relatedItem type="host"><titleInfo><title>Eur J Clin Pharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>691</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit68"><titleInfo><title>Drug‐induced QT prolongation (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tzivoni D. Drug‐induced QT prolongation (Letter). Isr Med Assoc J (2001); 3: 472.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>472</start></extent></part><relatedItem type="host"><titleInfo><title>Isr Med Assoc J</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>472</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit69"><titleInfo><title>Determinants of signal selection in a spontaneous reporting system for adverse drug reactions</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Van Puijenbroek EP, Van Grootheest K, Diemont WL, Leufkens HGM, Egberts ACG. Determinants of signal selection in a spontaneous reporting system for adverse drug reactions. Br J Clin Pharmacol (2001); 52: 579.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>579</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Clin Pharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>579</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit70"><titleInfo><title>A physician‐based voluntary reporting system for adverse events and medical errors</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Weingart SN, Callanan LD, Ship AN, Aronson MD. A physician‐based voluntary reporting system for adverse events and medical errors. J Gen Intern Med (2001); 16: 809.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>16</number></detail><extent unit="pages"><start>809</start></extent></part><relatedItem type="host"><titleInfo><title>J Gen Intern Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>16</number></detail><extent unit="pages"><start>809</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit71"><titleInfo><title>Electronic system alerts pharmacists to potential adverse drug events (News)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Young D. Electronic system alerts pharmacists to potential adverse drug events (News). Am J Health‐Syst Pharm (2001); 58: 2362.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>58</number></detail><extent unit="pages"><start>2362</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Health‐Syst Pharm</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>58</number></detail><extent unit="pages"><start>2362</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit72"><titleInfo><title>3. Anti‐infective agents</title></titleInfo><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit73"><titleInfo><title>Side effects of influenza vaccination in healthy older people: A randomised single‐blind placebo‐controlled trial</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Allsup SJ, Gosney M, Regan M, Haycox A, Fear S, Johnstone FCW. Side effects of influenza vaccination in healthy older people: A randomised single‐blind placebo‐controlled trial. Gerontology (2001); 47: 311.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>311</start></extent></part><relatedItem type="host"><titleInfo><title>Gerontology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>311</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit74"><titleInfo><title>Antibiotic‐induced agranulocytosis: A monocentric study of 21 cases (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Andres E, Maloisel F. Antibiotic‐induced agranulocytosis: A monocentric study of 21 cases (Letter). Arch Intern Med (2001); 161: 2619.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>2619</start></extent></part><relatedItem type="host"><titleInfo><title>Arch Intern Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>2619</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit75"><titleInfo><title>An unusual case of clarithromycin associated ergotism</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ausband SC, Goodman PE. An unusual case of clarithromycin associated ergotism. J Emerg Med (2001); 21: 411.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>411</start></extent></part><relatedItem type="host"><titleInfo><title>J Emerg Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>411</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit76"><titleInfo><title>Minocycline‐induced lupus‐like syndrome (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Balestrero S, Ciambellotti A, Parodi A, Rebora A. Minocycline‐induced lupus‐like syndrome (Letter). Int J Dermatol (2001); 40: 474.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>474</start></extent></part><relatedItem type="host"><titleInfo><title>Int J Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>474</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit77"><titleInfo><title>Severe neurotoxicity of cefepime in uremic patients (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Barbey F, Bugnon D, Wauters JP. Severe neurotoxicity of cefepime in uremic patients (Letter). Ann Intern Med (2001); 135: 1011.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>135</number></detail><extent unit="pages"><start>1011</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Intern Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>135</number></detail><extent unit="pages"><start>1011</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit78"><titleInfo><title>Churg‐Strauss vasculitis with brain involvement following hepatitis B vaccination</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Beretta L, Vanoli M, Caronni M, Scorza R. Churg‐Strauss vasculitis with brain involvement following hepatitis B vaccination. Clin Exp Rheumatol (2001); 19: 757.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>757</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Exp Rheumatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>757</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit79"><titleInfo><title>Sex differences in nevirapine rash (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bersoff‐Matcha S, Miller W, Mundy LM. Sex differences in nevirapine rash (Reply). Clin Infect Dis (2001); 33: 2097.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>2097</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Infect Dis</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>2097</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit80"><titleInfo><title>Comment: History of drug‐induced hepatitis and risk of amoxicillin/clavulanate‐induced hepatotoxicity (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Boyd IW. Comment: History of drug‐induced hepatitis and risk of amoxicillin/clavulanate‐induced hepatotoxicity (Letter). Ann Pharmacother (2001); 35: 1677.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1677</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Pharmacother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1677</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit81"><titleInfo><title>Safety and immunogenicity of tetravalent rhesus‐based rotavirus vaccine in Bangladesh</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bresee JS, El Arifeen S, Azim T, Chakraborty J, Mounts AW, Podder G, Gentsch JR, Ward RL, Black R, Glass RI, Yunus M. Safety and immunogenicity of tetravalent rhesus‐based rotavirus vaccine in Bangladesh. Pediatr Infect Dis J (2001); 20: 1136.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>1136</start></extent></part><relatedItem type="host"><titleInfo><title>Pediatr Infect Dis J</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>1136</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit82"><titleInfo><title>Safety and immunogenicity of live recombinant Salmonella enterica serovar typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bumann D, Metzger WG, Mansouri E, Palme O, Wendland M, Hurwitz R, Haas G, Aebischer T, Von Specht BU, Meyer TF. Safety and immunogenicity of live recombinant Salmonella enterica serovar typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine (2001); 20: 845.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>845</start></extent></part><relatedItem type="host"><titleInfo><title>Vaccine</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>845</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit83"><titleInfo><title>Quinolone‐associated tendonitis: A potential problem in COPD? (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Butler MW, Griffin JF, Quinlan WR, McDonnell TJ. Quinolone‐associated tendonitis: A potential problem in COPD? (Case Report). Ir J Med Sci (2001); 170: 198.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>170</number></detail><extent unit="pages"><start>198</start></extent></part><relatedItem type="host"><titleInfo><title>Ir J Med Sci</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>170</number></detail><extent unit="pages"><start>198</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit84"><titleInfo><title>Efficacy and safety of oral and early‐switch therapy for community‐acquired pneumonia: A randomized controlled trial</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Castro‐Guardiola A, Viejo‐Rodriguez AL, Soler‐Simon S, Armengou‐Arxe A, Bisbe‐Company V, Penarroja‐Matutano G, Bisbe‐Company J, Garcia‐Bragado F. Efficacy and safety of oral and early‐switch therapy for community‐acquired pneumonia: A randomized controlled trial. Am J Med (2001); 111: 367.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>111</number></detail><extent unit="pages"><start>367</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>111</number></detail><extent unit="pages"><start>367</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit85"><titleInfo><title>Combination vaccines: Postlicensure safety evaluation</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Chen RT, Pool V, Takahashi H, Weniger BG, Patel B. Combination vaccines: Postlicensure safety evaluation. Clin Infect Dis (2001); 33: S327.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>S327</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Infect Dis</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>S327</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit86"><titleInfo><title>The facts behind the MMR vaccination autism hypotheses (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Christie CDC. The facts behind the MMR vaccination autism hypotheses (Letter). West Indian Med J (2001); 50: 251.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>50</number></detail><extent unit="pages"><start>251</start></extent></part><relatedItem type="host"><titleInfo><title>West Indian Med J</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>50</number></detail><extent unit="pages"><start>251</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit87"><titleInfo><title>Vaccines and the risk of insulin‐dependent diabetes (IDDM): Potential mechanism of action</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Classen JB, Classen DC. Vaccines and the risk of insulin‐dependent diabetes (IDDM): Potential mechanism of action. Med Hypotheses (2001); 57: 532.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>532</start></extent></part><relatedItem type="host"><titleInfo><title>Med Hypotheses</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>532</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit88"><titleInfo><title>Peripheral neuropathy associated with fluoroquinolones</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cohen JS. Peripheral neuropathy associated with fluoroquinolones. Ann Pharmacother (2001); 35: 1540.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1540</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Pharmacother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1540</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit89"><titleInfo><title>Comment: Peripheral neuropathy syndrome and fluoroquinolones (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cohen JS. Comment: Peripheral neuropathy syndrome and fluoroquinolones (Reply). Ann Pharmacother (2001); 35: 1674.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1674</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Pharmacother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1674</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit90"><titleInfo><title>Meta‐analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for lower respiratory tract infections</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Contopoulosioannidis DG, Ioannidis JPA, Chew P, Lau J. Meta‐analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for lower respiratory tract infections. J Antimicrob Chemother (2001); 48:691.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>48</number></detail><extent unit="pages"><start>691</start></extent></part><relatedItem type="host"><titleInfo><title>J Antimicrob Chemother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>48</number></detail><extent unit="pages"><start>691</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit91"><titleInfo><title>Is peripartum zidovudine ‘safe and highly beneficial to African children’ (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Crowe DR. Is peripartum zidovudine ‘safe and highly beneficial to African children’ (Letter). AIDS (2001); 15: 2204.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>2204</start></extent></part><relatedItem type="host"><titleInfo><title>AIDS</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>2204</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit92"><titleInfo><title>Safety of quinolones administration in children? (Spanish)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Danes I, Arnau JM. Safety of quinolones administration in children? (Spanish). Med Clin (2001); 117: 676.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>117</number></detail><extent unit="pages"><start>676</start></extent></part><relatedItem type="host"><titleInfo><title>Med Clin</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>117</number></detail><extent unit="pages"><start>676</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit93"><titleInfo><title>Anaphylactic reactions due to chlorhexidine allergy (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Davies W. Anaphylactic reactions due to chlorhexidine allergy (Letter). Br J Anaesth (2001); 87: 941.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><extent unit="pages"><start>941</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Anaesth</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><extent unit="pages"><start>941</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit94"><titleInfo><title>Side effects of antituberculous treatment (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">De Maria A, Berardi M, Dignetti P, Ferrera L, Viassolo L, Canonica GW. Side effects of antituberculous treatment (Letter). Thorax (2001); 56: 983.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>983</start></extent></part><relatedItem type="host"><titleInfo><title>Thorax</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>983</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit95"><titleInfo><title>Fatal liver necrosis associated with the use of nitrofurantoin (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Edoute Y, Karmon Y, Roguin A, Ben Ami H. Fatal liver necrosis associated with the use of nitrofurantoin (Case Report). Isr Med Assoc J (2001); 3: 382.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>382</start></extent></part><relatedItem type="host"><titleInfo><title>Isr Med Assoc J</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>382</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit96"><titleInfo><title>A pilot study evaluating the safety and microbiologic efficacy of an economically viable antimicrobial lozenge in patients with head and neck cancer receiving radiation therapy</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">El Sayed S, Epstein J, Minish E, Burns P, Hay J, Laukkanen E. A pilot study evaluating the safety and microbiologic efficacy of an economically viable antimicrobial lozenge in patients with head and neck cancer receiving radiation therapy. Head Neck (2002); 24: 6.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>6</start></extent></part><relatedItem type="host"><titleInfo><title>Head Neck</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>6</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit97"><titleInfo><title>Evaluating the safety of combination vaccines</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ellenberg SS. Evaluating the safety of combination vaccines. Clin Infect Dis (2001); 33: S319.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>S319</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Infect Dis</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>S319</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit98"><titleInfo><title>Philosophic objection to vaccination as a risk for tetanus among children younger than 15 years (Online Paper)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Fair E, Murphy TV, Golaz A, Wharton M. Philosophic objection to vaccination as a risk for tetanus among children younger than 15 years (Online Paper). Pediatrics (2002); 109: U7.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>U7</start></extent></part><relatedItem type="host"><titleInfo><title>Pediatrics</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>U7</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit99"><titleInfo><title>Eosinophilic hepatitis associated with cefonicid therapy (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Famularo G, Bizzarri C, Federico M, Martiradonna C, Polchi S, Nicotra GC. Eosinophilic hepatitis associated with cefonicid therapy (Letter). Ann Pharmacother (2001); 35: 1669.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1669</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Pharmacother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1669</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit100"><titleInfo><title>Outbreak of acute renal failure due to cefodizime‐vancomycin association in a heart surgery unit</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Fiaccadori E, Maggiore U, Arisi A, Cabassi A, Beghi C, Campodonico R, Gherli T. Outbreak of acute renal failure due to cefodizime‐vancomycin association in a heart surgery unit. Intensive Care Med (2001); 27: 1819.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>1819</start></extent></part><relatedItem type="host"><titleInfo><title>Intensive Care Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>1819</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit101"><titleInfo><title>Rheumatological complications associated with the use of indinavir and other protease inhibitors</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Florence E, Schrooten W, Verdonck K, Dreezen C, Colebunders R. Rheumatological complications associated with the use of indinavir and other protease inhibitors. Ann Rheum Dis (2002); 61: 82.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>61</number></detail><extent unit="pages"><start>82</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Rheum Dis</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>61</number></detail><extent unit="pages"><start>82</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit102"><titleInfo><title>Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Frothingham R. Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin. Pharmacotherapy (2001); 21: 1468.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>1468</start></extent></part><relatedItem type="host"><titleInfo><title>Pharmacotherapy</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>1468</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit103"><titleInfo><title>Rubella vaccine and arthritic adverse reactions: An analysis of the Vaccine Adverse Events Reporting System (VAERS) database from 1991 through 1998</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Geier DA, Geier MR. Rubella vaccine and arthritic adverse reactions: An analysis of the Vaccine Adverse Events Reporting System (VAERS) database from 1991 through 1998. Clin Exp Rheumatol (2001); 19: 724.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>724</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Exp Rheumatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>724</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit104"><titleInfo><title>Mesalazine‐induced pustular drug eruption</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gibbon KL, Bewley AP, Thomas K. Mesalazine‐induced pustular drug eruption. J Am Acad Dermatol (2001); 45: S220.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>S220</start></extent></part><relatedItem type="host"><titleInfo><title>J Am Acad Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>S220</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit105"><titleInfo><title>Efficacy and safety of ciprofloxacin oral suspension versus trimethoprim‐sulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gomolin IH, Siami PF, Reuning‐Scherer J, Haverstock DC, Heyd A. Efficacy and safety of ciprofloxacin oral suspension versus trimethoprim‐sulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection. J Am Geriatr Soc (2001); 49: 1606.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>49</number></detail><extent unit="pages"><start>1606</start></extent></part><relatedItem type="host"><titleInfo><title>J Am Geriatr Soc</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>49</number></detail><extent unit="pages"><start>1606</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit106"><titleInfo><title>Influenza vaccine in patients infected with the human immunodeficiency virus: Should it be administered to all the patients? Reply (Letter) (Spanish)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gonzalez JA, Sanchez FG. Influenza vaccine in patients infected with the human immunodeficiency virus: Should it be administered to all the patients? Reply (Letter) (Spanish). Rev Clin Esp (2001); 201: 733.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>201</number></detail><extent unit="pages"><start>733</start></extent></part><relatedItem type="host"><titleInfo><title>Rev Clin Esp</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>201</number></detail><extent unit="pages"><start>733</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit107"><titleInfo><title>An attack of epilepsy following chemoprophylaxis with chloroquine (Letter) (French)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Guilloton L, Burckard E, Fresse S, Drouet A, Felten D. An attack of epilepsy following chemoprophylaxis with chloroquine (Letter) (French). Presse Med (2001); 30: 1745.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>1745</start></extent></part><relatedItem type="host"><titleInfo><title>Presse Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>1745</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit108"><titleInfo><title>MMR: Separate administration ‐ Has it been done? (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Halsey N, Hyman SL. MMR: Separate administration ‐ Has it been done? (Reply). Pediatrics (2002); 109: 172.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>172</start></extent></part><relatedItem type="host"><titleInfo><title>Pediatrics</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>172</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit109"><titleInfo><title>Combination vaccines: Defining and addressing current safety concerns</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Halsey NA. Combination vaccines: Defining and addressing current safety concerns. Clin Infect Dis (2001); 33: S312.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>S312</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Infect Dis</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>S312</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit110"><titleInfo><title>Efficacy and safety of gemifloxacin in the treatment of community‐acquired pneumonia: A randomized, double‐blind comparison with trovafloxacin (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hammerschlag MR. Efficacy and safety of gemifloxacin in the treatment of community‐acquired pneumonia: A randomized, double‐blind comparison with trovafloxacin (Letter). J Antimicrob Chemother (2001); 48: 735.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>48</number></detail><extent unit="pages"><start>735</start></extent></part><relatedItem type="host"><titleInfo><title>J Antimicrob Chemother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>48</number></detail><extent unit="pages"><start>735</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit111"><titleInfo><title>Gatifloxacin‐associated acute hepatitis (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Henann NE, Zambie MF. Gatifloxacin‐associated acute hepatitis (Case Report). Pharmacotherapy (2001); 21: 1579.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>1579</start></extent></part><relatedItem type="host"><titleInfo><title>Pharmacotherapy</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>1579</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit112"><titleInfo><title>Acute toxicity in erythroid bone marrow progenitors after antimonial therapy</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hernandez JA, Navarro JT, Force L. Acute toxicity in erythroid bone marrow progenitors after antimonial therapy. Haematologica (2001); 86: 1319.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>86</number></detail><extent unit="pages"><start>1319</start></extent></part><relatedItem type="host"><titleInfo><title>Haematologica</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>86</number></detail><extent unit="pages"><start>1319</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit113"><titleInfo><title>Pharmacokinetic interactions between nelfinavir and 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hsyu PH, Schultz‐Smith MD, Lillibridge JH, Lewis RH, Kerr BM. Pharmacokinetic interactions between nelfinavir and 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin. Antimicrob Agents Chemother (2001); 45: 3445.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>3445</start></extent></part><relatedItem type="host"><titleInfo><title>Antimicrob Agents Chemother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>3445</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit114"><titleInfo><title>Meta‐analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for upper respiratory tract infections</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ioannidis JPA, Contopoulos‐Ioannidis DG, Chew P, Lau J. Meta‐analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for upper respiratory tract infections. J Antimicrob Chemother (2001); 48:677.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>48</number></detail><extent unit="pages"><start>677</start></extent></part><relatedItem type="host"><titleInfo><title>J Antimicrob Chemother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>48</number></detail><extent unit="pages"><start>677</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit115"><titleInfo><title>Pyrogenic reactions following gentamicin therapy: An alternative explanation</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jaber BL. Pyrogenic reactions following gentamicin therapy: An alternative explanation. Med Hypotheses (2001); 57: 727.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>727</start></extent></part><relatedItem type="host"><titleInfo><title>Med Hypotheses</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>727</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit116"><titleInfo><title>Diagnostic confusion caused by dapsone‐induced methaemoglobinaemia (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kannan S. Diagnostic confusion caused by dapsone‐induced methaemoglobinaemia (Letter). Br J Anaesth (2001); 87: 802.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><extent unit="pages"><start>802</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Anaesth</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><extent unit="pages"><start>802</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit117"><titleInfo><title>Optic neuritis after anthrax vaccination</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kerrison JB, Lounsbury D, Thirkill CE, Lane RG, Schatz MP, Engler RM. Optic neuritis after anthrax vaccination. Ophthalmology (2002); 109: 99.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>99</start></extent></part><relatedItem type="host"><titleInfo><title>Ophthalmology</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>99</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit118"><titleInfo><title>Safety, vaccine virus shedding and immunogenicity of trivalent, cold‐adapted, live attenuated influenza vaccine administered to human immunodeficiency virus‐infected and noninfected children</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">King JC, Fast PE, Zangwill KM, Weinberg GA, Wolff M, Yan LH, Newman F, Belshe RB, Kovacs A, Deville JG, Jelonek M. Safety, vaccine virus shedding and immunogenicity of trivalent, cold‐adapted, live attenuated influenza vaccine administered to human immunodeficiency virus‐infected and noninfected children. Pediatr Infect Dis J (2001); 20: 1124.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>1124</start></extent></part><relatedItem type="host"><titleInfo><title>Pediatr Infect Dis J</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>1124</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit119"><titleInfo><title>Kerion celsi in an infant treated with oral terbinafine (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kobayashi M, Yamamoto O, Suenaga Y, Asahi M. Kerion celsi in an infant treated with oral terbinafine (Letter). J Dermatol (2001); 28: 108.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>108</start></extent></part><relatedItem type="host"><titleInfo><title>J Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>108</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit120"><titleInfo><title>Safety and immunogenicity of a yeast‐derived recombinant hepatitis B vaccine in Bulgarian newborns</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kojouharova M, Teoharov P, Bahtchevanova T, Maeva I, Eginlian A, Deneva M. Safety and immunogenicity of a yeast‐derived recombinant hepatitis B vaccine in Bulgarian newborns. Infection (2001); 29: 342.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>29</number></detail><extent unit="pages"><start>342</start></extent></part><relatedItem type="host"><titleInfo><title>Infection</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>29</number></detail><extent unit="pages"><start>342</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit121"><titleInfo><title>Quinine‐associated thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome: Frequency, clinical features, and long‐term outcomes</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kojouri K, Vesely SK, George JN. Quinine‐associated thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome: Frequency, clinical features, and long‐term outcomes. Ann Intern Med (2001); 135: 1047.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>135</number></detail><extent unit="pages"><start>1047</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Intern Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>135</number></detail><extent unit="pages"><start>1047</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit122"><titleInfo><title>Rate and risk factors of liver toxicity in patients receiving antiretroviral therapy (Spanish, English Abstract)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lana R, Nunez M, Mendoza JL, Soriano V. Rate and risk factors of liver toxicity in patients receiving antiretroviral therapy (Spanish, English Abstract). Med Clin (2001); 117: 607.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>117</number></detail><extent unit="pages"><start>607</start></extent></part><relatedItem type="host"><titleInfo><title>Med Clin</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>117</number></detail><extent unit="pages"><start>607</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit123"><titleInfo><title>Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: A prospective, randomized, single blind trial</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lebel MH, Mehra S. Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: A prospective, randomized, single blind trial. Pediatr Infect Dis J (2001); 20: 1149.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>1149</start></extent></part><relatedItem type="host"><titleInfo><title>Pediatr Infect Dis J</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>1149</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit124"><titleInfo><title>Toxic interaction of didanosine and acetaminophen leading to severe hepatitis and pancreatitis: A case report and review of the literature (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lederman JC, Nawaz H. Toxic interaction of didanosine and acetaminophen leading to severe hepatitis and pancreatitis: A case report and review of the literature (Letter). Am J Gastroenterol (2001); 96: 3474.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>3474</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Gastroenterol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>3474</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit125"><titleInfo><title>MMR: Separate administration ‐ Has it been done? (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Leitch R. MMR: Separate administration ‐ Has it been done? (Letter). Pediatrics (2002); 109: 172.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>172</start></extent></part><relatedItem type="host"><titleInfo><title>Pediatrics</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>172</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit126"><titleInfo><title>Terbinafine‐associated taste disturbance with normal taste threshold scores</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lemont H, Sabo M. Terbinafine‐associated taste disturbance with normal taste threshold scores. J Am Podiat Med Assoc (2001); 91: 540.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>91</number></detail><extent unit="pages"><start>540</start></extent></part><relatedItem type="host"><titleInfo><title>J Am Podiat Med Assoc</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>91</number></detail><extent unit="pages"><start>540</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit127"><titleInfo><title>Diagnostic confusion caused by dapsone‐induced methaemoglobinaemia (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lewis S, Clark P. Diagnostic confusion caused by dapsone‐induced methaemoglobinaemia (Letter). Br J Anaesth (2001); 87: 802.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><extent unit="pages"><start>802</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Anaesth</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><extent unit="pages"><start>802</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit128"><titleInfo><title>Anaphylactic reactions due to chlorhexidine allergy (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lockhart AS, Harle CC. Anaphylactic reactions due to chlorhexidine allergy (Letter). Br J Anaesth (2001); 87: 940.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><extent unit="pages"><start>940</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Anaesth</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><extent unit="pages"><start>940</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit129"><titleInfo><title>High occurrence of hepatotoxicity and rash in patients treated with oxacillin, compared with those treated with nafcillin and other commonly used antimicrobials</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Maraqa NF, Gomez MM, Rathore MH, Alvarez AM. High occurrence of hepatotoxicity and rash in patients treated with oxacillin, compared with those treated with nafcillin and other commonly used antimicrobials. Clin Infect Dis (2002); 34: 50.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>50</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Infect Dis</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>50</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit130"><titleInfo><title>Challenges to vaccine safety</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Marshall GS, Gellin BG. Challenges to vaccine safety. Prim Care (2001); 28: 853.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>853</start></extent></part><relatedItem type="host"><titleInfo><title>Prim Care</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>853</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit131"><titleInfo><title>Impaired absorption of rifabutin by concomitant administration of didanosine (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Marzolini C, Chave JP, Telenti A, Brenas‐Chinchon L, Biollaz J. Impaired absorption of rifabutin by concomitant administration of didanosine (Letter). AIDS (2001); 15: 2203.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>2203</start></extent></part><relatedItem type="host"><titleInfo><title>AIDS</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>2203</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit132"><titleInfo><title>Bacterial pneumopathy enhanced by diazepam during acute intoxication with chloroquine (Letter) (French)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Megarbane B, Goldgran‐Toledano D, Reziere D, N'Gueye P, Baud F. Bacterial pneumopathy enhanced by diazepam during acute intoxication with chloroquine (Letter) (French). Presse Med (2001); 30: 1686.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>1686</start></extent></part><relatedItem type="host"><titleInfo><title>Presse Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>1686</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit133"><titleInfo><title>Higher efavirenz plasma levels correlate with development of insomnia (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nunez M, De Requena DG, Gallego L, Jimenez‐Nacher I, Gonzalez‐Lahoz J, Soriano V. Higher efavirenz plasma levels correlate with development of insomnia (Letter). J Acquir Immune Defic Syndr Hum Retrovirol (2001); 28: 399.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>399</start></extent></part><relatedItem type="host"><titleInfo><title>J Acquir Immune Defic Syndr Hum Retrovirol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>399</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit134"><titleInfo><title>Addressing parents' concerns: Do multiple vaccines overwhelm or weaken the infant's immune system</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Offit PA, Quarles J, Gerber MA, Hackett CJ, Marcuse EK, Kollman TR, Gellin BG, Landry S. Addressing parents' concerns: Do multiple vaccines overwhelm or weaken the infant's immune system? Pediatrics (2002); 109: 124.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>124</start></extent></part><relatedItem type="host"><titleInfo><title>Pediatrics</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>124</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit135"><titleInfo><title>Vancomycin‐induced linear IgA disease with autoantibodies to BP180 and LAD285 (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Palmer RA, Allen J, Banerjee A, Ryatt KS, Ratnavel R, Wojnarowska F. Vancomycin‐induced linear IgA disease with autoantibodies to BP180 and LAD285 (Case Report). Br J Dermatol (2001); 145: 816.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>145</number></detail><extent unit="pages"><start>816</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>145</number></detail><extent unit="pages"><start>816</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit136"><titleInfo><title>Influenza vaccine in patients infected with the human immunodeficiency virus: Should it be administered to all the patients? (Letter) (Spanish)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Peiro AM, Rincon JMR, Rodero FG. Influenza vaccine in patients infected with the human immunodeficiency virus: Should it be administered to all the patients? (Letter) (Spanish). Rev Clin Esp (2001); 201: 732.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>201</number></detail><extent unit="pages"><start>732</start></extent></part><relatedItem type="host"><titleInfo><title>Rev Clin Esp</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>201</number></detail><extent unit="pages"><start>732</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit137"><titleInfo><title>Whipple's disease associated with pulmonary hypertension: Jarisch‐Hersheimer reaction after antibiotic therapy (French)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Peschard S, Brinkane A, Bergheul S, Crickx L, Gaudin B, Morcelet M, Levy R. Whipple's disease associated with pulmonary hypertension: Jarisch‐Hersheimer reaction after antibiotic therapy (French). Presse Med (2001); 30: 1549.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>1549</start></extent></part><relatedItem type="host"><titleInfo><title>Presse Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>1549</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit138"><titleInfo><title>Anthrax vaccine: Short‐term safety experience in humans</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Pittman PR, Gibbs PH, Cannon TL, Friedlander AM. Anthrax vaccine: Short‐term safety experience in humans. Vaccine (2001); 20: 972.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>972</start></extent></part><relatedItem type="host"><titleInfo><title>Vaccine</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>972</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit139"><titleInfo><title>Safety and immunogenicity of a new mammalian cell‐derived recombinant hepatitis B vaccine containing Pre‐S‐1 and Pre‐S‐2 antigens in adults</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Raz R, Koren R, Bass D. Safety and immunogenicity of a new mammalian cell‐derived recombinant hepatitis B vaccine containing Pre‐S‐1 and Pre‐S‐2 antigens in adults. Isr Med Assoc J (2001); 3: 328.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>328</start></extent></part><relatedItem type="host"><titleInfo><title>Isr Med Assoc J</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>328</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit140"><titleInfo><title>HIV‐associated lipodystrophy syndrome: Overview and summary of case reports (News)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Reid S. HIV‐associated lipodystrophy syndrome: Overview and summary of case reports (News). Can Med Assoc J (2002); 166: 87.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>166</number></detail><extent unit="pages"><start>87</start></extent></part><relatedItem type="host"><titleInfo><title>Can Med Assoc J</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>166</number></detail><extent unit="pages"><start>87</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit141"><titleInfo><title>Severe ototoxicity in a health care worker who received postexposure prophylaxis with stavudine, lamivudine, and nevirapine after occupational exposure to HIV (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rey D, L'Heritier A, Lang JM. Severe ototoxicity in a health care worker who received postexposure prophylaxis with stavudine, lamivudine, and nevirapine after occupational exposure to HIV (Letter). Clin Infect Dis (2002); 34: 418.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>418</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Infect Dis</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>418</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit142"><titleInfo><title>Hair loss after terbinafine treatment (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Richert B, Uhoda I, De la Brassinne M. Hair loss after terbinafine treatment (Letter). Br J Dermatol (2001); 145: 842.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>145</number></detail><extent unit="pages"><start>842</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>145</number></detail><extent unit="pages"><start>842</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit143"><titleInfo><title>Recurrent lupus vulgaris following repeated BCG (Bacillus Calmette Guerin) vaccination</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sasmaz R, Altinyazar HC, Tatlican S, Eskioglu F, Yurtsever P. Recurrent lupus vulgaris following repeated BCG (Bacillus Calmette Guerin) vaccination. J Dermatol (2001); 28: 762.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>762</start></extent></part><relatedItem type="host"><titleInfo><title>J Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>762</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit144"><titleInfo><title>A safe, effective, herbal antischistosomal therapy derived from myrrh</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sheir Z, Nasr AA, Massoud A, Salama O, Badra GA, El Shennawy H, Hassan N, Hammad SM. A safe, effective, herbal antischistosomal therapy derived from myrrh. Am J Trop Med Hyg (2001); 65: 700.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>65</number></detail><extent unit="pages"><start>700</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Trop Med Hyg</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>65</number></detail><extent unit="pages"><start>700</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit145"><titleInfo><title>Ototoxicity may be associated with protease inhibitor therapy (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Simdon J, Watters D, Bartlett S, Connick E. Ototoxicity may be associated with protease inhibitor therapy (Reply). Clin Infect Dis (2001); 33: 2101.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>2101</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Infect Dis</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>2101</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit146"><titleInfo><title>Hepatotoxicity associated with nevirapine or efavirenz‐containing antiretroviral therapy: Role of hepatitis C and B infections</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD. Hepatotoxicity associated with nevirapine or efavirenz‐containing antiretroviral therapy: Role of hepatitis C and B infections. Hepatology (2002); 35: 182.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>182</start></extent></part><relatedItem type="host"><titleInfo><title>Hepatology</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>182</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit147"><titleInfo><title>Comment: Peripheral neuropathy syndrome and fluoroquinolones (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tillotson GS. Comment: Peripheral neuropathy syndrome and fluoroquinolones (Letter). Ann Pharmacother (2001); 35: 1673.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1673</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Pharmacother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1673</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit148"><titleInfo><title>Pulmonary toxicity with mefloquine (Case Study)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Udry E, Bailly F, Dusmet M, Schnyder P, Lemoine R, Fitting JW. Pulmonary toxicity with mefloquine (Case Study). Eur Resp J (2001); 18: 890.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>890</start></extent></part><relatedItem type="host"><titleInfo><title>Eur Resp J</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>890</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit149"><titleInfo><title>Past exposure to vaccines and subsequent risk of Alzheimer's disease</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Verreault R, Laurin D, Lindsay J, De Serres G. Past exposure to vaccines and subsequent risk of Alzheimer's disease. Can Med Assoc J (2001); 165: 1495.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>165</number></detail><extent unit="pages"><start>1495</start></extent></part><relatedItem type="host"><titleInfo><title>Can Med Assoc J</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>165</number></detail><extent unit="pages"><start>1495</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit150"><titleInfo><title>Enhancing Vaccine Safety Surveillance: A capture‐recapture analysis of intussusception after rotavirus vaccination</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Verstraeten T, Baughman AL, Cadwell B, Zanardi L, Haber P, Chen RT. Enhancing Vaccine Safety Surveillance: A capture‐recapture analysis of intussusception after rotavirus vaccination. Am J Epidemiol (2001); 154: 1006.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>154</number></detail><extent unit="pages"><start>1006</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Epidemiol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>154</number></detail><extent unit="pages"><start>1006</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit151"><titleInfo><title>Safety, tolerance, and pharmacokinetics of high‐dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: Maximum tolerated dose study</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Walsh TJ, Goodman JL, Pappas P, Bekersky I, Buell DN, Roden M, Barrett J, Anaissie EJ. Safety, tolerance, and pharmacokinetics of high‐dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: Maximum tolerated dose study. Antimicrob Agents Chemother(2001); 45: 3487.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>3487</start></extent></part><relatedItem type="host"><titleInfo><title>Antimicrob Agents Chemother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>3487</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit152"><titleInfo><title>Association between efavirenz and selected psychiatric and neurological conditions (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Welch KJ, Morse A. Association between efavirenz and selected psychiatric and neurological conditions (Letter). J Infect Dis (2002); 185: 268.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>185</number></detail><extent unit="pages"><start>268</start></extent></part><relatedItem type="host"><titleInfo><title>J Infect Dis</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>185</number></detail><extent unit="pages"><start>268</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit153"><titleInfo><title>Ototoxicity may be associated with protease inhibitor therapy (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Williams B. Ototoxicity may be associated with protease inhibitor therapy (Letter). Clin Infect Dis (2001); 33: 2100.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>2100</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Infect Dis</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>2100</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit154"><titleInfo><title>Prednisolone does not prevent hypersensitivity reactions in antiretroviral drug regimens containing abacavir with or without nevirapine</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wit FWNM, Wood R, Horban A, Beniowski M, Schmidt RE, Gray G, Lazzarin A, Lafeuillade A, Paes D, Carlier H, Van Weert L, De Vries C, Van Leeuwen R, Lange JM. Prednisolone does not prevent hypersensitivity reactions in antiretroviral drug regimens containing abacavir with or without nevirapine. AIDS (2001); 15: 2423.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>2423</start></extent></part><relatedItem type="host"><titleInfo><title>AIDS</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>2423</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit155"><titleInfo><title>Amoxicillin‐induced aseptic meningitis</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wittmann A, Wooten GF. Amoxicillin‐induced aseptic meningitis. Neurology (2001); 57: 1734.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>1734</start></extent></part><relatedItem type="host"><titleInfo><title>Neurology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>1734</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit156"><titleInfo><title>Sex differences in nevirapine rash (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wong KH, Chan KCW, Lee SS. Sex differences in nevirapine rash (Letter). Clin Infect Dis (2001); 33: 2096.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>2096</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Infect Dis</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>2096</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit157"><titleInfo><title>Reversible metronidazole‐induced lesions of the cerebellar dentate nuclei (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Woodruff BK, Wijdicks EFM, Marshall WF. Reversible metronidazole‐induced lesions of the cerebellar dentate nuclei (Letter). N Engl J Med (2001); 346: 68.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>346</number></detail><extent unit="pages"><start>68</start></extent></part><relatedItem type="host"><titleInfo><title>N Engl J Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>346</number></detail><extent unit="pages"><start>68</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit158"><titleInfo><title>Rapidly progressive glomerulonephritis due to rifampicin therapy</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Yoshioka K, Satake N, Kasamatsu Y, Nakamura Y, Shikata N. Rapidly progressive glomerulonephritis due to rifampicin therapy. Nephron (2002); 90: 116.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>90</number></detail><extent unit="pages"><start>116</start></extent></part><relatedItem type="host"><titleInfo><title>Nephron</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>90</number></detail><extent unit="pages"><start>116</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit159"><titleInfo><title>A case of childhood generalized pustular psoriasis treated with dapsone</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Yu HJ, Park JW, Park JM, Hwang DK, Park YW. A case of childhood generalized pustular psoriasis treated with dapsone. J Dermatol (2001); 28: 316.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>316</start></extent></part><relatedItem type="host"><titleInfo><title>J Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>316</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit160"><titleInfo><title>4. Cardiovascular system agents</title></titleInfo><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit161"><titleInfo><title>Cilazapril‐induced SIADH (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Arinzon ZH, Lehman YA, Fidelman ZG. Cilazapril‐induced SIADH (Letter). J Am Geriatr Soc (2001); 49: 1735.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>49</number></detail><extent unit="pages"><start>1735</start></extent></part><relatedItem type="host"><titleInfo><title>J Am Geriatr Soc</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>49</number></detail><extent unit="pages"><start>1735</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit162"><titleInfo><title>Indapamide‐induced pemphigus foliaceus (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bayramgurler D, Ercin C, Apaydin R, Unal G. Indapamide‐induced pemphigus foliaceus (Case Report). J Dermatol Treat (2001); 12: 175.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>175</start></extent></part><relatedItem type="host"><titleInfo><title>J Dermatol Treat</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>175</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit163"><titleInfo><title>Amlodipine gynaecomastia (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cornes PGS, Hole AC. Amlodipine gynaecomastia (Case Report). Breast (2001); 10: 544.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>544</start></extent></part><relatedItem type="host"><titleInfo><title>Breast</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>544</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit164"><titleInfo><title>Safety and efficacy of intraarterial thrombolysis for perioperative stroke after cardiac operation (Invited commentary)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Davila‐Roman VG, Hogue CW. Safety and efficacy of intraarterial thrombolysis for perioperative stroke after cardiac operation (Invited commentary). Ann Thorac Surg (2001); 72: 1938.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>72</number></detail><extent unit="pages"><start>1938</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Thorac Surg</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>72</number></detail><extent unit="pages"><start>1938</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit165"><titleInfo><title>Use of cardiovascular drugs in Spain</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Del Pozo JG, Carvajal A, Sevillano ER, De Abajo FJ, Montero D, Madurga M. Use of cardiovascular drugs in Spain. Methods Find Exp Clin Pharmacol (2001); 23: 291.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>291</start></extent></part><relatedItem type="host"><titleInfo><title>Methods Find Exp Clin Pharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>291</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit166"><titleInfo><title>Severe polymorphous pustular vasculitis induced by losartan (French, English Abstract)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Franchimont CP, Henry F, Pierard GE. Severe polymorphous pustular vasculitis induced by losartan (French, English Abstract). Ann Dermatol Venereol (2001); 128: 1040.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>128</number></detail><extent unit="pages"><start>1040</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Dermatol Venereol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>128</number></detail><extent unit="pages"><start>1040</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit167"><titleInfo><title>Safety and efficacy of intraarterial thrombolysis for perioperative stroke after cardiac operation (Discussion)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Fullerton DA, Moazami N, Crosby IK, Kurlansky P. Safety and efficacy of intraarterial thrombolysis for perioperative stroke after cardiac operation (Discussion). Ann Thorac Surg (2001); 72: 1937.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>72</number></detail><extent unit="pages"><start>1937</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Thorac Surg</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>72</number></detail><extent unit="pages"><start>1937</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit168"><titleInfo><title>Other reports of cerivastatin‐induced rhabdomyolysis (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gabay M, Lodolce A. Other reports of cerivastatin‐induced rhabdomyolysis (Letter). Arch Intern Med (2001); 161: 2629.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>2629</start></extent></part><relatedItem type="host"><titleInfo><title>Arch Intern Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>2629</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit169"><titleInfo><title>Another report of acute rhabdomyolysis following cerivastatin monotherapy (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gonzalez‐Reimers E, Santolaria‐Fernandez F, Garcia‐Valdecasas‐Campelo E, Rodriguez‐Rodriguez E, Lopez‐Lirola A. Another report of acute rhabdomyolysis following cerivastatin monotherapy (Reply). Arch Intern Med (2001); 161: 2630.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>2630</start></extent></part><relatedItem type="host"><titleInfo><title>Arch Intern Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>2630</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit170"><titleInfo><title>Acute effects of sildenafil citrate (Viagra®) on intraocular pressure in open‐angle glaucoma</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Grunwald JE, Jacob SS, Siu K, Piltz J, Dupont J. Acute effects of sildenafil citrate (Viagra®) on intraocular pressure in open‐angle glaucoma. Am J Ophthalmol (2001); 132: 872.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>132</number></detail><extent unit="pages"><start>872</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Ophthalmol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>132</number></detail><extent unit="pages"><start>872</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit171"><titleInfo><title>Effect of sildenafil citrate (viagra) on the ocular circulation (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Grunwald JE. Effect of sildenafil citrate (viagra) on the ocular circulation (Reply). Am J Ophthalmol (2002); 133: 170.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>133</number></detail><extent unit="pages"><start>170</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Ophthalmol</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>133</number></detail><extent unit="pages"><start>170</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit172"><titleInfo><title>Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gupta AA, Leaker M, Andrew M, Massicotte P, Liu L, Benson LN, McCrindle BW. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children. J Pediatr (2001); 139: 682.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>139</number></detail><extent unit="pages"><start>682</start></extent></part><relatedItem type="host"><titleInfo><title>J Pediatr</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>139</number></detail><extent unit="pages"><start>682</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit173"><titleInfo><title>Effect of sildenafil citrate (Viagra) on the ocular circulation (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hayreh SS. Effect of sildenafil citrate (Viagra) on the ocular circulation (Letter). Am J Ophthalmol (2002); 133: 169.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>133</number></detail><extent unit="pages"><start>169</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Ophthalmol</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>133</number></detail><extent unit="pages"><start>169</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit174"><titleInfo><title>Adverse drug reaction monitoring: Digitoxin overdosage in the elderly</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hippius M, Humaid B, Sicker T, Hoffmann A, Gottler M, Hasford J. Adverse drug reaction monitoring: Digitoxin overdosage in the elderly. Int J Clin Pharm Ther (2001); 39: 336.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>336</start></extent></part><relatedItem type="host"><titleInfo><title>Int J Clin Pharm Ther</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>336</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit175"><titleInfo><title>Population pharmacokinetics of perhexiline from very sparse, routine monitoring data</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hussein R, Charles BG, Morris RG, Rasiah RL. Population pharmacokinetics of perhexiline from very sparse, routine monitoring data. Ther Drug Monit (2001); 23: 636.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>636</start></extent></part><relatedItem type="host"><titleInfo><title>Ther Drug Monit</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>636</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit176"><titleInfo><title>A case of lichenoid purpura possibly caused by diltiazem hydrochloride</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Inui S, Itami S, Yoshikawa K. A case of lichenoid purpura possibly caused by diltiazem hydrochloride. J Dermatol (2001); 28: 100.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>100</start></extent></part><relatedItem type="host"><titleInfo><title>J Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>100</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit177"><titleInfo><title>Nephrotoxicity in the elderly due to co‐prescription of ACE inhibitors and NSAIDs (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jolobe OMP. Nephrotoxicity in the elderly due to co‐prescription of ACE inhibitors and NSAIDs (Letter). J R Soc Med (2001); 94: 657.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>94</number></detail><extent unit="pages"><start>657</start></extent></part><relatedItem type="host"><titleInfo><title>J R Soc Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>94</number></detail><extent unit="pages"><start>657</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit178"><titleInfo><title>Epidemiologic evidence existing for calcium antagonists (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kizer JR, Kimmel SE. Epidemiologic evidence existing for calcium antagonists (Reply). Arch Intern Med (2001); 161: 2627.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>2627</start></extent></part><relatedItem type="host"><titleInfo><title>Arch Intern Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>2627</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit179"><titleInfo><title>Captopril is an unlikely cause of nephrotic syndrome (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Materson BJ. Captopril is an unlikely cause of nephrotic syndrome (Letter). Arch Intern Med (2001); 161: 2635.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>2635</start></extent></part><relatedItem type="host"><titleInfo><title>Arch Intern Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>2635</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit180"><titleInfo><title>Another report of acute rhabdomyolysis following cerivastatin monotherapy (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Milionis HJ, Tsagpoga TG, Elisaf MS. Another report of acute rhabdomyolysis following cerivastatin monotherapy (Letter). Arch Intern Med (2001); 161: 2629.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>2629</start></extent></part><relatedItem type="host"><titleInfo><title>Arch Intern Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>2629</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit181"><titleInfo><title>Safety and efficacy of intraarterial thrombolysis for perioperative stroke after cardiac operation</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Moazami N, Smedira NG, McCarthy PM, Katzan I, Sila CA, Lytle BW, Cosgrave DM. Safety and efficacy of intraarterial thrombolysis for perioperative stroke after cardiac operation. Ann Thorac Surg (2001); 72: 1933.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>72</number></detail><extent unit="pages"><start>1933</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Thorac Surg</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>72</number></detail><extent unit="pages"><start>1933</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit182"><titleInfo><title>Transient ischemic attack and stroke associated with sildenafil (Viagra) use</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Morgan JC, Alhatou M, Oberlies J, Johnston KC. Transient ischemic attack and stroke associated with sildenafil (Viagra) use. Neurology (2001); 57: 1730.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>1730</start></extent></part><relatedItem type="host"><titleInfo><title>Neurology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>1730</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit183"><titleInfo><title>Dipyridamole‐atropine‐induced myocardial infarction in a patient with patent epicardial coronary arteries</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nedeljkovic MA, Ostojic M, Beleslin B, Nedeljkovic IP, Stankovic G, Stojkovic S, Saponjski J, Babic R, Vukcevic V, Ristic AD, Orlic D. Dipyridamole‐atropine‐induced myocardial infarction in a patient with patent epicardial coronary arteries. Herz (2001); 26: 485.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>485</start></extent></part><relatedItem type="host"><titleInfo><title>Herz</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>485</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit184"><titleInfo><title>Metabolic effects and safety profile of nebivolol</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Pessina AC. Metabolic effects and safety profile of nebivolol. J Cardiovasc Pharmacol (2001); 38: S33.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>S33</start></extent></part><relatedItem type="host"><titleInfo><title>J Cardiovasc Pharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>S33</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit185"><titleInfo><title>Risk for hyperkalaemia during long‐term treatment with angiotensin‐converting enzyme inhibitors in insulin‐dependent type 2 diabetics in relation to the GFR (German, English Abstract)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Raml A, Schmekal B, Grafinger P, Biesenbach G. Risk for hyperkalaemia during long‐term treatment with angiotensin‐converting enzyme inhibitors in insulin‐dependent type 2 diabetics in relation to the GFR (German, English Abstract). Dtsch Med Wochenschr (2001); 126: 1327.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>126</number></detail><extent unit="pages"><start>1327</start></extent></part><relatedItem type="host"><titleInfo><title>Dtsch Med Wochenschr</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>126</number></detail><extent unit="pages"><start>1327</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit186"><titleInfo><title>Acute hepatitis induced by valsartan (Letter) (Spanish)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rene JM, Buenestado J, Sese E, Minana JM. Acute hepatitis induced by valsartan (Letter) (Spanish). Med Clin (2001); 117: 637.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>117</number></detail><extent unit="pages"><start>637</start></extent></part><relatedItem type="host"><titleInfo><title>Med Clin</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>117</number></detail><extent unit="pages"><start>637</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit187"><titleInfo><title>The prescription pattern of oral nitrates in coronary artery disease: Appropriateness and cost considerations</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Reuveni H, Aviram EE, Elhayani A, Lifshitz M, Peled R, Galai N, Sherf M, Paran E. The prescription pattern of oral nitrates in coronary artery disease: Appropriateness and cost considerations. Eur J Clin Pharmacol (2001); 57: 595.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>595</start></extent></part><relatedItem type="host"><titleInfo><title>Eur J Clin Pharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>595</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit188"><titleInfo><title>Rhabdomyolysis associated with combined cerivastatin‐gemfibrozil therapy (Letter) (Spanish)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rovira TB, Pou JAL, Forteza‐Rey J. Rhabdomyolysis associated with combined cerivastatin‐gemfibrozil therapy (Letter) (Spanish). Rev Clin Esp (2001); 201: 731.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>201</number></detail><extent unit="pages"><start>731</start></extent></part><relatedItem type="host"><titleInfo><title>Rev Clin Esp</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>201</number></detail><extent unit="pages"><start>731</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit189"><titleInfo><title>Impaired cognitive function and compliance with antihypertensive drugs in elderly: The Rotterdam Study</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Salas M, Int'Veld BA, Van der Linden PD, Hofman A, Breteler M, Stricker BH. Impaired cognitive function and compliance with antihypertensive drugs in elderly: The Rotterdam Study. Clin Pharm Ther (2001); 70: 561.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>70</number></detail><extent unit="pages"><start>561</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Pharm Ther</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>70</number></detail><extent unit="pages"><start>561</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit190"><titleInfo><title>Efficacy, safety and predictive factors of therapeutic success with sildenafil for erectile dysfunction in patients with different spinal cord injuries</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sanchez‐Ramos AS, Vidal J, Jauregui ML, Barrera M, Recio C, Giner M, Toribio L, Salvador S, Sanmartin A, De la Fuente M, Santos JF, De Juan FJ, Moraleda S, Mendez JL, Ramirez L, Casado RM. Efficacy, safety and predictive factors of therapeutic success with sildenafil for erectile dysfunction in patients with different spinal cord injuries. Spinal Cord (YR); 39: 637.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>637</start></extent></part><relatedItem type="host"><titleInfo><title>Spinal Cord</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>637</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit191"><titleInfo><title>Caudate hemorrhage as a possible complication of midodrine‐induced supine hypertension (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sandroni P, Benarroch EE, Wijdicks EFM. Caudate hemorrhage as a possible complication of midodrine‐induced supine hypertension (Letter). Mayo Clin Proc (2001); 76: 1275.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>76</number></detail><extent unit="pages"><start>1275</start></extent></part><relatedItem type="host"><titleInfo><title>Mayo Clin Proc</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>76</number></detail><extent unit="pages"><start>1275</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit192"><titleInfo><title>Case reports of rhabdomyolysis associated with cerivastatin therapy (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Simpson S. Case reports of rhabdomyolysis associated with cerivastatin therapy (Letter). Arch Intern Med (2001); 161: 2630.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>2630</start></extent></part><relatedItem type="host"><titleInfo><title>Arch Intern Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>2630</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit193"><titleInfo><title>Statins: Rhabdomyolysis and myopathy (News)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Vu D, Murty M, McMorran M. Statins: Rhabdomyolysis and myopathy (News). Can Med Assoc J (2002); 166: 85.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>166</number></detail><extent unit="pages"><start>85</start></extent></part><relatedItem type="host"><titleInfo><title>Can Med Assoc J</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>166</number></detail><extent unit="pages"><start>85</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit194"><titleInfo><title>Amiodarone‐induced thyroiditis</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ybarra J, Fuster D, Martin F, Lomena F, Torregrossa JV. Amiodarone‐induced thyroiditis. Lancet (2002); 359: 69.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>359</number></detail><extent unit="pages"><start>69</start></extent></part><relatedItem type="host"><titleInfo><title>Lancet</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>359</number></detail><extent unit="pages"><start>69</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit195"><titleInfo><title>Epidemiologic evidence existing for calcium antagonists (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Zuccala G, Bernabei R, Carbonin P, Cocchi A. Epidemiologic evidence existing for calcium antagonists (Letter). Arch Intern Med (2001); 161: 2627.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>2627</start></extent></part><relatedItem type="host"><titleInfo><title>Arch Intern Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>2627</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit196"><titleInfo><title>5. CNS Despressive agents</title></titleInfo><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit197"><titleInfo><title>Hepatocellular injury following the administration of propofol (Case Reports)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Anand K, Ramsay MA, Crippin JS. Hepatocellular injury following the administration of propofol (Case Reports). Anesthesiology (2001); 95: 1523.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>95</number></detail><extent unit="pages"><start>1523</start></extent></part><relatedItem type="host"><titleInfo><title>Anesthesiology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>95</number></detail><extent unit="pages"><start>1523</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit198"><titleInfo><title>New concerns about thalidomide (Current Commentary)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ances BM. New concerns about thalidomide (Current Commentary). Obstet Gynecol (2002); 99: 125.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>99</number></detail><extent unit="pages"><start>125</start></extent></part><relatedItem type="host"><titleInfo><title>Obstet Gynecol</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>99</number></detail><extent unit="pages"><start>125</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit199"><titleInfo><title>Hypohidrosis related to the administration of topiramate to children</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Arcas J, Ferrer T, Roche MC, Martinez‐Bermejo A, Lopez‐Martin V. Hypohidrosis related to the administration of topiramate to children. Epilepsia (2001); 42: 1363.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>1363</start></extent></part><relatedItem type="host"><titleInfo><title>Epilepsia</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>1363</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit200"><titleInfo><title>Life‐threatening adverse events of antiepileptic drugs</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Arroyo S, De la Morena A. Life‐threatening adverse events of antiepileptic drugs. Epilepsy Res (2001); 47: 155.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>155</start></extent></part><relatedItem type="host"><titleInfo><title>Epilepsy Res</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>155</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit201"><titleInfo><title>Methsuximide reduces valproic acid serum levels (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Besag FMC, Berry DJ, Vasey M. Methsuximide reduces valproic acid serum levels (Case Report). Ther Drug Monit (2001); 23: 694.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>694</start></extent></part><relatedItem type="host"><titleInfo><title>Ther Drug Monit</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>694</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit202"><titleInfo><title>Potentially dangerous labeling of levobupivacaine (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bromhead HJ, Walker D. Potentially dangerous labeling of levobupivacaine (Letter). Br J Anaesth (2002); 88: 154.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>88</number></detail><extent unit="pages"><start>154</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Anaesth</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>88</number></detail><extent unit="pages"><start>154</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit203"><titleInfo><title>A pregnant woman with previous anaphylactic reaction to local anesthetics: A case report</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Browne IM, Birnbach DJ. A pregnant woman with previous anaphylactic reaction to local anesthetics: A case report. Am J Obstet Gynecol (2001); 185: 1253.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>185</number></detail><extent unit="pages"><start>1253</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Obstet Gynecol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>185</number></detail><extent unit="pages"><start>1253</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit204"><titleInfo><title>Population pharmacokinetics of lamotrigine</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Chan V, Morris RG, Illet KF, Tett SE. Population pharmacokinetics of lamotrigine. Ther Drug Monit (2001); 23: 630.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>630</start></extent></part><relatedItem type="host"><titleInfo><title>Ther Drug Monit</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>630</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit205"><titleInfo><title>A case of a methadone‐induced movement disorder</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Clark JD, Elliott J. A case of a methadone‐induced movement disorder. Clin J Pain (2001); 17: 375.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>375</start></extent></part><relatedItem type="host"><titleInfo><title>Clin J Pain</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>375</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit206"><titleInfo><title>Ropivacaine neurotoxicity: A stab in the back? (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">De Jong RH. Ropivacaine neurotoxicity: A stab in the back? (Letter). Anesthesiology (2001); 95: 1531.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>95</number></detail><extent unit="pages"><start>1531</start></extent></part><relatedItem type="host"><titleInfo><title>Anesthesiology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>95</number></detail><extent unit="pages"><start>1531</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit207"><titleInfo><title>Phase I safety assessment of intrathecal injection of an American formulation of adenosine in humans</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Eisenach JC, Hood DD, Curry R. Phase I safety assessment of intrathecal injection of an American formulation of adenosine in humans. Anesthesiology (2002); 96: 24.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>24</start></extent></part><relatedItem type="host"><titleInfo><title>Anesthesiology</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>24</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit208"><titleInfo><title>Acetaminophen, aspirin, and chronic renal failure</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Fored CM, Ejerblad E, Lindblad P, Fryzek JP, Dickman PW, Signorello LB, Lipworth L, Elinder C, Blot WJ, McLaughlin JK, Zack MM, Nyren O. Acetaminophen, aspirin, and chronic renal failure. N Engl J Med (2001); 345: 1801.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>345</number></detail><extent unit="pages"><start>1801</start></extent></part><relatedItem type="host"><titleInfo><title>N Engl J Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>345</number></detail><extent unit="pages"><start>1801</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit209"><titleInfo><title>Ropivacaine neurotoxicity: A stab in the back? (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ganapathy S, Sandhu HB, Stockall CA, Hurley D. Ropivacaine neurotoxicity: A stab in the back? (Reply). Anesthesiology (2001); 95: 1531.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>95</number></detail><extent unit="pages"><start>1531</start></extent></part><relatedItem type="host"><titleInfo><title>Anesthesiology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>95</number></detail><extent unit="pages"><start>1531</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit210"><titleInfo><title>Subarachnoid sufentanil for early postoperative pain management in orthopedic patients: More disadvantages than benefits? (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gebhard RE, Fanelli G, Matuszczak M. Subarachnoid sufentanil for early postoperative pain management in orthopedic patients: More disadvantages than benefits? (Letter). Anesthesiology (2001); 95: 1531.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>95</number></detail><extent unit="pages"><start>1531</start></extent></part><relatedItem type="host"><titleInfo><title>Anesthesiology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>95</number></detail><extent unit="pages"><start>1531</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit211"><titleInfo><title>Generalized tonic‐clonic activity after remifentanil administration (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Haber GW, Litman RS. Generalized tonic‐clonic activity after remifentanil administration (Case Report). Anesth Analg (2001); 93: 1532.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>93</number></detail><extent unit="pages"><start>1532</start></extent></part><relatedItem type="host"><titleInfo><title>Anesth Analg</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>93</number></detail><extent unit="pages"><start>1532</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit212"><titleInfo><title>A preliminary report on possible naltrexone and nonsteroidal analgesic interactions (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kim SW, Grant JE, Adson DE, Remmel RP. A preliminary report on possible naltrexone and nonsteroidal analgesic interactions (Letter). J Clin Psychopharmacol (2001); 21: 632.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>632</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Psychopharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>632</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit213"><titleInfo><title>Levetiracetam psychosis in children with epilepsy</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kossoff EH, Bergey GK, Freeman JM, Vining EPG. Levetiracetam psychosis in children with epilepsy. Epilepsia (2001); 42: 1611.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>1611</start></extent></part><relatedItem type="host"><titleInfo><title>Epilepsia</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>1611</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit214"><titleInfo><title>Vigabatrin associated retinal dysfunction in children with epilepsy</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Koul R, Chacko A, Ganesh A, Bulusu S, Al Riyami K. Vigabatrin associated retinal dysfunction in children with epilepsy. Arch Dis Child (2001); 85: 469.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>469</start></extent></part><relatedItem type="host"><titleInfo><title>Arch Dis Child</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>469</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit215"><titleInfo><title>Asystole during anaesthetic induction with remifentanil and sevoflurane (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kurdi O, Deleuze A, Marret E, Bonnet F. Asystole during anaesthetic induction with remifentanil and sevoflurane (Letter). Br J Anaesth (2001); 87: 943.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><extent unit="pages"><start>943</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Anaesth</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><extent unit="pages"><start>943</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit216"><titleInfo><title>Gabapentin‐associated hepatotoxicity (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lasso de la Vega MC, Zapater P, Such J, Perez‐Mateo M, Horga JF. Gabapentin‐associated hepatotoxicity (Letter). Am J Gastroenterol (2001); 96: 3460.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>3460</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Gastroenterol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>3460</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit217"><titleInfo><title>Gabapentin‐related dyskinesia</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Norton JW, Quarles E. Gabapentin‐related dyskinesia. J Clin Psychopharmacol (2001); 21: 623.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>623</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Psychopharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>623</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit218"><titleInfo><title>No reversion in vigabatrin‐associated visual field defects</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nousiainen I, Mantyjarvi M, Kalviainen R. No reversion in vigabatrin‐associated visual field defects. Neurology (2001); 57: 1916.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>1916</start></extent></part><relatedItem type="host"><titleInfo><title>Neurology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>1916</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit219"><titleInfo><title>Epistasis of saliva as a complication of local anesthesia with lidocaine (German)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Schade G, Hess M. Epistasis of saliva as a complication of local anesthesia with lidocaine (German). HNO (2001); 49: 933.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>49</number></detail><extent unit="pages"><start>933</start></extent></part><relatedItem type="host"><titleInfo><title>HNO</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>49</number></detail><extent unit="pages"><start>933</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit220"><titleInfo><title>Agitation as a paradoxical effect of divalproex sodium: A case report (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sobhan T, Munoz C, Ryan W. Agitation as a paradoxical effect of divalproex sodium: A case report (Letter). J Neuropsychiatry Clin Neurosci (2001); 13: 528.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>528</start></extent></part><relatedItem type="host"><titleInfo><title>J Neuropsychiatry Clin Neurosci</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>528</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit221"><titleInfo><title>Subarachnoid sufentanil for early postoperative pain management in orthopedic patients: More disadvantages than benefits? (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Standl TG, Burmeister MA. Subarachnoid sufentanil for early postoperative pain management in orthopedic patients: More disadvantages than benefits? (Reply). Anesthesiology (2001); 95: 1532.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>95</number></detail><extent unit="pages"><start>1532</start></extent></part><relatedItem type="host"><titleInfo><title>Anesthesiology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>95</number></detail><extent unit="pages"><start>1532</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit222"><titleInfo><title>Pancreatitis induced by valproic acid: Report of a case</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Taira N, Nishi H, Mano M, Waki N, Tsugita Y, Takashima S, Fukuda K, Komatsubara S. Pancreatitis induced by valproic acid: Report of a case. Surg Today (2001); 31: 1027.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>31</number></detail><extent unit="pages"><start>1027</start></extent></part><relatedItem type="host"><titleInfo><title>Surg Today</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>31</number></detail><extent unit="pages"><start>1027</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit223"><titleInfo><title>Death attributed to methadone</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Vormfelde SV, Poser W. Death attributed to methadone. Pharmacopsychiatry (2001); 34: 217.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>217</start></extent></part><relatedItem type="host"><titleInfo><title>Pharmacopsychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>217</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit224"><titleInfo><title>Carbamazepine decreases antihypertensive effect of nilvadipine</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Yasui‐Furukori N, Tateishi T. Carbamazepine decreases antihypertensive effect of nilvadipine. J Clin Pharmacol (2002); 42: 100.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>100</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Pharmacol</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>100</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit225"><titleInfo><title>6. Non‐steroidal anti‐inflammatory agents</title></titleInfo><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit226"><titleInfo><title>Ibuprofen pediatric oral liquid: Gastrointestinal bleeding</title></titleInfo><genre>journal-article</genre><note type="citation/reference">Ibuprofen pediatric oral liquid: Gastrointestinal bleeding. Can Med Assoc J (2002); 166: 89.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>166</number></detail><extent unit="pages"><start>89</start></extent></part><relatedItem type="host"><titleInfo><title>Can Med Assoc J</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>166</number></detail><extent unit="pages"><start>89</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit227"><titleInfo><title>Cardiovascular events and COX‐2 inhibitors (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Burnakis TG. Cardiovascular events and COX‐2 inhibitors (Letter). JAMA (2001); 286: 2808.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2808</start></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2808</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit228"><titleInfo><title>A fatal case of Reye syndrome after varicella and ingestion of aspirin (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Caksen H, Guler E, Alper M, Ustunbas HB. A fatal case of Reye syndrome after varicella and ingestion of aspirin (Letter). J Dermatol (2001); 28: 286.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>286</start></extent></part><relatedItem type="host"><titleInfo><title>J Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>286</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit229"><titleInfo><title>Comparison of the efficacy and safety of naproxen CR and nabumetone in the treatment of patients with osteoarthritis of the knee</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cha HS, Koh JH, Jeon CH, Lee CK, Kim JS, Koh EM. Comparison of the efficacy and safety of naproxen CR and nabumetone in the treatment of patients with osteoarthritis of the knee. Int J Clin Pharm Ther (2001); 39: 539.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>539</start></extent></part><relatedItem type="host"><titleInfo><title>Int J Clin Pharm Ther</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>539</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit230"><titleInfo><title>Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long‐term treatment with non‐steroidal anti‐inflammatory drugs: A randomised trial</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Chan FKL, To KF, Wu JCY, Yung MY, Leung WK, Kwok T, Hui Y, Chan HLY, Chan CSY, Hui E, Woo J, Sung JJ. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long‐term treatment with non‐steroidal anti‐inflammatory drugs: A randomised trial. Lancet (2002); 359: 9.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>359</number></detail><extent unit="pages"><start>9</start></extent></part><relatedItem type="host"><titleInfo><title>Lancet</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>359</number></detail><extent unit="pages"><start>9</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit231"><titleInfo><title>Haemorrhage associated with combined clopidogrel and aspirin therapy (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Chapman TWL, Bowley DMG, Lambert AW, Walker AJ, Ashley SA, Wilkins DC. Haemorrhage associated with combined clopidogrel and aspirin therapy (Letter). Eur J Vasc Endovasc Surg (2001); 22: 478.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>478</start></extent></part><relatedItem type="host"><titleInfo><title>Eur J Vasc Endovasc Surg</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>478</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit232"><titleInfo><title>Hydroxychloroquine retinopathy (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Coyle JT. Hydroxychloroquine retinopathy (Reply). Ophthalmology (2001); 108: 2159.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>108</number></detail><extent unit="pages"><start>2159</start></extent></part><relatedItem type="host"><titleInfo><title>Ophthalmology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>108</number></detail><extent unit="pages"><start>2159</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit233"><titleInfo><title>Interstitial nephritis associated with celecoxib (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Demke D, Zhao S, Arellano FM. Interstitial nephritis associated with celecoxib (Letter). Lancet (2001); 358: 1726.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>358</number></detail><extent unit="pages"><start>1726</start></extent></part><relatedItem type="host"><titleInfo><title>Lancet</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>358</number></detail><extent unit="pages"><start>1726</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit234"><titleInfo><title>Hydroxychloroquine retinopathy (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Easterbrook M. Hydroxychloroquine retinopathy (Letter). Ophthalmology (2001); 108: 2158.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>108</number></detail><extent unit="pages"><start>2158</start></extent></part><relatedItem type="host"><titleInfo><title>Ophthalmology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>108</number></detail><extent unit="pages"><start>2158</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit235"><titleInfo><title>Intracerebral hemorrhage following possible interaction between celecoxib and clopidogrel (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Fisher AA, Le Couteur DG. Intracerebral hemorrhage following possible interaction between celecoxib and clopidogrel (Case Report). Ann Pharmacother (2001); 35: 1567.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1567</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Pharmacother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1567</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit236"><titleInfo><title>Cardiovascular events and COX‐2 inhibitors (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Fleming M. Cardiovascular events and COX‐2 inhibitors (Letter). JAMA (2001); 286: 2808.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2808</start></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2808</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit237"><titleInfo><title>Cardiovascular events and COX‐2 inhibitors (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Grant KD. Cardiovascular events and COX‐2 inhibitors (Letter). JAMA (2001); 286: 2809.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2809</start></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2809</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit238"><titleInfo><title>Cardiovascular events and COX‐2 inhibitors (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Haldey EJ, Pappagallo M. Cardiovascular events and COX‐2 inhibitors (Letter). JAMA (2001); 286: 2809.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2809</start></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2809</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit239"><titleInfo><title>Role of Helicobacter pylori infection and non‐steroidal antiinflammatory drugs in peptic‐ulcer disease: A meta‐analysis</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non‐steroidal antiinflammatory drugs in peptic‐ulcer disease: A meta‐analysis. Lancet (2002); 359: 14.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>359</number></detail><extent unit="pages"><start>14</start></extent></part><relatedItem type="host"><titleInfo><title>Lancet</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>359</number></detail><extent unit="pages"><start>14</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit240"><titleInfo><title>Effects of parecoxib, a parenteral COX‐2‐specific inhibitor, on the pharmacokinetics and pharmacodynamics of propofol</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ibrahim A, Park S, Feldman J, Karim A, Kharasch ED. Effects of parecoxib, a parenteral COX‐2‐specific inhibitor, on the pharmacokinetics and pharmacodynamics of propofol. Anesthesiology (2002); 96: 88.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>88</start></extent></part><relatedItem type="host"><titleInfo><title>Anesthesiology</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>88</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit241"><titleInfo><title>A flexible daily dosage regimen of oxaprozin potassium in patients with acute knee pain associated with osteoarthritis: 24‐hour analgesic durability and safety</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kivitz AJ, Makarowski WS, Fiechtner JJ, Recker DP. A flexible daily dosage regimen of oxaprozin potassium in patients with acute knee pain associated with osteoarthritis: 24‐hour analgesic durability and safety. Clin Drug Invest (2001); 21: 745.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>745</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Drug Invest</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>745</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit242"><titleInfo><title>Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kivitz AJ, Moskowitz RW, Woods E, Hubbard RC, Verburg KM, Lefkowith JB, Geis GS. Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip. J Int Med Res (2001); 29: 467.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>29</number></detail><extent unit="pages"><start>467</start></extent></part><relatedItem type="host"><titleInfo><title>J Int Med Res</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>29</number></detail><extent unit="pages"><start>467</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit243"><titleInfo><title>Cardiovascular events and COX‐2 inhibitors (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Konstam MA, Demopoulos LA. Cardiovascular events and COX‐2 inhibitors (Letter). JAMA (2001); 286: 2809.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2809</start></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2809</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit244"><titleInfo><title>Naproxen‐induced pseudoporphyria (German) (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Maerker JM, Harm A, Foeldvari I, Hoger PH. Naproxen‐induced pseudoporphyria (German) (Letter). Hautarzt (2001); 52: 1026.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>1026</start></extent></part><relatedItem type="host"><titleInfo><title>Hautarzt</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>1026</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit245"><titleInfo><title>Efficacy and long‐term safety of dexibuprofen [S(+)‐ibuprofen]: A short‐term efficacy study in patients with osteoarthritis of the hip and a 1‐year tolerability study in patients with rheumatic disorders</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mayrhofer F. Efficacy and long‐term safety of dexibuprofen [S(+)‐ibuprofen]: A short‐term efficacy study in patients with osteoarthritis of the hip and a 1‐year tolerability study in patients with rheumatic disorders. Clin Rheumatol (2001); 20: 22.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>22</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Rheumatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>22</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit246"><titleInfo><title>Skin necrosis following injection of non‐steroidal anti‐inflammatory drug (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">McGee AM, Davison PM. Skin necrosis following injection of non‐steroidal anti‐inflammatory drug (Case Report). Br J Anaesth (2002); 88: 139.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>88</number></detail><extent unit="pages"><start>139</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Anaesth</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>88</number></detail><extent unit="pages"><start>139</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit247"><titleInfo><title>Cardiovascular events and COX‐2 inhibitors (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">McGeer PL, McGeer EG, Yasojima K. Cardiovascular events and COX‐2 inhibitors (Letter). JAMA (2001); 286: 2810.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2810</start></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2810</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit248"><titleInfo><title>Hypersensitivity reactions associated with exposure to naproxen and ibuprofen: A cohort study</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">McMahon AD, Evans JMM, MacDonald TM. Hypersensitivity reactions associated with exposure to naproxen and ibuprofen: A cohort study. J Clin Epidemiol (2001); 54: 1271.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>54</number></detail><extent unit="pages"><start>1271</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Epidemiol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>54</number></detail><extent unit="pages"><start>1271</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit249"><titleInfo><title>Acute pancreatitis after treatment by levofloxacin and methylprednisolone (Letter) (French)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mennecier D, Thiolet C, Bredin C, Potier V, Vergeau B, Farret O. Acute pancreatitis after treatment by levofloxacin and methylprednisolone (Letter) (French). Gastroenterol Clin Biol (2001); 25: 921.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>921</start></extent></part><relatedItem type="host"><titleInfo><title>Gastroenterol Clin Biol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>921</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit250"><titleInfo><title>Cardiovascular events and COX‐2 inhibitors (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Minic M. Cardiovascular events and COX‐2 inhibitors (Letter). JAMA (2001); 286: 2810.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2810</start></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2810</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit251"><titleInfo><title>Over‐the‐counter oral nonsteroidal anti‐inflammatory drugs: A pharmacoepidemiologic study in southern Italy</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Motola G, Russo F, Mazzeo F, Rinaldi B, Capuano A, Rossi F, Filippelli A. Over‐the‐counter oral nonsteroidal anti‐inflammatory drugs: A pharmacoepidemiologic study in southern Italy. Advan Ther (2001); 18: 216.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>216</start></extent></part><relatedItem type="host"><titleInfo><title>Advan Ther</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>216</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit252"><titleInfo><title>Cardiovascular events and COX‐2 inhibitors (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mukherjee D. Cardiovascular events and COX‐2 inhibitors (Reply). JAMA (2001); 286: 2811.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2811</start></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2811</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit253"><titleInfo><title>Gastro‐duodenal protection in an era of cyclo‐oxygenase‐2‐selective nonsteroidal anti‐inflammatory drugs</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Naesdal J, Wilson I. Gastro‐duodenal protection in an era of cyclo‐oxygenase‐2‐selective nonsteroidal anti‐inflammatory drugs. Eur J Gastroenterol Hepatol (2001); 13: 1401.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>1401</start></extent></part><relatedItem type="host"><titleInfo><title>Eur J Gastroenterol Hepatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>1401</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit254"><titleInfo><title>Pretreatment with montelukast blocks NSAID‐induced urticaria and angioedema (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Perez C, Sanchez‐Borges M, Capriles E. Pretreatment with montelukast blocks NSAID‐induced urticaria and angioedema (Letter). J Allergy Clin Immunol (2001); 108: 1060.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>108</number></detail><extent unit="pages"><start>1060</start></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>108</number></detail><extent unit="pages"><start>1060</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit255"><titleInfo><title>Anaphylactoid reaction to a cyclooxygenase‐2 inhibitor in a patient who had a reaction to a cyclooxygenase‐1 inhibitor (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Schellenberg RR, Isserow SH. Anaphylactoid reaction to a cyclooxygenase‐2 inhibitor in a patient who had a reaction to a cyclooxygenase‐1 inhibitor (Letter). N Engl J Med (2001); 345: 1856.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>345</number></detail><extent unit="pages"><start>1856</start></extent></part><relatedItem type="host"><titleInfo><title>N Engl J Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>345</number></detail><extent unit="pages"><start>1856</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit256"><titleInfo><title>ABC of the upper gastrointestinal tract: Indigestion and non‐steroidal anti‐inflammatory drugs</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Seager JM, Hawkey CJ. ABC of the upper gastrointestinal tract: Indigestion and non‐steroidal anti‐inflammatory drugs. Br Med J (2001); 323: 1236.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>323</number></detail><extent unit="pages"><start>1236</start></extent></part><relatedItem type="host"><titleInfo><title>Br Med J</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>323</number></detail><extent unit="pages"><start>1236</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit257"><titleInfo><title>Cardiovascular events and COX‐2 inhibitors (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sherwood LM. Cardiovascular events and COX‐2 inhibitors (Reply). JAMA (2001); 286: 2812.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2812</start></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2812</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit258"><titleInfo><title>Cardiovascular events and COX‐2 inhibitors (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Singh G. Cardiovascular events and COX‐2 inhibitors (Letter). JAMA (2001); 286: 2810.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2810</start></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2810</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit259"><titleInfo><title>Diclofenac‐induced colitis complicated by Klebsiella oxytoca infection (French)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Soussi F, Tchirikhtchian K, Ramaholimihaso F, Yaziji N, Coussinet S, Diebold MD, Cadiot G, Thiefin G. Diclofenac‐induced colitis complicated by Klebsiella oxytoca infection (French). Gastroenterol Clin Biol (2001); 25: 814.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>814</start></extent></part><relatedItem type="host"><titleInfo><title>Gastroenterol Clin Biol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>814</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit260"><titleInfo><title>Cardiovascular events and COX‐2 inhibitors (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sperber K. Cardiovascular events and COX‐2 inhibitors (Letter). JAMA (2001); 286: 2812.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2812</start></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2812</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit261"><titleInfo><title>Contribution of nonsteroidal anti‐inflammatory drugs to deaths associated with peptic ulcer disease: A prospective toxicological analysis of autopsy blood samples</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tsokos M, Schmoldt A. Contribution of nonsteroidal anti‐inflammatory drugs to deaths associated with peptic ulcer disease: A prospective toxicological analysis of autopsy blood samples. Arch Pathol Lab Med (2001); 125: 1572.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>125</number></detail><extent unit="pages"><start>1572</start></extent></part><relatedItem type="host"><titleInfo><title>Arch Pathol Lab Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>125</number></detail><extent unit="pages"><start>1572</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit262"><titleInfo><title>Fulminant necrotizing fasciitis and nonsteroidal anti‐inflammatory drugs (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Veenstra RP, Manson WE, Van der Werf TS, Fijen JW, Tulleken JE, Zijlstra JG, Ligtenberg JJM. Fulminant necrotizing fasciitis and nonsteroidal anti‐inflammatory drugs (Letter). Intensive Care Med (2001); 27: 1831.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>1831</start></extent></part><relatedItem type="host"><titleInfo><title>Intensive Care Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>1831</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit263"><titleInfo><title>Early hydroxychloroquine macular toxicity (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Warner AE. Early hydroxychloroquine macular toxicity (Case Report). Arthritis Rheum (2001); 44: 1959.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>44</number></detail><extent unit="pages"><start>1959</start></extent></part><relatedItem type="host"><titleInfo><title>Arthritis Rheum</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>44</number></detail><extent unit="pages"><start>1959</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit264"><titleInfo><title>GI events leading to death in association with celecoxib and rofecoxib (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Weaver J, Bonnel RA, Karwoski CB, Brinker AD, Beitz J. GI events leading to death in association with celecoxib and rofecoxib (Letter). Am J Gastroenterol (2001); 96: 3449.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>3449</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Gastroenterol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>3449</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit265"><titleInfo><title>Cardiovascular events and COX‐2 inhibitors (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">White WB, Whelton A. Cardiovascular events and COX‐2 inhibitors (Letter). JAMA (2001); 286: 2811.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2811</start></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2811</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit266"><titleInfo><title>Identification of sulfonamide‐like adverse drug reactions to celecoxib in the World Health Organization database</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wiholm BE. Identification of sulfonamide‐like adverse drug reactions to celecoxib in the World Health Organization database. Curr Med Res Opin (2001); 17: 210.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>210</start></extent></part><relatedItem type="host"><titleInfo><title>Curr Med Res Opin</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>210</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit267"><titleInfo><title>Sulfasalazine‐induced extrinsic allergic alveolitis in a patient with psoriatic arthritis</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Woltsche M, Woltsche‐Kahr I, Roeger GM, Aberer W, Popper H. Sulfasalazine‐induced extrinsic allergic alveolitis in a patient with psoriatic arthritis. Eur J Med Res (2001); 6: 495.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>495</start></extent></part><relatedItem type="host"><titleInfo><title>Eur J Med Res</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>495</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit268"><titleInfo><title>7. CNS agents</title></titleInfo><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit269"><titleInfo><title>Two cases of parotid gland swelling in patients taking clozapine</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Acosta‐Armas AJ. Two cases of parotid gland swelling in patients taking clozapine. Hosp Med (2001); 62: 704.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>704</start></extent></part><relatedItem type="host"><titleInfo><title>Hosp Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>704</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit270"><titleInfo><title>A probable interaction between a very low‐dose oral contraceptive and the antidepressant nefazodone: A case report</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Adson DE, Kotlyar M. A probable interaction between a very low‐dose oral contraceptive and the antidepressant nefazodone: A case report. J Clin Psychopharmacol (2001); 21: 618.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>618</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Psychopharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>618</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit271"><titleInfo><title>Falsely elevated imipramine levels in a patient taking quetiapine (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Al Mateen CS, Wolf CE. Falsely elevated imipramine levels in a patient taking quetiapine (Letter). J Am Acad Child Adolesc Psychiatry (2002); 41: 5.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>41</number></detail><extent unit="pages"><start>5</start></extent></part><relatedItem type="host"><titleInfo><title>J Am Acad Child Adolesc Psychiatry</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>41</number></detail><extent unit="pages"><start>5</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit272"><titleInfo><title>Acute cholestatic hepatitis induced by bupropion prescribed as pharmacological support to stop smoking. A case report</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Alvaro D, Onetti‐Muda A, Moscatelli R, Attili AF. Acute cholestatic hepatitis induced by bupropion prescribed as pharmacological support to stop smoking. A case report. Dig Liver Dis (2001); 33: 703.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>703</start></extent></part><relatedItem type="host"><titleInfo><title>Dig Liver Dis</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>703</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit273"><titleInfo><title>Are African American patients at a higher risk for olanzapine‐induced glucose intolerance? (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ananth J, Gunatilake S, Aquino S, Bach V, Costa J. Are African American patients at a higher risk for olanzapine‐induced glucose intolerance? (Letter). Psychopharmacology (2001); 157: 324.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>157</number></detail><extent unit="pages"><start>324</start></extent></part><relatedItem type="host"><titleInfo><title>Psychopharmacology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>157</number></detail><extent unit="pages"><start>324</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit274"><titleInfo><title>Antipsychotic drugs and obesity: Is prolactin involved</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Baptista T, Lacruz A, Meza T, Contreras Q, Delgado C, Mejias MA, Hernandez L. Antipsychotic drugs and obesity: Is prolactin involved? Can J Psychiatry (2001); 46: 829.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>46</number></detail><extent unit="pages"><start>829</start></extent></part><relatedItem type="host"><titleInfo><title>Can J Psychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>46</number></detail><extent unit="pages"><start>829</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit275"><titleInfo><title>Body weight gain, insulin, and leptin in olanzapine‐treated patients (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Baptista T, Beaulieu S. Body weight gain, insulin, and leptin in olanzapine‐treated patients (Letter). J Clin Psychiatry (2001); 62: 902.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>902</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Psychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>902</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit276"><titleInfo><title>Quetiapine poisoning (Letter) (Spanish)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Barroso MG, Anes MU, Vicente SM, Baquerizo JA. Quetiapine poisoning (Letter) (Spanish). Med Clin (2001); 117: 638.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>117</number></detail><extent unit="pages"><start>638</start></extent></part><relatedItem type="host"><titleInfo><title>Med Clin</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>117</number></detail><extent unit="pages"><start>638</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit277"><titleInfo><title>Daily headache as a manifestation of lithium intoxication</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bigal ME, Bordini CA, Speciali JG. Daily headache as a manifestation of lithium intoxication. Neurology (2001); 57: 1733.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>1733</start></extent></part><relatedItem type="host"><titleInfo><title>Neurology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>1733</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit278"><titleInfo><title>Ten‐year follow‐up of thyroid function in lithium patients</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bocchetta A, Mossa P, Velluzzi F, Mariotti S, Del Zompo M, Loviselli A. Ten‐year follow‐up of thyroid function in lithium patients. J Clin Psychopharmacol (2001); 21: 594.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>594</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Psychopharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>594</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit279"><titleInfo><title>Continuation of clozapine after priapism (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bongale RN, Tekell JL, Haraguchi GE, Navarro EM. Continuation of clozapine after priapism (Letter). Am J Psychiatry (2001); 158: 2087.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>158</number></detail><extent unit="pages"><start>2087</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Psychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>158</number></detail><extent unit="pages"><start>2087</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit280"><titleInfo><title>Favorable effect on neuronal viability in the anterior cingulate gyrus due to long‐term treatment with atypical antipsychotics: An MRSI study</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Braus DF, Ende G, Weber Fahr W, Demirakca T, Henn FA. Favorable effect on neuronal viability in the anterior cingulate gyrus due to long‐term treatment with atypical antipsychotics: An MRSI study. Pharmacopsychiatry (2001); 34: 251.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>251</start></extent></part><relatedItem type="host"><titleInfo><title>Pharmacopsychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>251</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit281"><titleInfo><title>Delirium associated with zolpidem (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Brodeur MR, Stirling AL. Delirium associated with zolpidem (Case Report). Ann Pharmacother (2001); 35: 1562.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1562</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Pharmacother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1562</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit282"><titleInfo><title>Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: A randomised, double‐blind, parallel group study</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cassano GB, Jori MC. Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: A randomised, double‐blind, parallel group study. Int Clin Psychopharmacol (2002); 17: 27.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>27</start></extent></part><relatedItem type="host"><titleInfo><title>Int Clin Psychopharmacol</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>27</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit283"><titleInfo><title>Acute, progressive akinetic‐rigid syndrome induced by neuroleptics in a case of Wilson's disease (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Chroni E, Lekka NP, Tsibri E, Economou A, Paschalis C. Acute, progressive akinetic‐rigid syndrome induced by neuroleptics in a case of Wilson's disease (Letter). J Neuropsychiatry Clin Neurosci (2001); 13: 531.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>531</start></extent></part><relatedItem type="host"><titleInfo><title>J Neuropsychiatry Clin Neurosci</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>531</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit284"><titleInfo><title>Neuroleptic‐related dyskinesias in children and adolescents</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Connor DF, Fletcher KE, Wood JS. Neuroleptic‐related dyskinesias in children and adolescents. J Clin Psychiatry (2001); 62: 967.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>967</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Psychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>967</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit285"><titleInfo><title>A fatal case of moclobemide‐citalopram intoxication (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Dams R, Benijts THP, Lambert WE, Van Bocxlaer JF, Van Peteghem C, De Leenheer A, Van Varenbergh D. A fatal case of moclobemide‐citalopram intoxication (Reply). J Anal Toxicol (2001); 25: 717.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>717</start></extent></part><relatedItem type="host"><titleInfo><title>J Anal Toxicol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>717</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit286"><titleInfo><title>Neuroleptic‐induced pseudo‐catatonia (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Deuschle M. Neuroleptic‐induced pseudo‐catatonia (Reply). Pharmacopsychiatry (2001); 34: 263.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>263</start></extent></part><relatedItem type="host"><titleInfo><title>Pharmacopsychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>263</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit287"><titleInfo><title>Neuroleptic‐induced pseudo‐catatonial (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Dose M. Neuroleptic‐induced pseudo‐catatonial (Letter). Pharmacopsychiatry (2001); 34: 262.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>262</start></extent></part><relatedItem type="host"><titleInfo><title>Pharmacopsychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>262</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit288"><titleInfo><title>Acute fetal hepatitis related to sertraline (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Fartoux‐Heymann L, Hezode C, Zafrani ES, Dhumeaux D, Mallat A. Acute fetal hepatitis related to sertraline (Letter). J Hepatol (2001); 35: 683.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>683</start></extent></part><relatedItem type="host"><titleInfo><title>J Hepatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>683</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit289"><titleInfo><title>Evaluation of the association between St. John's wort and elevated thyroid‐stimulating hormone (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ferko N, Levine MAH. Evaluation of the association between St. John's wort and elevated thyroid‐stimulating hormone (Case Report). Pharmacotherapy (2001); 21: 1574.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>1574</start></extent></part><relatedItem type="host"><titleInfo><title>Pharmacotherapy</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>1574</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit290"><titleInfo><title>Gastrointestinal bleeding in antidepressant therapy: A rarely seen undesirable effect of serotonin reabsorption inhibitors (German)(Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Finzen A. Gastrointestinal bleeding in antidepressant therapy: A rarely seen undesirable effect of serotonin reabsorption inhibitors (German)(Letter). Psychiatr Prax (2001); 28: 412.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>412</start></extent></part><relatedItem type="host"><titleInfo><title>Psychiatr Prax</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>412</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit291"><titleInfo><title>Cyproheptadine versus propranolol for the treatment of acute neuroleptic‐induced akathisia: A comparative double‐blind study</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Fischel T, Hermesh H, Aizenberg D, Zemishlany Z, Munitz H, Benjamini Y, Weizman A. Cyproheptadine versus propranolol for the treatment of acute neuroleptic‐induced akathisia: A comparative double‐blind study. J Clin Psychopharmacol (2001); 21: 612.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>612</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Psychopharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>612</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit292"><titleInfo><title>Withdrawal symptoms after discontinuation of SSRI (German)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Fischer RB, Hodzic M. Withdrawal symptoms after discontinuation of SSRI (German). Psychiatr Prax (2001); 28: 408.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>408</start></extent></part><relatedItem type="host"><titleInfo><title>Psychiatr Prax</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>408</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit293"><titleInfo><title>Asymptomatic bradycardia associated with amisulpride (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gil FP, Grohmann R, Ruther E. Asymptomatic bradycardia associated with amisulpride (Case Report). Pharmacopsychiatry (2001); 34: 259.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>259</start></extent></part><relatedItem type="host"><titleInfo><title>Pharmacopsychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>259</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit294"><titleInfo><title>Comment: Sudden cardiac death with clozapine and sertraline combination (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gillespie JA. Comment: Sudden cardiac death with clozapine and sertraline combination (Letter). Ann Pharmacother (2001); 35: 1671.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1671</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Pharmacother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1671</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit295"><titleInfo><title>Olanzapine induces remarkable weight gain in adolescent patients (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Haapasalo‐Pesu KM, Saarijarvi S. Olanzapine induces remarkable weight gain in adolescent patients (Case Report). Eur Child Adolesc Psychiatry (2001); 10: 205.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>205</start></extent></part><relatedItem type="host"><titleInfo><title>Eur Child Adolesc Psychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>205</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit296"><titleInfo><title>Antipsychotic induced hyperprolactinaemia: A series of illustrative case reports</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Haddad PM, Hellewell JSE, Wieck A. Antipsychotic induced hyperprolactinaemia: A series of illustrative case reports. J Psychopharmacol (2001); 15: 293.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>293</start></extent></part><relatedItem type="host"><titleInfo><title>J Psychopharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>293</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit297"><titleInfo><title>Fluoxetine toxicity in a breastfed infant</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hale TW, Shum S, Grossberg M. Fluoxetine toxicity in a breastfed infant. Clin Pediatr (Phila) (2001); 40: 681.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>681</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Pediatr (Phila)</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>681</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit298"><titleInfo><title>Venlafaxine and breast‐feeding (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hendrick V, Altshuler L, Wertheimer A, Dunn WA. Venlafaxine and breast‐feeding (Letter). Am J Psychiatry (2001); 158: 2089.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>158</number></detail><extent unit="pages"><start>2089</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Psychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>158</number></detail><extent unit="pages"><start>2089</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit299"><titleInfo><title>Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hendrick V, Stowe ZN, Altshuler LL, Mintz J, Hwang S, Hostetter A, Suri R, Leight K, Fukuchi A. Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk. Biol Psychiatry (2001); 50: 775.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>50</number></detail><extent unit="pages"><start>775</start></extent></part><relatedItem type="host"><titleInfo><title>Biol Psychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>50</number></detail><extent unit="pages"><start>775</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit300"><titleInfo><title>Neuroleptic‐induced pseudo‐catatonia (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hesslinger B, Walden J, Normann C. Neuroleptic‐induced pseudo‐catatonia (Letter). Pharmacopsychiatry (2001); 34: 264.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>264</start></extent></part><relatedItem type="host"><titleInfo><title>Pharmacopsychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>264</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit301"><titleInfo><title>Comment: Sudden cardiac death with clozapine and sertraline combination (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hoehns JD, Kelly MW. Comment: Sudden cardiac death with clozapine and sertraline combination (Reply). Ann Pharmacother (2001); 35: 1672.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1672</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Pharmacother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1672</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit302"><titleInfo><title>The efficacy and safety of risperidone for the treatment of geriatric psychosis</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hwang JP, Yang CH, Yu HC, Chang JW, Cheng CY, Tsai SJ. The efficacy and safety of risperidone for the treatment of geriatric psychosis. J Clin Psychopharmacol (2001); 21: 583.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>583</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Psychopharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>583</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit303"><titleInfo><title>Efficacy and safety of zotepine for the treatment of Taiwanese schizophrenic patients: A double‐blind comparison with haloperidol</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hwang TJ, Lin SK, Lin HN. Efficacy and safety of zotepine for the treatment of Taiwanese schizophrenic patients: A double‐blind comparison with haloperidol. J Formos Med Assoc (2001); 100: 811.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>100</number></detail><extent unit="pages"><start>811</start></extent></part><relatedItem type="host"><titleInfo><title>J Formos Med Assoc</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>100</number></detail><extent unit="pages"><start>811</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit304"><titleInfo><title>Citalopram‐induced photopigmentation</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Inaloz HS, Kirtak N, Herken H, Ozgoztasi O, Aynacioglu AS. Citalopram‐induced photopigmentation. J Dermatol (2001); 28: 742.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>742</start></extent></part><relatedItem type="host"><titleInfo><title>J Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>742</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit305"><titleInfo><title>Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome? (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Isbister GK, Dawson A, Whyte IM, Prior FH, Clancy C, Smith AJ. Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome? (Letter). Arch Dis Child (2001); 85: F147.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>F147</start></extent></part><relatedItem type="host"><titleInfo><title>Arch Dis Child</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>F147</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit306"><titleInfo><title>A fatal case of moclobemide‐citalopram intoxication</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Isbister GK, McGettigan P, Dawson A. A fatal case of moclobemide‐citalopram intoxication. J Anal Toxicol (2001); 25: 716.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>716</start></extent></part><relatedItem type="host"><titleInfo><title>J Anal Toxicol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>716</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit307"><titleInfo><title>Treatment of anticholinergic‐induced ileus with neostigmine (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Isbister GK, Oakley, Whyte I, Dawson A. Treatment of anticholinergic‐induced ileus with neostigmine (Case Report). Ann Emerg Med (2001); 38: 689.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>689</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Emerg Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>689</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit308"><titleInfo><title>Citalopram‐induced bradycardia and presyncope (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Isbister GK, Prior FH, Foy A. Citalopram‐induced bradycardia and presyncope (Case Report). Ann Pharmacother (2001); 35: 1552.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1552</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Pharmacother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1552</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit309"><titleInfo><title>Comment: Serotonin syndrome induced by fluvoxamine and mirtazapine (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Isbister GK, Dawson AH, Whyte IM. Comment: Serotonin syndrome induced by fluvoxamine and mirtazapine (Letter). Ann Pharmacother (2001); 35: 1674.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1674</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Pharmacother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1674</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit310"><titleInfo><title>Differences in haloperidol epidemiologic pharmacokinetic studies (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jann MW, Chang WH, Lane HY. Differences in haloperidol epidemiologic pharmacokinetic studies (Letter). J Clin Psychopharmacol (2001); 21: 628.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>628</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Psychopharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>628</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit311"><titleInfo><title>Aggravation of glaucoma with fluvoxamine (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jimenez‐Jimenez FJ, Orti‐Pareja M, Zurdo JM. Aggravation of glaucoma with fluvoxamine (Case Report). Ann Pharmacother (2001); 35: 1565.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1565</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Pharmacother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1565</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit312"><titleInfo><title>Increasing insulin dose for olanzapine‐related diabetes (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Johnson RP, Al Taher MT, Madlock LE, Guo M, Nasdahl CS. Increasing insulin dose for olanzapine‐related diabetes (Letter). Am J Psychiatry (2002); 159: 150.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>159</number></detail><extent unit="pages"><start>150</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Psychiatry</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>159</number></detail><extent unit="pages"><start>150</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit313"><titleInfo><title>Atypical antipsychotic drugs and hyperglycemia in adolescent</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Koller E, Malozowski S, Doraiswamy PM. Atypical antipsychotic drugs and hyperglycemia in adolescent. JAMA (2001); 286: 2547.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2547</start></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>2547</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit314"><titleInfo><title>Associations between side effects of nemonapride and plasma concentrations of the drug and prolactin</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kondo T, Ishida M, Tokinaga N, Mihara K, Yasui‐Furukori N, Ono S, Kaneko S. Associations between side effects of nemonapride and plasma concentrations of the drug and prolactin. Prog Neuropsychopharmacol Biol Psychiatry (2002); 26: 287.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>287</start></extent></part><relatedItem type="host"><titleInfo><title>Prog Neuropsychopharmacol Biol Psychiatry</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>287</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit315"><titleInfo><title>Toxic interaction between risperidone and clozapine: A case report</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kontaxakis VP, Havaki‐Kontaxaki BJ, Stamouli SS, Christodoulou GN. Toxic interaction between risperidone and clozapine: A case report. Prog Neuropsychopharmacol Biol Psychiatry (2002); 26: 407.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>407</start></extent></part><relatedItem type="host"><titleInfo><title>Prog Neuropsychopharmacol Biol Psychiatry</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>407</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit316"><titleInfo><title>QT prolongation and torsade de pointes tachycardia with maprotiline: A note of caution (Case Report) (German)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lentini S, Rao ML, Schroder R, Luderitz B, Bauriedel G. QT prolongation and torsade de pointes tachycardia with maprotiline: A note of caution (Case Report) (German). Dtsch Med Wochenschr (2001); 126: 1396.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>126</number></detail><extent unit="pages"><start>1396</start></extent></part><relatedItem type="host"><titleInfo><title>Dtsch Med Wochenschr</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>126</number></detail><extent unit="pages"><start>1396</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit317"><titleInfo><title>Topiramate for reversing atypical antipsychotic weight gain (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lessig MC, Shapira NA, Murphy TK. Topiramate for reversing atypical antipsychotic weight gain (Letter). J Am Acad Child Adolesc Psychiatry (2001); 40: 1364.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>1364</start></extent></part><relatedItem type="host"><titleInfo><title>J Am Acad Child Adolesc Psychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>1364</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit318"><titleInfo><title>Differences between in vitro and in vivo determination of fluvoxamine‐clozapine interaction</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lu ML, Lane HY, Chang WH. Differences between in vitro and in vivo determination of fluvoxamine‐clozapine interaction. J Clin Psychopharmacol (2001); 21: 625.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>625</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Psychopharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>625</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit319"><titleInfo><title>Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: A claims‐based approach</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lund BC, Perry PJ, Brooks JM, Arndt S. Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: A claims‐based approach. Arch Gen Psychiatry (2001); 58: 1172.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>58</number></detail><extent unit="pages"><start>1172</start></extent></part><relatedItem type="host"><titleInfo><title>Arch Gen Psychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>58</number></detail><extent unit="pages"><start>1172</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit320"><titleInfo><title>Donepezil in schizophrenia: Is it helpful? An experimental design case study (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">MacEwan GW, Ehmann TS, Khanbhai I, Wrixon C. Donepezil in schizophrenia: Is it helpful? An experimental design case study (Case Report). Acta Psychiatr Scand (2001); 104: 469.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>104</number></detail><extent unit="pages"><start>469</start></extent></part><relatedItem type="host"><titleInfo><title>Acta Psychiatr Scand</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>104</number></detail><extent unit="pages"><start>469</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit321"><titleInfo><title>Hypotension and bradycardia in a healthy volunteer following a single 5 mg dose of olanzapine</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Markowitz JS, De Vane CL, Boulton DW, Liston HL, Risch SC. Hypotension and bradycardia in a healthy volunteer following a single 5 mg dose of olanzapine. J Clin Pharmacol (2002); 42: 104.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>104</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Pharmacol</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>104</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit322"><titleInfo><title>Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed‐dose, placebo‐controlled study</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Marshall RD, Beebe KL, Oldham M, Zaninelli R. Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed‐dose, placebo‐controlled study. Am J Psychiatry (2001); 158: 1982.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>158</number></detail><extent unit="pages"><start>1982</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Psychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>158</number></detail><extent unit="pages"><start>1982</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit323"><titleInfo><title>Venlafaxine‐ and trazodone‐induced serotonin syndrome (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">McCue RE, Joseph M. Venlafaxine‐ and trazodone‐induced serotonin syndrome (Letter). Am J Psychiatry (2001); 158: 2088.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>158</number></detail><extent unit="pages"><start>2088</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Psychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>158</number></detail><extent unit="pages"><start>2088</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit324"><titleInfo><title>Psychotropic prescribing practices of paediatricians in the UK</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">McNicholas F. Psychotropic prescribing practices of paediatricians in the UK. Child Care Health Dev (2001); 27: 497.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>497</start></extent></part><relatedItem type="host"><titleInfo><title>Child Care Health Dev</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>497</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit325"><titleInfo><title>Body weight gain, insulin, and leptin in olanzapine‐treated patients (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Melkersson K, Hulting AL, Brismar K. Body weight gain, insulin, and leptin in olanzapine‐treated patients (Reply). J Clin Psychiatry (2001); 62: 903.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>903</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Psychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>903</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit326"><titleInfo><title>Thrombocytopenia associated with clozapine and fluphenazine (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mihaljevic‐Peles A, Jakovljevic M, Mrsic M, Sagud M. Thrombocytopenia associated with clozapine and fluphenazine (Letter). Nord J Psychiatry (2001); 55: 449.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>55</number></detail><extent unit="pages"><start>449</start></extent></part><relatedItem type="host"><titleInfo><title>Nord J Psychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>55</number></detail><extent unit="pages"><start>449</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit327"><titleInfo><title>Prescription of methylphenidate to children and youth, 1990‐1996</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Miller AR, Lalonde CE, McGrail KM, Armstrong RW. Prescription of methylphenidate to children and youth, 1990‐1996. Can Med Assoc J (2001); 165: 1489.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>165</number></detail><extent unit="pages"><start>1489</start></extent></part><relatedItem type="host"><titleInfo><title>Can Med Assoc J</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>165</number></detail><extent unit="pages"><start>1489</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit328"><titleInfo><title>A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: The Quetiapine Experience with Safety and Tolerability (QUEST) study</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mullen J, Jibson MD, Sweitzer D. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: The Quetiapine Experience with Safety and Tolerability (QUEST) study. Clin Ther (2001); 23: 1839.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>1839</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Ther</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>1839</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit329"><titleInfo><title>Is it possible to distinguish between benign and malignant neutropenia in clozapine‐treated patients by means of a hydrocortisone test? (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Murry P, Laurent A. Is it possible to distinguish between benign and malignant neutropenia in clozapine‐treated patients by means of a hydrocortisone test? (Letter). Psychopharmacology (2001); 158: 329.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>158</number></detail><extent unit="pages"><start>329</start></extent></part><relatedItem type="host"><titleInfo><title>Psychopharmacology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>158</number></detail><extent unit="pages"><start>329</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit330"><titleInfo><title>Abnormalities of thermoregulation induced by fluvoxamine (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Okada F, Okajima. Abnormalities of thermoregulation induced by fluvoxamine (Letter). J Clin Psychopharmacol (2001); 21: 619.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>619</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Psychopharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>619</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit331"><titleInfo><title>Antidepressant drug prescribing in Italy, 2000: Analysis of a general practice database</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Pietraru C, Barbui C, Poggio L, Tognoni G. Antidepressant drug prescribing in Italy, 2000: Analysis of a general practice database. Eur J Clin Pharmacol (2001); 57: 605.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>605</start></extent></part><relatedItem type="host"><titleInfo><title>Eur J Clin Pharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>605</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit332"><titleInfo><title>Olanzapine‐induced diabetic ketoacidosis (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ragucci KR, Wells BJ. Olanzapine‐induced diabetic ketoacidosis (Case Report). Ann Pharmacother (2001); 35: 1556.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1556</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Pharmacother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1556</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit333"><titleInfo><title>Antipsychotics and the risk of sudden cardiac death</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ray WA, Meredith S, Thapa PB, Meador KG, Hall K, Murray KT. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry (2001); 58: 1161.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>58</number></detail><extent unit="pages"><start>1161</start></extent></part><relatedItem type="host"><titleInfo><title>Arch Gen Psychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>58</number></detail><extent unit="pages"><start>1161</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit334"><titleInfo><title>Hepatotoxicity after short‐term trazodone therapy (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rettman KS, McClintock C. Hepatotoxicity after short‐term trazodone therapy (Case Report). Ann Pharmacother (2001); 35: 1559.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1559</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Pharmacother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1559</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit335"><titleInfo><title>Donepezil in the treatment of Alzheimer's disease: Long‐term efficacy and safety</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rocca P, Cocuzza E, Marchiano L, Bogetto F. Donepezil in the treatment of Alzheimer's disease: Long‐term efficacy and safety. Prog Neuropsychopharmacol Biol Psychiatry (2002); 26: 369.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>369</start></extent></part><relatedItem type="host"><titleInfo><title>Prog Neuropsychopharmacol Biol Psychiatry</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>369</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit336"><titleInfo><title>Diabetes mellitus associated with olanzapine use (Spanish) (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rojas, Arancibia, Bravo V, Varela S. Diabetes mellitus associated with olanzapine use (Spanish) (Case Report). Rev Med Chil (2001); 129: 1183.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>129</number></detail><extent unit="pages"><start>1183</start></extent></part><relatedItem type="host"><titleInfo><title>Rev Med Chil</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>129</number></detail><extent unit="pages"><start>1183</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit337"><titleInfo><title>How efficacious and safe is short‐acting methylphenidate for the treatment of attention‐deficit disorder in children and adolescents? A meta‐analysis</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Schachter HA, King J, Langford S, Moher D. How efficacious and safe is short‐acting methylphenidate for the treatment of attention‐deficit disorder in children and adolescents? A meta‐analysis. Can Med Assoc J (2001); 165: 1475.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>165</number></detail><extent unit="pages"><start>1475</start></extent></part><relatedItem type="host"><titleInfo><title>Can Med Assoc J</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>165</number></detail><extent unit="pages"><start>1475</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit338"><titleInfo><title>Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Schillevoort I, De Boer A, Herings RMC, Roos RAC. Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine. Ann Pharmacother (2001); 35: 1517.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1517</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Pharmacother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1517</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit339"><titleInfo><title>Contingency valuation and preferences of health states associated with side effects of antipsychotic medications in schizophrenia</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sevy S, Nathanson K, Schechter C, Fulop G. Contingency valuation and preferences of health states associated with side effects of antipsychotic medications in schizophrenia. Schizophr Bull (2001); 27: 643.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>643</start></extent></part><relatedItem type="host"><titleInfo><title>Schizophr Bull</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>643</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit340"><titleInfo><title>Neuroleptic malignant syndrome and quetiapine (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sing KJ, Ramaekers GMGI, Van Harten PN. Neuroleptic malignant syndrome and quetiapine (Letter). Am J Psychiatry (2002); 159: 149.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>159</number></detail><extent unit="pages"><start>149</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Psychiatry</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>159</number></detail><extent unit="pages"><start>149</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit341"><titleInfo><title>Olanzapine‐induced priapism (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Songer DA, Barclay JC. Olanzapine‐induced priapism (Letter). Am J Psychiatry (2001); 158: 2087.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>158</number></detail><extent unit="pages"><start>2087</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Psychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>158</number></detail><extent unit="pages"><start>2087</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit342"><titleInfo><title>Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome? (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Stiskal JA, Ito S. Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome? (Reply). Arch Dis Child (2001); 85: F148.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>F148</start></extent></part><relatedItem type="host"><titleInfo><title>Arch Dis Child</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>F148</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit343"><titleInfo><title>Development of parkinsonian symptoms after discontinuation of carbamazepine in patients concurrently treated with risperidone: Two case reports</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Takahashi H, Yoshida K, Higuchi H, Shimizu T. Development of parkinsonian symptoms after discontinuation of carbamazepine in patients concurrently treated with risperidone: Two case reports. Clin Neuropharmacol (2001); 24: 358.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>358</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Neuropharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>358</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit344"><titleInfo><title>Late onset neutropenia during clozapine treatment (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tamam L, Kulan E, Ozpoyraz N. Late onset neutropenia during clozapine treatment (Letter). Psychiatr Clin Neurosci (2001); 55: 547.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>55</number></detail><extent unit="pages"><start>547</start></extent></part><relatedItem type="host"><titleInfo><title>Psychiatr Clin Neurosci</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>55</number></detail><extent unit="pages"><start>547</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit345"><titleInfo><title>A randomized double‐blind, placebo controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E. A randomized double‐blind, placebo controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. J Am Geriatr Soc (2001); 49: 1590.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>49</number></detail><extent unit="pages"><start>1590</start></extent></part><relatedItem type="host"><titleInfo><title>J Am Geriatr Soc</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>49</number></detail><extent unit="pages"><start>1590</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit346"><titleInfo><title>Imipramine toxicity and terbinafine (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Teitelbaum ML, Pearson VE. Imipramine toxicity and terbinafine (Letter). Am J Psychiatry (2001); 158: 2086.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>158</number></detail><extent unit="pages"><start>2086</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Psychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>158</number></detail><extent unit="pages"><start>2086</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit347"><titleInfo><title>Prevalence of obesity in adolescent and young adult patients with and without schizophrenia and in relationship to antipsychotic medication</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Theisen FM, Linden A, Geller F, Schafer H, Martin M, Remschmidt H, Hebebrand J. Prevalence of obesity in adolescent and young adult patients with and without schizophrenia and in relationship to antipsychotic medication. J Psychiatr Res (2001); 35: 339.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>339</start></extent></part><relatedItem type="host"><titleInfo><title>J Psychiatr Res</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>339</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit348"><titleInfo><title>Clozapine and sudden death</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tie H, Walker BD, Singleton CB, Bursill JA, Wyse KR, Campbell TJ, Valenzuela SM, Breit SN. Clozapine and sudden death. J Clin Psychopharmacol (2001); 21: 630.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>630</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Psychopharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>630</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit349"><titleInfo><title>Olanzapine‐induced agranulocytosis: A case report and review of the literature</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tolosa‐Vilella C, Ruiz‐Ripoll A, Mari‐Alfonso B, Naval‐Sendra E. Olanzapine‐induced agranulocytosis: A case report and review of the literature. Prog Neuropsychopharmacol Biol Psychiatry (2002); 26: 411.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>411</start></extent></part><relatedItem type="host"><titleInfo><title>Prog Neuropsychopharmacol Biol Psychiatry</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>411</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit350"><titleInfo><title>Characteristics of fluvoxamine‐induced nausea</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ueda N, Yoshimura R, Shinkai K, Terao T, Nakamura J. Characteristics of fluvoxamine‐induced nausea. Psychiatr Res (2001); 104: 259.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>104</number></detail><extent unit="pages"><start>259</start></extent></part><relatedItem type="host"><titleInfo><title>Psychiatr Res</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>104</number></detail><extent unit="pages"><start>259</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit351"><titleInfo><title>Olanzapine, new‐onset diabetes mellitus, and risk for insulin overdose (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Van Meter SA, Seaburg H, McLendon B, Doraiswamy PM. Olanzapine, new‐onset diabetes mellitus, and risk for insulin overdose (Letter). J Clin Psychiatry (2001); 62: 993.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>993</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Psychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>993</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit352"><titleInfo><title>Atypical antipsychotics and neuroleptic malignant syndrome (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Velamoor VR. Atypical antipsychotics and neuroleptic malignant syndrome (Letter). Can J Psychiatry (2001); 46: 865.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>46</number></detail><extent unit="pages"><start>865</start></extent></part><relatedItem type="host"><titleInfo><title>Can J Psychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>46</number></detail><extent unit="pages"><start>865</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit353"><titleInfo><title>SSRIs associated with behavioral activation and suicidal ideation</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Vorstman J, Lahuis B, Buitelaar JK. SSRIs associated with behavioral activation and suicidal ideation. J Am Acad Child Adolesc Psychiatry (2001); 40: 1364.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>1364</start></extent></part><relatedItem type="host"><titleInfo><title>J Am Acad Child Adolesc Psychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>1364</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit354"><titleInfo><title>SSRIs and ejaculation: A double‐blind, randomized, fixed dose study with paroxetine and citalopram</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Waldinger MD, Zwinderman AH, Olivier B. SSRIs and ejaculation: A double‐blind, randomized, fixed dose study with paroxetine and citalopram. J Clin Psychopharmacol (2001); 21: 556.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>556</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Psychopharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>556</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit355"><titleInfo><title>The effect of CYP2C19 and CYP2D6 genotypes on the metabolism of clomipramine in Japanese psychiatric patients</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Yokono A, Morita S, Someya T, Hirokane G, Okawa M, Shimoda K. The effect of CYP2C19 and CYP2D6 genotypes on the metabolism of clomipramine in Japanese psychiatric patients. J Clin Psychopharmacol (2001); 21: 549.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>549</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Psychopharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>549</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit356"><titleInfo><title>Pharmacoepidemiologic investigation of a clonazepam‐carbamazepine interaction by mixed effect modelling using routine clinical pharmacokinetic data in Japanese patients</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Yukawa E, Nonaka T, Yukawa M, Ohdo S, Higuchi S, Kuroda T, Goto Y. Pharmacoepidemiologic investigation of a clonazepam‐carbamazepine interaction by mixed effect modelling using routine clinical pharmacokinetic data in Japanese patients. J Clin Psychopharmacol (2001);21: 588.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>588</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Psychopharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>588</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit357"><titleInfo><title>Pharmacoepidemiologic investigation of clonazepam relative clearance by mixed‐effect modeling using routine clinical pharmacokinetic data in Japanese patients</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Yukawa E, Satou M, Nonaka T, Yukawa M, Ohdo S, Higuchi S, Kuroda T, Goto Y. Pharmacoepidemiologic investigation of clonazepam relative clearance by mixed‐effect modeling using routine clinical pharmacokinetic data in Japanese patients. J Clin Pharmacol (2002); 42: 81.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>81</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Pharmacol</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>81</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit358"><titleInfo><title>Sudden cardiac death and antipsychotic drugs: Do we know enough? (Commentary)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Zarate CA, Patel J. Sudden cardiac death and antipsychotic drugs: Do we know enough? (Commentary). Arch Gen Psychiatry (2001); 58: 1168.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>58</number></detail><extent unit="pages"><start>1168</start></extent></part><relatedItem type="host"><titleInfo><title>Arch Gen Psychiatry</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>58</number></detail><extent unit="pages"><start>1168</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit359"><titleInfo><title>8. Anti‐neoplastic agents</title></titleInfo><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit360"><titleInfo><title>Cognitive effects of standard‐dose chemotherapy in patients with cancer</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ahles TA, Saykin A. Cognitive effects of standard‐dose chemotherapy in patients with cancer. Cancer Invest (2001); 19: 812.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>812</start></extent></part><relatedItem type="host"><titleInfo><title>Cancer Invest</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>812</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit361"><titleInfo><title>A case with cerebral thrombosis receiving tamoxifen treatment (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Akdal G, Donmez B, Cakmakci H, Yener GG. A case with cerebral thrombosis receiving tamoxifen treatment (Letter). Eur J Neurol (2001); 8: 723.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>723</start></extent></part><relatedItem type="host"><titleInfo><title>Eur J Neurol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>723</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit362"><titleInfo><title>Gemcitabine, ifosfamide and navelbine (GIN): Activity and safety of a non‐platinum‐based triplet in advanced non‐small‐cell lung cancer (NSCLC)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Baldini E, Ardizzoni A, Prochilo T, Cafferata MA, Boni L, Tibaldi C, Neumaier C, Conte PF, Rosso R. Gemcitabine, ifosfamide and navelbine (GIN): Activity and safety of a non‐platinum‐based triplet in advanced non‐small‐cell lung cancer (NSCLC). Br J Cancer (2001); 85: 1452.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>1452</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Cancer</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>1452</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit363"><titleInfo><title>Gemcitabine‐induced systemic capillary leak syndrome (Clinical Case)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">De Pas T, Curigliano G, Franceschelli L, Catania C, Spaggiari L, De Braud F. Gemcitabine‐induced systemic capillary leak syndrome (Clinical Case). Ann Oncol (2001); 12: 1651.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>1651</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Oncol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>1651</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit364"><titleInfo><title>Oral vinorelbine: Feasibility and safety profile</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Depierre A, Freyer G, Jassem J, Orfeuvre H, Ramlau R, Lemarie E, Koralewski P, Mauriac L, Breton JL, Delozier T, Trillet‐Lenoir V. Oral vinorelbine: Feasibility and safety profile. Ann Oncol (2001); 12: 1677.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>1677</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Oncol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>1677</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit365"><titleInfo><title>Coronary insufficiency after an oral intake of capecitabine (Letter) (French)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Desrame J, Bronstein JA, Thiolet C, Bredin C, Ceccaldi B, Vergeau B, Farret O. Coronary insufficiency after an oral intake of capecitabine (Letter) (French). Gastroenterol Clin Biol (2001); 25: 829.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>829</start></extent></part><relatedItem type="host"><titleInfo><title>Gastroenterol Clin Biol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>829</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit366"><titleInfo><title>Flutamide‐induced acute hepatitis in advanced prostate cancer patients</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kraus I, Vitezic D, Oguic R. Flutamide‐induced acute hepatitis in advanced prostate cancer patients. Int J Clin Pharm Ther (2001); 39: 395.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>395</start></extent></part><relatedItem type="host"><titleInfo><title>Int J Clin Pharm Ther</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>395</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit367"><titleInfo><title>Hand‐foot syndrome associated with short infusions of combination chemotherapy with gemcitabine and vinorelbine</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Laack E, Mende T, Knuffmann C, Hossfeld DK. Hand‐foot syndrome associated with short infusions of combination chemotherapy with gemcitabine and vinorelbine. Ann Oncol (2001); 12: 1761.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>1761</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Oncol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>1761</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit368"><titleInfo><title>Endometrial histologic changes in post‐menopausal breast cancer patients using tamoxifen</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Marchesoni D, Driul L, Fabiani G, Di Loreto C, Cataldi P, Mozzanega B. Endometrial histologic changes in post‐menopausal breast cancer patients using tamoxifen. Int J Gynecol Obstet (2001); 75: 257.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>75</number></detail><extent unit="pages"><start>257</start></extent></part><relatedItem type="host"><titleInfo><title>Int J Gynecol Obstet</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>75</number></detail><extent unit="pages"><start>257</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit369"><titleInfo><title>Efficacy and safety of chlorambucil in intractable noninfectious uveitis: The Massachusetts Eye and Ear Infirmary experience</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Miserocchi E, Baltatzis S, Ekong A, Roque M, Foster CS. Efficacy and safety of chlorambucil in intractable noninfectious uveitis: The Massachusetts Eye and Ear Infirmary experience. Ophthalmology (2002); 109: 137.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>137</start></extent></part><relatedItem type="host"><titleInfo><title>Ophthalmology</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>137</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit370"><titleInfo><title>Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life‐threatening vincristine neurotoxicity</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Naumann R, Mohm J, Reuner U, Kroschinsky F, Rautenstrauss B, Ehninger G. Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life‐threatening vincristine neurotoxicity. Br J Haematol (2001); 115: 323.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>115</number></detail><extent unit="pages"><start>323</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Haematol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>115</number></detail><extent unit="pages"><start>323</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit371"><titleInfo><title>Cytoprotection against doxorubicin toxicity (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Perkins TE, Malkinson FD, Finnerud CW. Cytoprotection against doxorubicin toxicity (Letter). Arch Dermatol (2001); 137: 1528.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>137</number></detail><extent unit="pages"><start>1528</start></extent></part><relatedItem type="host"><titleInfo><title>Arch Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>137</number></detail><extent unit="pages"><start>1528</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit372"><titleInfo><title>Protective effects of fosfomycin on cisplatin‐induced nephrotoxicity in patients with lung cancer</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rojanasthien N, Kumsorn B, Atikachai B, Leotrakul S, Thongprasert S. Protective effects of fosfomycin on cisplatin‐induced nephrotoxicity in patients with lung cancer. Int J Clin Pharm Ther (2001); 39: 121.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>121</start></extent></part><relatedItem type="host"><titleInfo><title>Int J Clin Pharm Ther</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>121</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit373"><titleInfo><title>Clinical picture: Leopard‐like vitiligo with capecitabine</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Schmid‐Wendtner MH, Wendtner CM, Volkenandt M, Heinemann V. Clinical picture: Leopard‐like vitiligo with capecitabine. Lancet (2001); 358: 1575.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>358</number></detail><extent unit="pages"><start>1575</start></extent></part><relatedItem type="host"><titleInfo><title>Lancet</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>358</number></detail><extent unit="pages"><start>1575</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit374"><titleInfo><title>Idiosyncratic reaction after oxaliplatin: Circumvention by use of a continuous infusional administration schedule (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Schull B, Kornek GV, Scheithauer W. Idiosyncratic reaction after oxaliplatin: Circumvention by use of a continuous infusional administration schedule (Letter). Ann Oncol (2001); 12: 1653.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>1653</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Oncol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>1653</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit375"><titleInfo><title>Efficacy and safety of gemtuzumab ozogamicin in patients with CD33‐positive acute myeloid leukaemia in first relapse</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sievers EL. Efficacy and safety of gemtuzumab ozogamicin in patients with CD33‐positive acute myeloid leukaemia in first relapse. Expert Opin Biol Ther (2001); 1: 893.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>1</number></detail><extent unit="pages"><start>893</start></extent></part><relatedItem type="host"><titleInfo><title>Expert Opin Biol Ther</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>1</number></detail><extent unit="pages"><start>893</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit376"><titleInfo><title>Coronary vasospasm in chemotherapy with 5‐fluoracil (Case Report) (German, English Abstract)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sucker C, Scheffold N. Coronary vasospasm in chemotherapy with 5‐fluoracil (Case Report) (German, English Abstract). Dtsch Med Wochenschr (2001); 126: 1300.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>126</number></detail><extent unit="pages"><start>1300</start></extent></part><relatedItem type="host"><titleInfo><title>Dtsch Med Wochenschr</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>126</number></detail><extent unit="pages"><start>1300</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit377"><titleInfo><title>Signal‐averaged electrocardiography in children with anthracycline‐induced cardiomyopathy</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Vaksmann G, Gutierrez R, Duhamel A, Nelken B, Francart C, Kouakam C, Mazingue F, Rey C. Signal‐averaged electrocardiography in children with anthracycline‐induced cardiomyopathy. Pediatr Cardiol (2001); 22: 494.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>494</start></extent></part><relatedItem type="host"><titleInfo><title>Pediatr Cardiol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>494</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit378"><titleInfo><title>Complement activation plays a key role in the side‐effects of rituximab treatment</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Van der Kolk LE, Grillo‐Lopez AJ, Baars JW, Hack CE, Van Oers MHJ. Complement activation plays a key role in the side‐effects of rituximab treatment. Br J Haematol (2001); 115: 807.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>115</number></detail><extent unit="pages"><start>807</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Haematol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>115</number></detail><extent unit="pages"><start>807</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit379"><titleInfo><title>Life‐threatening hypersensitivity pneumonitis induced by docetaxel (taxotere)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wang GS, Yang KY, Perng RP. Life‐threatening hypersensitivity pneumonitis induced by docetaxel (taxotere). Br J Cancer (2001); 85: 1247.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>1247</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Cancer</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>1247</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit380"><titleInfo><title>9. Haematological agents</title></titleInfo><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit381"><titleInfo><title>Acute generalized exanthematous pustulosis induced by icodextrin (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Al Hoqail IA, Crawford RI. Acute generalized exanthematous pustulosis induced by icodextrin (Letter). Br J Dermatol (2001); 145: 1026.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>145</number></detail><extent unit="pages"><start>1026</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>145</number></detail><extent unit="pages"><start>1026</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit382"><titleInfo><title>The endocarditis that was not: An unusual case of heparin‐induced thrombocytopenia with unusual complications</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bergeron S, Demers C, Bogaty P, Poirier P. The endocarditis that was not: An unusual case of heparin‐induced thrombocytopenia with unusual complications. Can J Cardiol (2001); 17: 1180.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>1180</start></extent></part><relatedItem type="host"><titleInfo><title>Can J Cardiol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>1180</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit383"><titleInfo><title>Heparin‐induced priapism (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bschleipfer T, Hauck EW, Diemer T, Bitzer M, Kirkpatrick CJ, Pust RA, Weidner W. Heparin‐induced priapism (Case Report). Int J Impot Res (2001); 13: 357.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>357</start></extent></part><relatedItem type="host"><titleInfo><title>Int J Impot Res</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>357</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit384"><titleInfo><title>Ticlopidine associated with acute arthritis</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Dakik HA, Salti I, Haidar R, Uthman IW. Ticlopidine associated with acute arthritis. Br Med J (2002); 324: 27.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>324</number></detail><extent unit="pages"><start>27</start></extent></part><relatedItem type="host"><titleInfo><title>Br Med J</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>324</number></detail><extent unit="pages"><start>27</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit385"><titleInfo><title>Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">De Jonge E, Levi M, Buller HR, Berends F, Kesecioglu J. Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects. Intensive Care Med (2001); 27: 1825.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>1825</start></extent></part><relatedItem type="host"><titleInfo><title>Intensive Care Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>1825</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit386"><titleInfo><title>Two cases of fatal thrombosis after aminocaproic acid therapy and deep hypothermic circulatory arrest (Case Reports)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Fanashawe MP, Shore‐Lesserson L, Reich DL. Two cases of fatal thrombosis after aminocaproic acid therapy and deep hypothermic circulatory arrest (Case Reports). Anesthesiology (2001); 95: 1525.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>95</number></detail><extent unit="pages"><start>1525</start></extent></part><relatedItem type="host"><titleInfo><title>Anesthesiology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>95</number></detail><extent unit="pages"><start>1525</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit387"><titleInfo><title>Venous thromboembolism during pregnancy: A retrospective study of enoxaparin safety in 624 pregnancies</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lepercq J, Conard J, Borel‐Derlon A, Darmon JY, Boudignat O, Francoual C, Priollet P, Cohen C, Yvelin N, Schved JF, Tournaire M, Borg JY. Venous thromboembolism during pregnancy: A retrospective study of enoxaparin safety in 624 pregnancies. Br J Obstet Gynaecol (2001);108: 1134.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>108</number></detail><extent unit="pages"><start>1134</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Obstet Gynaecol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>108</number></detail><extent unit="pages"><start>1134</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit388"><titleInfo><title>A randomized trial to compare the efficacy, safety, cost and platelet aggregation effects of enoxaparin and unfractionated heparin (the ESCAPEU trial)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Malhotra S, Bhargava VK, Grover A, Pandhi P, Sharma YP. A randomized trial to compare the efficacy, safety, cost and platelet aggregation effects of enoxaparin and unfractionated heparin (the ESCAPEU trial). Int J Clin Pharm Ther (2001); 39: 110.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>110</start></extent></part><relatedItem type="host"><titleInfo><title>Int J Clin Pharm Ther</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>110</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit389"><titleInfo><title>Recombinant factor VIIa (NovoSeven®) and the safety of treatment</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Roberts HR. Recombinant factor VIIa (NovoSeven®) and the safety of treatment. Semin Hematol (2001); 38: 48.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>48</start></extent></part><relatedItem type="host"><titleInfo><title>Semin Hematol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>48</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit390"><titleInfo><title>Delayed cutaneous hypersensitivity reactions to hirudin (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Smith KJ, Rosario‐Collazo J, Skelton H. Delayed cutaneous hypersensitivity reactions to hirudin (Case Report). Arch Pathol Lab Med (2001); 125: 1585.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>125</number></detail><extent unit="pages"><start>1585</start></extent></part><relatedItem type="host"><titleInfo><title>Arch Pathol Lab Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>125</number></detail><extent unit="pages"><start>1585</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit391"><titleInfo><title>Drug‐induced hypersensitivity syndrome due to fluindione (French, English Abstract)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sparsa A, Bedane C, Benazahary H, De Vencay P, Gauthier ML, Le Brun V, Boulinguez S, Loustaud‐Ratti V, Soria P, Vidal E, Bonnetblanc JM. Drug‐induced hypersensitivity syndrome due to fluindione (French, English Abstract). Ann Dermatol Venereol (2001); 128: 1014.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>128</number></detail><extent unit="pages"><start>1014</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Dermatol Venereol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>128</number></detail><extent unit="pages"><start>1014</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit392"><titleInfo><title>Hypersensitivity to warfarin in a patient with a mechanical aortic prosthesis</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tak T, Smith JF. Hypersensitivity to warfarin in a patient with a mechanical aortic prosthesis. J Heart Valve Dis (2001); 10: 832.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>832</start></extent></part><relatedItem type="host"><titleInfo><title>J Heart Valve Dis</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>832</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit393"><titleInfo><title>Necrotizing hepatitis associated with phenprocoumon (Letter) (German)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Weber T, Hinterreiter M, Knoflach P. Necrotizing hepatitis associated with phenprocoumon (Letter) (German). Dtsch Med Wochenschr (2001); 126: 1060.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>126</number></detail><extent unit="pages"><start>1060</start></extent></part><relatedItem type="host"><titleInfo><title>Dtsch Med Wochenschr</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>126</number></detail><extent unit="pages"><start>1060</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit394"><titleInfo><title>10. Neuroregulator‐blocking agents</title></titleInfo><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit395"><titleInfo><title>Comment: Serotonin syndrome, mydriasis, and cyproheptadine (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Isbister GK. Comment: Serotonin syndrome, mydriasis, and cyproheptadine (Letter). Ann Pharmacother (2001); 35: 1672.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1672</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Pharmacother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1672</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit396"><titleInfo><title>The efficacy and safety of once‐daily Kytril® (granisetron hydrochloride) tablets in the prophylaxis of nausea and emesis following fractionated upper abdominal radiotherapy</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lanciano R, Sherman DM, Michalski J, Preston AJ, Yocom K, Friedman C. The efficacy and safety of once‐daily Kytril® (granisetron hydrochloride) tablets in the prophylaxis of nausea and emesis following fractionated upper abdominal radiotherapy. Cancer Invest (2001);19: 763.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>763</start></extent></part><relatedItem type="host"><titleInfo><title>Cancer Invest</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>763</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit397"><titleInfo><title>Efficacy, tolerability and safety profile of propiverine in the treatment of the overactive bladder (non‐neurogenic and neurogenic)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Madersbacher H, Murtz G. Efficacy, tolerability and safety profile of propiverine in the treatment of the overactive bladder (non‐neurogenic and neurogenic). World J Urol (2001); 19: 324.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>324</start></extent></part><relatedItem type="host"><titleInfo><title>World J Urol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>324</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit398"><titleInfo><title>Comment: Serotonin syndrome, mydriasis and cyproheptadine (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">McDaniel WW. Comment: Serotonin syndrome, mydriasis and cyproheptadine (Reply). Ann Pharmacother (2001); 35: 1673.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1673</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Pharmacother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1673</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit399"><titleInfo><title>Efficacy and safety of an oral formulation of cetirizine and prolonged‐release pseudoephedrine versus xylometazoline nasal spray in nasal congestion</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Stubner UP, Toth J, Marks B, Berger UE, Burtin B, Horak F. Efficacy and safety of an oral formulation of cetirizine and prolonged‐release pseudoephedrine versus xylometazoline nasal spray in nasal congestion. Arzneimittelforschung (2001); 51: 904.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>51</number></detail><extent unit="pages"><start>904</start></extent></part><relatedItem type="host"><titleInfo><title>Arzneimittelforschung</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>51</number></detail><extent unit="pages"><start>904</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit400"><titleInfo><title>11. Dermatological agents</title></titleInfo><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit401"><titleInfo><title>Anaphylaxis to 5‐methoxypsoralen during photochemotherapy (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Legat FJ, Wolf P, Kranke B. Anaphylaxis to 5‐methoxypsoralen during photochemotherapy (Case Report). Br J Dermatol (2001); 145: 821.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>145</number></detail><extent unit="pages"><start>821</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>145</number></detail><extent unit="pages"><start>821</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit402"><titleInfo><title>Assessment of acitretin‐treated female patients of childbearing age and subsequent risk of teratogenicity (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Maier H, Honigsmann H. Assessment of acitretin‐treated female patients of childbearing age and subsequent risk of teratogenicity (Letter). Br J Dermatol (2001); 145: 1028.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>145</number></detail><extent unit="pages"><start>1028</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>145</number></detail><extent unit="pages"><start>1028</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit403"><titleInfo><title>Pyogenic granuloma‐like lesions associated with topical retinoid therapy (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Pierson JC, Owens NM. Pyogenic granuloma‐like lesions associated with topical retinoid therapy (Letter). J Am Acad Dermatol (2001); 45: 967.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>967</start></extent></part><relatedItem type="host"><titleInfo><title>J Am Acad Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>967</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit404"><titleInfo><title>Systemic allergic contact dermatitis to 8‐methoxypsoralen (8‐MOP)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ravenscroft J, Goulden V, Wilkinson M. Systemic allergic contact dermatitis to 8‐methoxypsoralen (8‐MOP). J Am Acad Dermatol (2001); 45: S218.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>S218</start></extent></part><relatedItem type="host"><titleInfo><title>J Am Acad Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>S218</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit405"><titleInfo><title>Churg‐Strauss syndrome associated with fluticasone therapy (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Termeer C, Simon JC, Schopf E. Churg‐Strauss syndrome associated with fluticasone therapy (Letter). Arch Dermatol (2001); 137: 1527.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>137</number></detail><extent unit="pages"><start>1527</start></extent></part><relatedItem type="host"><titleInfo><title>Arch Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>137</number></detail><extent unit="pages"><start>1527</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit406"><titleInfo><title>Heparin‐binding epidermal‐growth‐factor‐like growth factor activation of keratinocyte ErbB receptors mediates epidermal hyperplasia, a prominent side‐effect of retinoid therapy</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Varani J, Zeigler M, Dame MK, Kang SW, Fisher GJ, Voorhees JJ, Stoll SW, Elder JT. Heparin‐binding epidermal‐growth‐factor‐like growth factor activation of keratinocyte ErbB receptors mediates epidermal hyperplasia, a prominent side‐effect of retinoid therapy. J Investig Dermatol (2001); 117: 1335.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>117</number></detail><extent unit="pages"><start>1335</start></extent></part><relatedItem type="host"><titleInfo><title>J Investig Dermatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>117</number></detail><extent unit="pages"><start>1335</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit407"><titleInfo><title>12. Immunosuppressive agents</title></titleInfo><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit408"><titleInfo><title>Asymptomatic gallstones and duration of cyclosporine use in kidney transplant recipients (Spanish, English Abstract)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Alberu J, Gatica M, Cachfeiro‐Vilar M, Robles‐Diaz G, Bezaury P, Paz‐Pinedo F, Vargas‐Vorackova F. Asymptomatic gallstones and duration of cyclosporine use in kidney transplant recipients (Spanish, English Abstract). Rev Invest Clin (2001); 53: 396.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>53</number></detail><extent unit="pages"><start>396</start></extent></part><relatedItem type="host"><titleInfo><title>Rev Invest Clin</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>53</number></detail><extent unit="pages"><start>396</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit409"><titleInfo><title>Etanercept‐induced subacute cutaneous lupus erythematosus (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bleumink GS, Ter Borg EJ, Ramselaar CG, Stricker BHC. Etanercept‐induced subacute cutaneous lupus erythematosus (Letter). Rheumatology (2001); 40: 1317.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>1317</start></extent></part><relatedItem type="host"><titleInfo><title>Rheumatology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>1317</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit410"><titleInfo><title>Severe pancytopenia associated with low‐dose methotrexate therapy for rheumatoid arthritis (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Calvo‐Romero JM. Severe pancytopenia associated with low‐dose methotrexate therapy for rheumatoid arthritis (Case Report). Ann Pharmacother (2001); 35: 1575.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1575</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Pharmacother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1575</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit411"><titleInfo><title>Cyclosporine nephrotoxicity: Associated allograft dysfunction at low trough concentration</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jankauskiene A, Druskis V, Laurinavicius A. Cyclosporine nephrotoxicity: Associated allograft dysfunction at low trough concentration. Clin Nephrol (2001); 56: S27.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>S27</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Nephrol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>S27</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit412"><titleInfo><title>Differential influence of two cyclosporine formulations on everolimus pharmacokinetics: A clinically relevant pharmacokinetic interaction</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kovarik JM, Kalbag J, Figueiredo J, Rouilly M, O'Bannon LF, Rordorf C. Differential influence of two cyclosporine formulations on everolimus pharmacokinetics: A clinically relevant pharmacokinetic interaction. J Clin Pharmacol (2002); 42: 95.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>95</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Pharmacol</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>95</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit413"><titleInfo><title>Re: Posttransplantation diabetes mellitus in FK‐506‐treated renal transplant recipients: Analysis of incidence and risk factors. Transplantation 2001; 72: 1655</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Krentz AJ. Re: Posttransplantation diabetes mellitus in FK‐506‐treated renal transplant recipients: Analysis of incidence and risk factors. Transplantation 2001; 72: 1655. Transplantation (2001); 72: 1593.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>72</number></detail><extent unit="pages"><start>1593</start></extent></part><relatedItem type="host"><titleInfo><title>Transplantation</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>72</number></detail><extent unit="pages"><start>1593</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit414"><titleInfo><title>Posttransplantation diabetes mellitus in FK‐506‐treated renal transplant recipients: Analysis of incidence and risk factors</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Maes BD, Kuypers D, Messiaen T, Evenepoel P, Mathieu C, Coosemans W, Pirenne J, Vanrenterghem YFC. Posttransplantation diabetes mellitus in FK‐506‐treated renal transplant recipients: Analysis of incidence and risk factors. Transplantation (2001); 72:1655.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>72</number></detail><extent unit="pages"><start>1655</start></extent></part><relatedItem type="host"><titleInfo><title>Transplantation</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>72</number></detail><extent unit="pages"><start>1655</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit415"><titleInfo><title>Infliximab‐induced aseptic meningitis</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Marotte H, Charrin JE, Miossec P. Infliximab‐induced aseptic meningitis. Lancet (2001); 358: 1784.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>358</number></detail><extent unit="pages"><start>1784</start></extent></part><relatedItem type="host"><titleInfo><title>Lancet</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>358</number></detail><extent unit="pages"><start>1784</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit416"><titleInfo><title>Biliary sepsis in a patient on anti‐TNFα therapy (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">McNamara DA, Molony D, Mulsow J, O'Connell PR. Biliary sepsis in a patient on anti‐TNFα therapy (Letter). Ir J Med Sci (2001); 170: 210.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>170</number></detail><extent unit="pages"><start>210</start></extent></part><relatedItem type="host"><titleInfo><title>Ir J Med Sci</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>170</number></detail><extent unit="pages"><start>210</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit417"><titleInfo><title>Eosinophilia as a side‐effect of methotrexate in patients with chronic arthritis (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Savolainen HA, Leirisalo‐Repo M. Eosinophilia as a side‐effect of methotrexate in patients with chronic arthritis (Letter). Clin Rheumatol (2001); 20: 432.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>432</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Rheumatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>432</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit418"><titleInfo><title>Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexatein rheumatoid arthritis: A forty‐eight‐week, multicenter, randomized, double‐blind, placebo‐controlled study</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Van Ede AE, Laan RFJM, Rood MJ, Huizinga TWJ, Van de Laar MAFJ, Van Denderen CJ, Westgeest TAA, Romme TC, De Rooij DJRAM, Jacobs MJM, De Boo TM, Van der Wilt GJ, Severens JL, Hartman M, Krabbe PF, Dijkmans BA, Breedveld FC, Van de Putte LB. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexatein rheumatoid arthritis: A forty‐eight‐week, multicenter, randomized, double‐blind, placebo‐controlled study. Arthritis Rheum (2001); 44: 1515.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>44</number></detail><extent unit="pages"><start>1515</start></extent></part><relatedItem type="host"><titleInfo><title>Arthritis Rheum</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>44</number></detail><extent unit="pages"><start>1515</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit419"><titleInfo><title>Immunosuppressant side effect profile does not differ between organ transplant types</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Winsett RP, Stratta RJ, Alloway R, Wicks MN, Hathaway DK. Immunosuppressant side effect profile does not differ between organ transplant types. Clin Transpl (2001); 15: 46.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>46</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Transpl</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>46</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit420"><titleInfo><title>Toxicity of methotrexate treatment in psoriasis and psoriatic arthritis: Short‐ and long‐term toxicity in 104 patients</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wollina U, Stander K, Barta U. Toxicity of methotrexate treatment in psoriasis and psoriatic arthritis: Short‐ and long‐term toxicity in 104 patients. Clin Rheumatol (2001); 20: 406.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>406</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Rheumatol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>406</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit421"><titleInfo><title>13. Autonomic agents</title></titleInfo><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit422"><titleInfo><title>Chronic pericardial constriction linked to the antiparkinsonian dopamine agonist pergolide (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Balachandran KP, Stewart D, Berg GA, Oldroyd KG. Chronic pericardial constriction linked to the antiparkinsonian dopamine agonist pergolide (Case Report). Postgrad Med J (2002); 78: 49.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>78</number></detail><extent unit="pages"><start>49</start></extent></part><relatedItem type="host"><titleInfo><title>Postgrad Med J</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>78</number></detail><extent unit="pages"><start>49</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit423"><titleInfo><title>Intracranial hemorrhages associated with sumatriptan (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Combremont P, Marcus EM. Intracranial hemorrhages associated with sumatriptan (Reply). Neurology (2001); 57: 2322.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>2322</start></extent></part><relatedItem type="host"><titleInfo><title>Neurology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>2322</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit424"><titleInfo><title>Intracranial hemorrhages associated with sumatriptan (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mulder LJMM. Intracranial hemorrhages associated with sumatriptan (Letter). Neurology (2001); 57: 2322.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>2322</start></extent></part><relatedItem type="host"><titleInfo><title>Neurology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>2322</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit425"><titleInfo><title>A double‐masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open‐angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nordmann JP, Mertz B, Yannoulis NC, Schwenninger C, Kapik B, Shams N. A double‐masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open‐angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data. Am J Ophthalmol (2002); 133: 1.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>133</number></detail><extent unit="pages"><start>1</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Ophthalmol</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>133</number></detail><extent unit="pages"><start>1</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit426"><titleInfo><title>Abnormal daytime somnolence, “sleep attacks”, and antiparkinson drugs (French)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rascol O, Ferreira J, Montastruc JL. Abnormal daytime somnolence, “sleep attacks”, and antiparkinson drugs (French). Rev Neurol (2001); 157: 1313.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>157</number></detail><extent unit="pages"><start>1313</start></extent></part><relatedItem type="host"><titleInfo><title>Rev Neurol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>157</number></detail><extent unit="pages"><start>1313</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit427"><titleInfo><title>Pharmacokinetics and safety of oral eletriptan during different phases of the menstrual cycle in healthy volunteers</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Shah AK, La Boy‐Goral L, Scott N, Morse T, Apseloff G. Pharmacokinetics and safety of oral eletriptan during different phases of the menstrual cycle in healthy volunteers. J Clin Pharmacol (2001); 41: 1339.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>41</number></detail><extent unit="pages"><start>1339</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Pharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>41</number></detail><extent unit="pages"><start>1339</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit428"><titleInfo><title>Intracranial hemorrhages associated with sumatriptan (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Spierings ELH. Intracranial hemorrhages associated with sumatriptan (Letter). Neurology (2001); 57: 2322.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>2322</start></extent></part><relatedItem type="host"><titleInfo><title>Neurology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>2322</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit429"><titleInfo><title>Systemic adverse effects of ophthalmic β‐blockers</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Van der Zanden JA, Valuck RJ, Bunch CL, Perlman JI, Anderson C, Wortman GI. Systemic adverse effects of ophthalmic β‐blockers. Ann Pharmacother (2001); 35: 1633.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1633</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Pharmacother</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>1633</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit430"><titleInfo><title>14. Respiratory system agents</title></titleInfo><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit431"><titleInfo><title>Montelukast and improvement of eczema: Observations from a prescription event monitoring study in England</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Biswas P, Wilton LV, Shakir SAW. Montelukast and improvement of eczema: Observations from a prescription event monitoring study in England. Int J Clin Pharm Ther (2001); 39: 529.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>529</start></extent></part><relatedItem type="host"><titleInfo><title>Int J Clin Pharm Ther</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>529</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit432"><titleInfo><title>Long‐term safety of flunisolide hydrofluoroalkane metered‐dose inhaler in adults and adolescents with asthma</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Casale TB, Nelson HS, Corren J, Newman K. Long‐term safety of flunisolide hydrofluoroalkane metered‐dose inhaler in adults and adolescents with asthma. Clin Drug Invest (2001); 21: 755.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>755</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Drug Invest</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>755</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit433"><titleInfo><title>Severe liver injury associated with zafirlukast (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Danese S, De Vitis I, Gasbarrini A. Severe liver injury associated with zafirlukast (Letter). Ann Intern Med (2001); 135: 930.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>135</number></detail><extent unit="pages"><start>930</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Intern Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>135</number></detail><extent unit="pages"><start>930</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit434"><titleInfo><title>Systematic effects of inhaled steroids (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Harrison T, Tattersfield A. Systematic effects of inhaled steroids (Reply). Thorax (2001); 56: 981.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>981</start></extent></part><relatedItem type="host"><titleInfo><title>Thorax</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>981</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit435"><titleInfo><title>Under‐reporting of hemorrhagic stroke associated with phenylpropanolamine</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">La Grenade L, Graham D, Nourjah P. Under‐reporting of hemorrhagic stroke associated with phenylpropanolamine. JAMA (2001); 286: 3081.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>3081</start></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>3081</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit436"><titleInfo><title>Alendronate for the prevention of bone loss in patients on inhaled steroid therapy</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lau EMC, Woo J, Chan YH, Li M. Alendronate for the prevention of bone loss in patients on inhaled steroid therapy. Bone (2001); 29: 506.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>29</number></detail><extent unit="pages"><start>506</start></extent></part><relatedItem type="host"><titleInfo><title>Bone</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>29</number></detail><extent unit="pages"><start>506</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit437"><titleInfo><title>Safety of budesonide inhalation suspension (Pulmicort Respules) after up to 52 weeks of treatment in infants and young children with persistent asthma</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Leflein JG, Gawchik SM, Galant SP, Lyzell E, Young M, Cruz‐Rivera M, Walton‐Bowen K, Smith JA, Fitzpatrick S. Safety of budesonide inhalation suspension (Pulmicort Respules) after up to 52 weeks of treatment in infants and young children with persistent asthma. Allergy Asthma Proc (2001); 22: 359.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>359</start></extent></part><relatedItem type="host"><titleInfo><title>Allergy Asthma Proc</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>359</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit438"><titleInfo><title>Systemic effects of inhaled steroids (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lipworth BJ. Systemic effects of inhaled steroids (Letter). Thorax (2001); 56: 980.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>980</start></extent></part><relatedItem type="host"><titleInfo><title>Thorax</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>980</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit439"><titleInfo><title>Growth as a biological marker of inhaled corticosteroid activity</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Malozowski S, Purucker M. Growth as a biological marker of inhaled corticosteroid activity. Curr Ther Res (2001); 62: 796.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>796</start></extent></part><relatedItem type="host"><titleInfo><title>Curr Ther Res</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>796</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit440"><titleInfo><title>Systemic effects of inhaled steroids (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mckenzie SA. Systemic effects of inhaled steroids (Letter). Thorax (2001); 56: 981.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>981</start></extent></part><relatedItem type="host"><titleInfo><title>Thorax</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>981</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit441"><titleInfo><title>Low‐dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterol</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Milgrom H, Skoner DR, Bensch G, Kim KT, Claus R, Baumgartner RA. Low‐dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterol. J Allergy Clin Immunol (2001); 108: 938.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>108</number></detail><extent unit="pages"><start>938</start></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>108</number></detail><extent unit="pages"><start>938</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit442"><titleInfo><title>15. Neuromuscular agents</title></titleInfo><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit443"><titleInfo><title>A randomized double‐blind, placebo‐controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bakheit AMO, Pittock S, Moore AP, Wurker M, Otto S, Erbguth F, Coxon L. A randomized double‐blind, placebo‐controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Eur J Neurol (2001); 8:559.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>559</start></extent></part><relatedItem type="host"><titleInfo><title>Eur J Neurol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>559</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit444"><titleInfo><title>Rocuronium: High risk for anaphylaxis? (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Booij LHDJ, Houweling PJ. Rocuronium: High risk for anaphylaxis? (Letter). Br J Anaesth (2001); 87: 805.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><extent unit="pages"><start>805</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Anaesth</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><extent unit="pages"><start>805</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit445"><titleInfo><title>Rocuronium has fewer side effects (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">England AJ. Rocuronium has fewer side effects (Letter). Hosp Med (2001); 62: 796.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>796</start></extent></part><relatedItem type="host"><titleInfo><title>Hosp Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>796</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit446"><titleInfo><title>Adverse events following repeated injection with botulinum toxin A in children with spasticity (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mohamed KA, Morre AP, Rosenbloom L. Adverse events following repeated injection with botulinum toxin A in children with spasticity (Letter). Dev Med Child Neurol (2001); 43: 791.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>43</number></detail><extent unit="pages"><start>791</start></extent></part><relatedItem type="host"><titleInfo><title>Dev Med Child Neurol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>43</number></detail><extent unit="pages"><start>791</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit447"><titleInfo><title>Prolongation of rapacuronium neuromuscular blockade by clindamycin and magnesium (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sloan PA, Rasul M. Prolongation of rapacuronium neuromuscular blockade by clindamycin and magnesium (Case Report). Anesth Analg (2002); 94: 123.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>94</number></detail><extent unit="pages"><start>123</start></extent></part><relatedItem type="host"><titleInfo><title>Anesth Analg</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>94</number></detail><extent unit="pages"><start>123</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit448"><titleInfo><title>16. Reproductive system agents</title></titleInfo><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit449"><titleInfo><title>Danazol and limb‐threatening arterial thrombosis: Two case reports</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Alvarado RG, Liu JY, Zwolak RM. Danazol and limb‐threatening arterial thrombosis: Two case reports. J Vasc Surg (2001); 34: 1123.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>1123</start></extent></part><relatedItem type="host"><titleInfo><title>J Vasc Surg</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>1123</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit450"><titleInfo><title>Spontaneous reports of pulmonary embolism in association with raloxifene (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Brinker A, Beitz J. Spontaneous reports of pulmonary embolism in association with raloxifene (Letter). Obstet Gynecol (2001); 98: 1151.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>98</number></detail><extent unit="pages"><start>1151</start></extent></part><relatedItem type="host"><titleInfo><title>Obstet Gynecol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>98</number></detail><extent unit="pages"><start>1151</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit451"><titleInfo><title>The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: Evidence from a multicentre study in Spain</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Burgues S. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: Evidence from a multicentre study in Spain. Hum Reprod (2001); 16: 2525.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>16</number></detail><extent unit="pages"><start>2525</start></extent></part><relatedItem type="host"><titleInfo><title>Hum Reprod</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>16</number></detail><extent unit="pages"><start>2525</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit452"><titleInfo><title>Recombinant versus urinary follicle‐stimulating hormone in the low‐dose regimen of anovulatory patients with polycystic ovary syndrome: A safer and more effective treatment</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Fulghesu AM, Apa R, Belosi C, Ciampelli M, Selvaggi L, Cucinelli F, Caruso A, Mancuso S, Lanzone A. Recombinant versus urinary follicle‐stimulating hormone in the low‐dose regimen of anovulatory patients with polycystic ovary syndrome: A safer and more effective treatment. Hormone Res (2001); 55: 224.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>55</number></detail><extent unit="pages"><start>224</start></extent></part><relatedItem type="host"><titleInfo><title>Hormone Res</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>55</number></detail><extent unit="pages"><start>224</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit453"><titleInfo><title>Controversial issues in climacteric medicine II: Hormone replacement therapy and cancer</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Genazzani AR, Gadducci A, Gambacciani M. Controversial issues in climacteric medicine II: Hormone replacement therapy and cancer. Maturitas (2001); 40: 117.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>117</start></extent></part><relatedItem type="host"><titleInfo><title>Maturitas</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>117</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit454"><titleInfo><title>Prospective, randomized study on the efficacy and safety of the 1M‐and 3M‐depot of leuprorelinacetate in patients with uterine fibroids (German, English Abstract)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kienle E, Hillger H, Hubner R, Jost V. Prospective, randomized study on the efficacy and safety of the 1M‐and 3M‐depot of leuprorelinacetate in patients with uterine fibroids (German, English Abstract). Geburtshilfliche Frauenheilk (2001); 61: .</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>61</number></detail></part><relatedItem type="host"><titleInfo><title>Geburtshilfliche Frauenheilk</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>61</number></detail></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit455"><titleInfo><title>Enlarged focal nodular hyperplasia of the liver under the influence of oral contraceptives</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kubota T, Shimizu K, Sonoyama T, Ikeda E, Kurioka H, Ouchi T, Suyama Y, Hoskawa Y, Yamagishi H. Enlarged focal nodular hyperplasia of the liver under the influence of oral contraceptives. Hepatogastroenterology (2001); 48: 1736.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>48</number></detail><extent unit="pages"><start>1736</start></extent></part><relatedItem type="host"><titleInfo><title>Hepatogastroenterology</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>48</number></detail><extent unit="pages"><start>1736</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit456"><titleInfo><title>Haemolysis and the combined oral contraceptive pill? (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mainwaring CJ, James CM, Butcher J, Clarke S. Haemolysis and the combined oral contraceptive pill? (Letter). Br J Haematol (2001); 115: 710.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>115</number></detail><extent unit="pages"><start>710</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Haematol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>115</number></detail><extent unit="pages"><start>710</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit457"><titleInfo><title>Evolution of antithrombin activity and plasma fibrinogen levels and of hematologic values among women in child‐bearing age on treatment with the new hormonal oral contraceptive (Spanish, English Abstract)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Romero JMC, Rodrigez EML, Rodriguez MTP, Dacal PB, Miranda MP. Evolution of antithrombin activity and plasma fibrinogen levels and of hematologic values among women in child‐bearing age on treatment with the new hormonal oral contraceptive (Spanish, English Abstract). Rev Clin Esp (2001); 201: 701.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>201</number></detail><extent unit="pages"><start>701</start></extent></part><relatedItem type="host"><titleInfo><title>Rev Clin Esp</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>201</number></detail><extent unit="pages"><start>701</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit458"><titleInfo><title>Lamotrigine plasma levels reduced by oral contraceptives</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sabers A, Buchholt JM, Uldall P, Hansen EL. Lamotrigine plasma levels reduced by oral contraceptives. Epilepsy Res (2001); 47: 151.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>151</start></extent></part><relatedItem type="host"><titleInfo><title>Epilepsy Res</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>151</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit459"><titleInfo><title>Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Schildkraut JM, Calingaert B, Marchbanks PA, Moorman PG, Rodriguez GC. Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk. J Nat Cancer Inst (2002); 94: 32.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>94</number></detail><extent unit="pages"><start>32</start></extent></part><relatedItem type="host"><titleInfo><title>J Nat Cancer Inst</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>94</number></detail><extent unit="pages"><start>32</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit460"><titleInfo><title>Evaluating the safety of medicines with particular reference to contraception</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Skegg DCG. Evaluating the safety of medicines with particular reference to contraception. Stat Med (2001); 20: 3557.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>3557</start></extent></part><relatedItem type="host"><titleInfo><title>Stat Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>3557</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit461"><titleInfo><title>Efficacy and side effects of Norplant use in Thai women above the age of 35 years</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Taneepanichskul S, Intharasakda P. Efficacy and side effects of Norplant use in Thai women above the age of 35 years. Contraception (2001); 64: 305.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>64</number></detail><extent unit="pages"><start>305</start></extent></part><relatedItem type="host"><titleInfo><title>Contraception</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>64</number></detail><extent unit="pages"><start>305</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit462"><titleInfo><title>Oral contraceptives and the risk of myocardial infarction</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tanis BC, Van den Bosch MAAJ, Kemmeren JM, Cats VM, Helmerhorst FM, Algra A, Van der Graaf Y, Rosendaal FR. Oral contraceptives and the risk of myocardial infarction. N Engl J Med (2001); 345: 1787.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>345</number></detail><extent unit="pages"><start>1787</start></extent></part><relatedItem type="host"><titleInfo><title>N Engl J Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>345</number></detail><extent unit="pages"><start>1787</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit463"><titleInfo><title>17. Gastrointestinal system agents</title></titleInfo><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit464"><titleInfo><title>Erythrodermia induced by omeprazole (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Borras‐Blasco J, Navarro‐Ruiz A, Navarro‐Blasco F, Tovar‐Beltran J, Gonzalez‐Delgado M. Erythrodermia induced by omeprazole (Case Report). Int J Clin Pharm Ther (2001); 39: 219.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>219</start></extent></part><relatedItem type="host"><titleInfo><title>Int J Clin Pharm Ther</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>219</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit465"><titleInfo><title>Platelet gigantism associated with cholestyramine therapy (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Latger‐Cannard V, Sommelet D, Guerci B, Trechot P, Lecompte T. Platelet gigantism associated with cholestyramine therapy (Letter). Arch Intern Med (2001); 161: 2619.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>2619</start></extent></part><relatedItem type="host"><titleInfo><title>Arch Intern Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>2619</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit466"><titleInfo><title>Acute interstitial nephritis due to omeprazole (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Myers RP, McLaughlin K, Hollomby DJ. Acute interstitial nephritis due to omeprazole (Case Report). Am J Gastroenterol (2001); 96: 3428.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>3428</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Gastroenterol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>3428</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit467"><titleInfo><title>Prescriptions for antiulcer drugs in Australia: Volume, trends, and costs</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Westbrook JI, Duggan AE, McIntosh JH. Prescriptions for antiulcer drugs in Australia: Volume, trends, and costs. Br Med J (2001); 323: 1338.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>323</number></detail><extent unit="pages"><start>1338</start></extent></part><relatedItem type="host"><titleInfo><title>Br Med J</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>323</number></detail><extent unit="pages"><start>1338</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit468"><titleInfo><title>18. Anti‐inflammatory agents ‐ Steroidal</title></titleInfo><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit469"><titleInfo><title>Glucocorticoid‐induced osteoporosis: Summary of a workshop</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Canalis E, Giustina A. Glucocorticoid‐induced osteoporosis: Summary of a workshop. J Clin Endocrinol Metab (2001); 86: 5681.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>86</number></detail><extent unit="pages"><start>5681</start></extent></part><relatedItem type="host"><titleInfo><title>J Clin Endocrinol Metab</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>86</number></detail><extent unit="pages"><start>5681</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit470"><titleInfo><title>Safety of steroid injections in the treatment of nasofrontal recess obstruction</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Dutton JM, Bumsted RM. Safety of steroid injections in the treatment of nasofrontal recess obstruction. Am J Rhinol (2001); 15: 391.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>391</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Rhinol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>391</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit471"><titleInfo><title>Characterizing adverse events as errors: Example in a patient using steroids daily</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hasler S, McNutt R, Abrams R, Dimou C, Brill J, Rosen R, Reiner Y, Korla V, Buzyna L, Levin S. Characterizing adverse events as errors: Example in a patient using steroids daily. Endocrinologist (2001); 11: 451.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>451</start></extent></part><relatedItem type="host"><titleInfo><title>Endocrinologist</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>451</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit472"><titleInfo><title>Evolution of plasma proinflammatory cytokines in malaria‐related ARDS treated with corticosteroids</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hiekkanen T, Skogberg K, Pettila K. Evolution of plasma proinflammatory cytokines in malaria‐related ARDS treated with corticosteroids. Intensive Care Med (2001); 27: 1823.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>1823</start></extent></part><relatedItem type="host"><titleInfo><title>Intensive Care Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>1823</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit473"><titleInfo><title>Does the combined antenatal use of corticosteroids and antibiotics increase late‐onset neonatal sepsis in the very low birth weight infant</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">How HY, Sutler D, Khoury JC, Donovan EF, Siddiqi TA, Spinnato JA. Does the combined antenatal use of corticosteroids and antibiotics increase late‐onset neonatal sepsis in the very low birth weight infant? Am J Obstet Gynecol (2001); 185: 1081.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>185</number></detail><extent unit="pages"><start>1081</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Obstet Gynecol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>185</number></detail><extent unit="pages"><start>1081</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit474"><titleInfo><title>Risk of steroid withdrawal in pediatric renal transplant patients with suspected steroid toxicity</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Klaus G, Jeck N, Konrad M, Forster B, Soergel M. Risk of steroid withdrawal in pediatric renal transplant patients with suspected steroid toxicity. Clin Nephrol (2001); 56: S37.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>S37</start></extent></part><relatedItem type="host"><titleInfo><title>Clin Nephrol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>S37</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit475"><titleInfo><title>Corticosteroid‐related bilateral orbital lipomatosis (French)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Martin L, Gironet N, Machet L. Corticosteroid‐related bilateral orbital lipomatosis (French). Ann Dermatol Venereol (2001); 128: 1051.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>128</number></detail><extent unit="pages"><start>1051</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Dermatol Venereol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>128</number></detail><extent unit="pages"><start>1051</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit476"><titleInfo><title>Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Oinuma K, Harada Y, Nawata Y, Takabayashi K, Abe I, Kamikawa K, Moriya H. Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment. Ann Rheum Dis (2001); 60: 1145.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>60</number></detail><extent unit="pages"><start>1145</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Rheum Dis</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>60</number></detail><extent unit="pages"><start>1145</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit477"><titleInfo><title>Molecular mechanisms of glucocorticoid‐induced osteoporosis</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Patschan D, Loddenkemper K, Buttgereit F. Molecular mechanisms of glucocorticoid‐induced osteoporosis. Bone (2001); 29: 498.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>29</number></detail><extent unit="pages"><start>498</start></extent></part><relatedItem type="host"><titleInfo><title>Bone</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>29</number></detail><extent unit="pages"><start>498</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit478"><titleInfo><title>Low‐dose glucocorticoids are neither safe nor effective for the long‐term treatment of rheumatoid arthritis</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Saag KG. Low‐dose glucocorticoids are neither safe nor effective for the long‐term treatment of rheumatoid arthritis. Arthritis Rheum (2001); 45: 468.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>468</start></extent></part><relatedItem type="host"><titleInfo><title>Arthritis Rheum</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>468</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit479"><titleInfo><title>Low‐dose prednisone therapy for patients with early active rheumatoid arthritis: Clinical efficacy, disease‐modifying properties, and side effects ‐ A randomized, double‐blind, placebo‐controlled clinical trial</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Van Everdingen AA, Jacobs JWG, Van Reesema DRS, Bijlsma JWJ. Low‐dose prednisone therapy for patients with early active rheumatoid arthritis: Clinical efficacy, disease‐modifying properties, and side effects ‐ A randomized, double‐blind, placebo‐controlled clinical trial. Ann Intern Med (2002); 136: 1.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>136</number></detail><extent unit="pages"><start>1</start></extent></part><relatedItem type="host"><titleInfo><title>Ann Intern Med</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>136</number></detail><extent unit="pages"><start>1</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit480"><titleInfo><title>19. Teratogens/fetal exposure</title></titleInfo><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit481"><titleInfo><title>Are weekly courses of antenatal steroids beneficial or dangerous? (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ambrus JL, Ambrus CM. Are weekly courses of antenatal steroids beneficial or dangerous? (Letter). JAMA (2002); 287: 188.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>287</number></detail><extent unit="pages"><start>188</start></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>287</number></detail><extent unit="pages"><start>188</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit482"><titleInfo><title>A call for action: Prevention of fetal exposure to isotretinoin. A position paper by the Organization of Teratology Information Services Public Affairs Committee</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Carver V, Coyle B, Koren G, Lavigne S, Martinez L, Robertson J, Polifka J, Stepanuk K. A call for action: Prevention of fetal exposure to isotretinoin. A position paper by the Organization of Teratology Information Services Public Affairs Committee. Reprod Toxicol (2001);15: 729.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>729</start></extent></part><relatedItem type="host"><titleInfo><title>Reprod Toxicol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>729</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit483"><titleInfo><title>The teratogenic risk of trimethoprim‐sulfonamides: A population based case‐control study</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. The teratogenic risk of trimethoprim‐sulfonamides: A population based case‐control study. Reprod Toxicol (2001); 15: 637.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>637</start></extent></part><relatedItem type="host"><titleInfo><title>Reprod Toxicol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>637</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit484"><titleInfo><title>Neonatal thyroid enlargement associated with propylthiouracil therapy of Graves' disease during pregnancy: A problem revisited</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gallagher MP, Schachner HC, Levine LS, Fisher DA, Berdon WE, Oberfield SE. Neonatal thyroid enlargement associated with propylthiouracil therapy of Graves' disease during pregnancy: A problem revisited. J Pediatr (2001); 139: 896.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>139</number></detail><extent unit="pages"><start>896</start></extent></part><relatedItem type="host"><titleInfo><title>J Pediatr</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>139</number></detail><extent unit="pages"><start>896</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit485"><titleInfo><title>Are weekly courses of antenatal steroids beneficial or dangerous? (Reply)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Guinn DA, Atkinson MW, Sullivan L, Lee MJ, McGregor S, Parilla BV, Davies J, Hanlon‐Lundberg K, Simpson L, Stone J, Wing D, Ogasawara K, Muraskas J. Are weekly courses of antenatal steroids beneficial or dangerous? (Reply). JAMA (2002); 287: 189.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>287</number></detail><extent unit="pages"><start>189</start></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>287</number></detail><extent unit="pages"><start>189</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit486"><titleInfo><title>Are weekly courses of antenatal steroids beneficial or dangerous? (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jenkins TM, Wapner RJ, Thom EA, Das AF, Spong CY. Are weekly courses of antenatal steroids beneficial or dangerous? (Letter). JAMA (2002); 287: 187.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>287</number></detail><extent unit="pages"><start>187</start></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>287</number></detail><extent unit="pages"><start>187</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit487"><titleInfo><title>Is first trimester exposure to the combination of antiretroviral therapy and folate antagonists a risk factor for congenital abnormalities</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jungmann EM, Mercey D, De Ruiter A, Edwards S, Donoghue S, Booth T, Mohan D, Lyall H, Taylor GP. Is first trimester exposure to the combination of antiretroviral therapy and folate antagonists a risk factor for congenital abnormalities? Sex Transm Infect (2001); 77: 441.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>77</number></detail><extent unit="pages"><start>441</start></extent></part><relatedItem type="host"><titleInfo><title>Sex Transm Infect</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>77</number></detail><extent unit="pages"><start>441</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit488"><titleInfo><title>A comparison of fetal behaviour in term fetuses exposed to anticonvulsant medication with unexposed controls</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kean LH, Gargari SS, Suwanrath C, Sahota DS, James DK. A comparison of fetal behaviour in term fetuses exposed to anticonvulsant medication with unexposed controls. Br J Obstet Gynaecol (2001); 108: 1159.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>108</number></detail><extent unit="pages"><start>1159</start></extent></part><relatedItem type="host"><titleInfo><title>Br J Obstet Gynaecol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>108</number></detail><extent unit="pages"><start>1159</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit489"><titleInfo><title>Use of atypical antipsychotics during pregnancy and the risk of neural tube defects in infants</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Koren G, Cohn T, Chitayat D, Kapur H, Remington G, Reid DM, Zipursky RB. Use of atypical antipsychotics during pregnancy and the risk of neural tube defects in infants. Am J Psychiatry (2002); 159: 136.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>159</number></detail><extent unit="pages"><start>136</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Psychiatry</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>159</number></detail><extent unit="pages"><start>136</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit490"><titleInfo><title>Are weekly courses of antenatal steroids beneficial or dangerous? (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Murphy KE, Hannah M, Brocklehurst P. Are weekly courses of antenatal steroids beneficial or dangerous? (Letter). JAMA (2002); 287: 188.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>287</number></detail><extent unit="pages"><start>188</start></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>287</number></detail><extent unit="pages"><start>188</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit491"><titleInfo><title>Assessment of fetal risk associated with exposure to cancer chemotherapy during pregnancy: A multicenter study</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Peres RM, Sanseverino MTV, Guimaraes JLM, Coser V, Giuliani L, Moreira RK, Omsten T, Schuler‐Faccini L. Assessment of fetal risk associated with exposure to cancer chemotherapy during pregnancy: A multicenter study. Braz J Med Biol Res (2001); 34: 1551.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>1551</start></extent></part><relatedItem type="host"><titleInfo><title>Braz J Med Biol Res</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>1551</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit492"><titleInfo><title>Effect of antenatal and postnatal corticosteroid therapy on weight gain and head circumference growth in the nursery</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Thorp JA, Jones PG, Peabody JL, Knox E, Clark RH. Effect of antenatal and postnatal corticosteroid therapy on weight gain and head circumference growth in the nursery. Obstet Gynecol (2002); 99: 109.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>99</number></detail><extent unit="pages"><start>109</start></extent></part><relatedItem type="host"><titleInfo><title>Obstet Gynecol</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>99</number></detail><extent unit="pages"><start>109</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit493"><titleInfo><title>Does antenatal corticosteroid therapy affect birth weight and head circumference</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Thorp JA, Jones PG, Knox E, Clark RH. Does antenatal corticosteroid therapy affect birth weight and head circumference. Obstet Gynecol (2002); 99: 101.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>99</number></detail><extent unit="pages"><start>101</start></extent></part><relatedItem type="host"><titleInfo><title>Obstet Gynecol</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>99</number></detail><extent unit="pages"><start>101</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit494"><titleInfo><title>Is this drug safe in pregnancy (Commentary)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Webster WS, Freeman JAD. Is this drug safe in pregnancy (Commentary). Reprod Toxicol (2001); 15: 619.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>619</start></extent></part><relatedItem type="host"><titleInfo><title>Reprod Toxicol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>619</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit495"><titleInfo><title>Maternal medication use and risks of gastroschisis and small intestinal atresia</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Werler MM, Sheehan JE, Mitchell AA. Maternal medication use and risks of gastroschisis and small intestinal atresia. Am J Epidemiol (2002); 155: 26.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>155</number></detail><extent unit="pages"><start>26</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Epidemiol</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>155</number></detail><extent unit="pages"><start>26</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit496"><titleInfo><title>20. Others</title></titleInfo><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit497"><titleInfo><title>Change from propylthiouracil to carbimazole proves fatal (Case Report)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Burt MG, Conaglen JV. Change from propylthiouracil to carbimazole proves fatal (Case Report). N Z Med J (2001); 114: 553.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>114</number></detail><extent unit="pages"><start>553</start></extent></part><relatedItem type="host"><titleInfo><title>N Z Med J</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>114</number></detail><extent unit="pages"><start>553</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit498"><titleInfo><title>Alendronate: Suspected pancreatitis (News)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cadario B. Alendronate: Suspected pancreatitis (News). Can Med Assoc J (2002); 166: 86.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>166</number></detail><extent unit="pages"><start>86</start></extent></part><relatedItem type="host"><titleInfo><title>Can Med Assoc J</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>166</number></detail><extent unit="pages"><start>86</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit499"><titleInfo><title>Dystonia following administration of intravenous radiographic contrast material</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gabbay DS, Chen SM. Dystonia following administration of intravenous radiographic contrast material. J Emerg Med (2001); 21: 415.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>415</start></extent></part><relatedItem type="host"><titleInfo><title>J Emerg Med</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>415</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit500"><titleInfo><title>Possible association between glucosamine treatment and renal toxicity: Comment on the letter by Danao‐Camara (Letter)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Guillaume MP, Peretz A. Possible association between glucosamine treatment and renal toxicity: Comment on the letter by Danao‐Camara (Letter). Arthritis Rheum (2001); 44: 2943.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>44</number></detail><extent unit="pages"><start>2943</start></extent></part><relatedItem type="host"><titleInfo><title>Arthritis Rheum</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>44</number></detail><extent unit="pages"><start>2943</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit501"><titleInfo><title>Metformin and the risks of anesthesia (Reply) (German)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gundel UF. Metformin and the risks of anesthesia (Reply) (German). Dtsch Med Wochenschr (2001); 126: 1060.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>126</number></detail><extent unit="pages"><start>1060</start></extent></part><relatedItem type="host"><titleInfo><title>Dtsch Med Wochenschr</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>126</number></detail><extent unit="pages"><start>1060</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit502"><titleInfo><title>The expanded clinical spectrum of deferoxamine retinopathy</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Haimovici R, D'Amico DJ, Gragoudas ES, Sokol S. The expanded clinical spectrum of deferoxamine retinopathy. Ophthalmology (2002); 109: 164.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>164</start></extent></part><relatedItem type="host"><titleInfo><title>Ophthalmology</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>164</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit503"><titleInfo><title>Sulfonylureas are not associated with increased mortality in diabetics treated with thrombolysis for acute myocardial infarction</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Halkin A, Roth A, Jonas M, Behar S. Sulfonylureas are not associated with increased mortality in diabetics treated with thrombolysis for acute myocardial infarction. J Thromb Thrombolysis (2001); 12: 177.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>177</start></extent></part><relatedItem type="host"><titleInfo><title>J Thromb Thrombolysis</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>177</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit504"><titleInfo><title>Fatal allopurinol‐induced hypersensitivity syndrome in asymptomatic hyperuricaemia (Case Reports) (German)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hammer B, Link A, Wagner A, Bohm M. Fatal allopurinol‐induced hypersensitivity syndrome in asymptomatic hyperuricaemia (Case Reports) (German). Dtsch Med Wochenschr (2001); 126: 1331.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>126</number></detail><extent unit="pages"><start>1331</start></extent></part><relatedItem type="host"><titleInfo><title>Dtsch Med Wochenschr</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>126</number></detail><extent unit="pages"><start>1331</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit505"><titleInfo><title>Giant esophageal ulcer probably due to etidronate (Letter) (French)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Maroy B. Giant esophageal ulcer probably due to etidronate (Letter) (French). Gastroenterol Clin Biol (2001); 25: 917.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>917</start></extent></part><relatedItem type="host"><titleInfo><title>Gastroenterol Clin Biol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>917</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit506"><titleInfo><title>Allergic reactions at repeat femoral angiography with ioxaglate</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nilsson S, Bergstrand L, Erikson U, Johansson J, Smedby O, Walldius G. Allergic reactions at repeat femoral angiography with ioxaglate. Acta Radiol (2001); 42: 608.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>608</start></extent></part><relatedItem type="host"><titleInfo><title>Acta Radiol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>608</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit507"><titleInfo><title>Eyelid hypertrichosis associated with latanoprost is reversible</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">O'Toole L, Cahill M, O'Brien C. Eyelid hypertrichosis associated with latanoprost is reversible. Eur J Ophthalmol (2001); 11: 377.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>377</start></extent></part><relatedItem type="host"><titleInfo><title>Eur J Ophthalmol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>377</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit508"><titleInfo><title>Treatment of osteoporosis among older adults discharged from hospital in Italy</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Onder G, Pedone C, Gambassi G, Landi F, Cesari M, Bernabei R. Treatment of osteoporosis among older adults discharged from hospital in Italy. Eur J Clin Pharmacol (2001); 57: 599.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>599</start></extent></part><relatedItem type="host"><titleInfo><title>Eur J Clin Pharmacol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>57</number></detail><extent unit="pages"><start>599</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit509"><titleInfo><title>Blue urticaria: A previously unreported adverse event associated with isosulfan blue</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sadiq TS, Burns WW, Taber DJ, Damitz L, Ollila DW. Blue urticaria: A previously unreported adverse event associated with isosulfan blue. Arch Surg (2001); 136: 1433.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>136</number></detail><extent unit="pages"><start>1433</start></extent></part><relatedItem type="host"><titleInfo><title>Arch Surg</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>136</number></detail><extent unit="pages"><start>1433</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit510"><titleInfo><title>Is Exolise® hepatotoxic (Letter) (French)</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Seddick M, Lucidarme D, Creusy C, Filoche B. Is Exolise® hepatotoxic (Letter) (French)? Gastroenterol Clin Biol (2001); 25: 834.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>834</start></extent></part><relatedItem type="host"><titleInfo><title>Gastroenterol Clin Biol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>834</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit511"><titleInfo><title>Contrast‐medium‐induced nephrotoxicity: Are all answers in for acetylcysteine?</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Thomsen HS. Contrast‐medium‐induced nephrotoxicity: Are all answers in for acetylcysteine?. Eur Radiol (2001); 11: 2351.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>2351</start></extent></part><relatedItem type="host"><titleInfo><title>Eur Radiol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>2351</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit512"><titleInfo><title>Using highly concentrated gadobutrol as an MR contrast agent in patients also requiring hemodialysis: Safety and dialysability</title></titleInfo><name type="personal"><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tombach B, Bremer C, Reimer P, Matzkies F, Schaefer RM, Ebert W, Geens V, Eisele J, Heindel W. Using highly concentrated gadobutrol as an MR contrast agent in patients also requiring hemodialysis: Safety and dialysability. Am J Roentgenol (2002); 178:105.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>178</number></detail><extent unit="pages"><start>105</start></extent></part><relatedItem type="host"><titleInfo><title>Am J Roentgenol</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>178</number></detail><extent unit="pages"><start>105</start></extent></part></relatedItem></relatedItem><identifier type="istex">FE49A01C08E6D3C543D17E6F9A4EA88920C928E8</identifier><identifier type="ark">ark:/67375/WNG-87JH6LG4-8</identifier><identifier type="DOI">10.1002/pds.660</identifier><identifier type="ArticleID">PDS660</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2002 John Wiley & Sons, Ltd.</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource><recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2019-11-16</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-87JH6LG4-8/record.json</uri></json:item></metadata><author></author><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F24 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000F24 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:FE49A01C08E6D3C543D17E6F9A4EA88920C928E8
|texte= Current Awareness
}}
| This area was generated with Dilib version V0.6.33. |  |